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Abstract 
 
Cell competition is a type of cell-cell interaction first described in Drosophila by Morato and 
Ripoll (1976), whereupon the co-existence of two cell populations with different metabolic 
properties or growth rates results in the growth of the stronger population at the expensive of 
the weaker one. BMP2 and 4 are the Drosophila homologues of Decapentaplegic which has 
been shown to have roles in cell competition.  Based on data from studies on Drosophila 
models of cell competition, the lab generated mESCs null for Bmpr1a and investigated their 
behaviour when co-cultured with wild-type mESCs as a mammalian model of cell 
competition.   
 
This report further investigates changes in proliferation and apoptosis among competing cells 
and begins to investigate the signalling pathways which drive loser cells to initiate apoptosis.  
We report that apoptosis is caspase-dependent and possibly mediated by ERK and Wnt 
signalling as modulating these pathways changes the dynamics of competing cells.  The 
report utilises a transwell growth system to demonstrate that cell competition is mediated by 
unknown signalling factors, an observation which has also been described in models of 
competing cells in Drosophila.  The report shows that differentiation of mESCs is an 
important inducing factor for cell competition as naïve mESCs do not compete.  Lastly this 
study shows that cell competition is a general mechanism of maintaining stem cell quality as 
other mutations which incur a growth or metabolic disadvantage as mESCs with defects in 
autophagy or are tetraploid are also eliminated by cell competition when co-cultured with 
wild-type cells.  
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Chapter 1 - Introduction 
 
1.1 Early Mammalian Development 
1.1.1 The Preimplantation Embryo 
 
Murine development starts in the female oviduct, where the haploid sperm and oocyte fuse to 
form a fertilised egg.  This totipotent cell gives rise to the whole embryo through a series of 
cell divisions and gradual restrictions in cell fate.    
 
1.1.2 First Cell Fate Decision – Inner Cell Mass or Trophectoderm? 
 
By E2.5 the fertilized oocyte has undergone multiple cell divisions and is comprised of eight 
blastomeres.  At this stage the embryo undergoes compaction, which increases cell-cell 
contact and adhesion between blastomeres and generates apical-basal polarity in each cell 
(Pratt et al., 1982).  After compaction the cells undergo two more rounds of asymmetric cell 
division and generate cells positioned on the inside of the blastocyst and cells positioned on 
the outside.   
 
Although it is not known how this is initiated,  all cells of the compacted morula can express 
caudal-type homeobox protein 2 (Cdx2) and Pou5f1 transcription factor Oct3/4; however 
expression of these genes starts to become segregated by E3.0 (Jedrusik et al., 2008; Niwa et 
al., 2005).  Specification of inside (Inner Cell Mass - ICM) and outside (Trophectoderm -TE) 
cell fate is mediated by the Hippo signalling pathway, which integrates cell polarity and cell 
adhesion cues into cell fate The inside-outside polarity and differences in cell adhesion result 
in changes in localisation of members of the Hippo signalling pathway.  
 
In outside cells, which have established apical-basal polarity Hippo signalling is repressed by 
localisation of Angiomotin (Amot) to the apical membrane, bound to actin and inactive.  This 
allows for the nuclear translocation of the transcriptional co-activator Yes-associated protein 
(Yap1).  Yap1 binds to its partner TEA domain family transcription factor 4 (Tead4) and 
activates expression of TE -specific genes such as Cdx2 (Nishioka et al., 2009; Yagi et al., 
2007).  Inside cells of the compacted morula are apolar and form adherens junctions with 
 15 
 
Figure 1.1 Early murine development (Niwa, 2007) 
Schematic showing the different stages of murine early development.  As development progresses, the 
embryo undergoes morphological changes and cells within the embryo differentiate.  The different cell 
types and major signalling proteins expressed in each cell type are shown.   
other neighbouring cells.  Members of the Hippo signalling pathway, such as Nf2 and Lats1/2 
kinase are localised there in a functional complex with Amot. Amot binds to Nf2 via its N-
terminus, and Lats1/2 kinase phosphorylates Amot at S167 and stabilises the complex.  Yap is 
phosphorylated and remains cytoplasmic, and does not translocate to the nucleus as in outside 
cells, and these cells become ICM (Cockburn et al., 2013; Hirate et al., 2013; Manzanares 
and Rodriguez, 2013)  
 
Expression of the Oct3/4 is mutually exclusive of Cdx2 and its expression becomes gradually 
restricted to inside cells fated to become inner cell mass (ICM). By E3.5 the early blastocyst 
is comprised of two distinct cell types, the ICM, which expresses Oct3/4 and the overlying 
TE, which expresses Cdx2 (Jedrusik et al., 2008; Niwa et al., 2005; Strumpf et al., 2005).  
Oct4 is essential for maintaining pluripotency within the ICM (Nichols et al., 1998); whereas 
Tead4 and Cdx2 are required for maintenance and expansion of the TE (Strumpf et al., 2005).  
The cavity of the blastocyst forms, primarily as secretion of intracellular vacuoles which 
when externalized coalesce forming the blastocoel.  Due to the constraints of the surrounding 
zona pellucida, this creates a compressed elongated shape with the ICM at one end, 
generating the embryonic-abembryonic axis (Rossant and Tam, 2009).  Morphological 
changes in the embryo and key associated lineage-specific genes are illustrated in Figure 1.1. 
(Niwa, 2007). 
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1.1.3 Second cell fate – PrE or Epiblast? 
 
At E3.5 the ICM is not a homogenous population, throughout cells express either Nanog or 
GATA6 in a random “salt and pepper” pattern, suggesting that their fate is already 
determined as either primitive endoderm (PrE) or epiblast (also known as embryonic 
ectoderm) (Chazaud et al., 2006).  GATA6-expressing cells are sorted, in a Disabled-2 
(Dab2) dependent manner, to the distal surface of the ICM and fated to become PrE(Yang et 
al., 2002); whist Nanog and Oct4 expressing cells remain within the ICM and become 
epiblast.  There is recent evidence that Oct4 expressing cells retain less plasticity than 
GATA6-positive PrE fated cells, and are thus less able to respond to signals inducing and 
maintaining PrE fate, hence their ability to remain undifferentiated and within the ICM 
(Grabarek et al., 2012; Kang et al., 2013).   This view has been challenged by Frum and co-
workers who show that Fibroblast Growth Factor (FGF) 4 signalling from neighbouring ICM 
fated cells induce Oct4 mediated signalling in neighbouring cells to induce PrE specific gene 
expression (Frum et al., 2013; Livigni and Brickman, 2013). By E4.5 the ICM is segregated 
into these two different populations with PrE cells overlying the pluripotent epiblast.   
 
1.1.4 Implantation and Formation of the Egg-cylinder 
 
At E4.5 the blastocyst hatches from the zona pellucida and implants into the uterine wall.  For 
implantation to be successful, both the peri-implantation embryo and uterine wall need to be 
‘competent’ to allow attachment and invasion of the embryo into the uterine wall.  Locally 
produced signals from the embryo alongside ovarian hormones specify uterine receptivity 
(Wang and Dey, 2006).  Blastocyst activation (competence) is also determined by multiple 
factors including changes in cell cycle; signalling and energy metabolic pathways.  Xie and 
co-workers (2008) have implicated the Wnt signalling pathway in blastocyst implantation, as 
mutants lacking maternal and zygotic β-catenin fail to implant and remain dormant (Xie et 
al., 2008). 
 
Concurrent with implantation the embryo undergoes morphological changes, transforming 
from a blastocyst to form the ‘egg-cylinder’ stage embryo, as illustrated in Figure 1.1 D 
(Niwa, 2007).  The TE proliferates to form the ectoplacental cone at the proximal tip of the 
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egg cylinder with the extraembryonic ectoderm (ExE) underlying it, two structures which 
eventually form the embryo supporting tissues such as the placenta.  The PrE differentiates 
into two further structures; the parietal endoderm (PE) and the visceral endoderm (VE).  The 
PE migrates from the surface of the ICM and contacts the maternal tissue directly.  In 
contrast the VE overlies the epiblast and the ExE (Arnold and Robertson, 2009). 
 
Proliferation of the ExE forces the epiblast to move towards the distal part of the embryo.   At 
this point the epiblast is a solid mass of cells surrounded by the PE.  During a process known 
as cavitation this ball of cells forms a pseudostratified columnar epithelium surrounding a 
central pro-amniotic cavity.  Bone Morphogenetic Protein (BMP) signals from within the 
epiblast are required for VE differentiation but also act as pro-apoptotic signals for inner cells 
of the epiblast.  The remaining epiblast cells survive due to pro-survival signals mediated by 
their adherence to the basal membrane between them and the overlying VE. The epiblast 
becomes a polarized layer of cells surrounding a cavity, with apical surfaces facing towards 
the cavity and a basal surface adhered to the underlying basal membrane (Coucouvanis and 
Martin, 1995, 1999; Rossant and Tam, 2009).  
  
1.1.5 Formation of the Anterior-Posterior (A-P) axis 
 
Interplay between the signalling pathways of the transforming growth factor-β (TGFβ); Wnt 
and FGF families set up the embryonic axis and pattern the embryo.  These pathways 
generate regionalised areas of gene expression that are required for subsequent development 
of cell lineages and tissue differentiation (Tam and Loebel, 2007; Tam et al., 2006).   
 
Around E5.0 Nodal preproteins are produced in the ExE tissues and cleaved by convertases 
Fucin and Pace4 (Spc1/Spc4) to pattern the adjacent epiblast (Beck et al., 2002; Brennan et 
al., 2001).  Nodal signals within the epiblast set up a feedback loop to maintain BMP signals 
in the ExE.  BMP signalling from the ExE back to the epiblast induces Wnt signals and 
maintains Nodal signalling (Brennan et al., 2001; Lu et al., 2001; Quail et al., 2013; Shen, 
2007; Vincent et al., 2003).   In the overlying VE Smad2 is phosphorylated by Nodal signals 
but these are restricted to the most distal part of the VE by inhibitory Smad1 signals caused 
by BMP signalling in the overlying ExE (Rodriguez et al., 2005; Yamamoto et al., 2009).  
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This results in the formation of the DVE a signalling centre where pSmad2; Foxa2; Lhx1 and 
Eomes act in concert to induce expression of Nodal signalling inhibitors Lefty1/2 and  
Cerberus-like (Cerl) and Wnt inhibitor Dikkopf  (Belo et al., 2000; Kimura-Yoshida et al., 
2005; Meno et al., 2001; Nowotschin et al., 2013; Yamamoto et al., 2004).  These inhibitory 
signals from the newly formed DVE restrict Nodal and Wnt expression to the then, proximal 
epiblast resulting in the formation of the proximal-distal axis. 
 
By E5.5 the DVE is visible as a thickened part of the VE with columnar morphology of cells 
with heterogeneous expression markers including Hex; Hesx1; homeobox protein Lhx1 
(Lim1) and Cerberus-like 1 (Cerl) (Belo et al., 1997; Shawlot et al., 1999; Srinivas, 2006; 
Srinivas et al., 2004; Thomas and Beddington, 1996; Thomas et al., 1998).  Around this time 
the DVE lose their columnar morphology, become cuboidal and actively migrate to the 
anterior side of the embryo forming the AVE (Srinivas et al., 2004).  Migration of the DVE to 
the anterior side of the embryo to form the AVE is facilitated by a variety of mechanisms, 
including Nodal-driven differential proliferation of the epiblast; (Stuckey et al., 2011b; 
Yamamoto et al., 2004) and formation of multi-cellular rosettes within the VE to help the 
DVE migrate as a coherent orderly group of cells (Takaoka and Hamada, 2012).  In addition 
to changes in proliferation and cell movement, Wnt and Nodal signals and their antagonists 
Lefty; Cerl and Dkk1, act as repulsive and attractant cues respectively to guide DVE 
migration (Kimura-Yoshida et al., 2005; Srinivas, 2006; Stern and Downs, 2012; Yamamoto 
et al., 2004). 
 
By E6.0 DVE cells have migrated to extra-embryonic/embryonic border, which inhibits 
further movement and redirects movement of the DVE laterally where they lose expression of 
DVE markers (Trichas et al., 2011; Trichas et al., 2012).  However, AVE is still being formed 
at the distal part of the VE and previously formed AVE starts to migrate towards the proximal 
side of the embryo until the AVE fully occupies the anterior side of the embryo by E6.5 
(Srinivas et al., 2004; Takaoka and Hamada, 2012; Takaoka et al., 2011; Tam and Loebel, 
2007; Trichas et al., 2011; Trichas et al., 2012).  Like the DVE, AVE signals maintain the 
anterior character of the adjacent epiblast and consequently generate an A-P molecular 
asymmetry of Nodal and Wnt signalling throughout the epiblast prior to gastrulation 
(Srinivas, 2006).   
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1.1.6 Gastrulation and Formation of the Germ Layers 
 
The onset of gastrulation is marked by a movement of epiblast cells converging on the 
proximal posterior pole of the embryo to form the primitive streak (PS) at around E6.0 
(Beddington and Robertson, 1999; Tam and Behringer, 1997; Tam et al., 2006).  High levels 
of Nodal; Wnt and BMP signalling at the proximal posterior epiblast are required for PS 
induction, and these levels are maintained by auto-regulatory and reciprocal signals between 
the epiblast and ExE (Tam and Loebel, 2007).  At the primitive streak, cells undergo an 
epithelial-to-mesenchymal transition (EMT) and ingress into the posterior epiblast at the 
junction with the ExE.  Over time more epiblast cells become incorporated into the primitive 
streak as it migrates and lengthens up to the distal tip of the embryo.  Once incorporated 
primitive streak cells subsequently emerge as mesoderm or incorporate the definitive 
endoderm (Tam and Behringer, 1997). 
 
Different regions of the primitive streak differ in gene expression; microenvironment and 
thus developmental potential, allocating gastrulating cells to specific lineages (Lawson et al., 
1991; Tzouanacou et al., 2009).   Epiblast cells which are the first to ingress into the PS give 
rise to extraembryonic mesoderm.  As the PS elongates and migrates towards the distal tip of 
the embryo, cells ingress through more anterior parts of the PS and thus give rise to 
progressively more anterior cell fates. Mesoderm fates arise from epiblast cells which ingress 
through the more posterior parts of the PS, whilst definitive endoderm develops from epiblast 
cells that transit the most anterior region of the PS.  At the most anterior part of the PS a 
specialised signalling structure, the node is distinguished and acts as an important signalling 
centre for A-P and left-right (L-R) patterning.  Lastly, ectoderm arises from anterior epiblast 
which is thought not to enter the PS (Tam and Loebel, 2007).  A small subset of cells is set 
aside during development as primordial germ cells (PGCs). 
 
1.2 Pluripotent Stem Cell Lines 
1.2.1 Embryonic Stem Cells 
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During development two populations of cells can be isolated from different developmental 
time points in the embryo and grown indefinitely in culture.  The first of these are murine 
embryonic stem cells (mESCs) which can be derived from the ICM of mouse blastocysts.  
These were derived for the first time in 1981 and characterised by two essential properties – 
their ability to self-renew under appropriate conditions; and their ability to differentiate into 
derivatives of the three germ layers (Evans and Kaufman, 1981; Martin, 1981).  Isolation of 
an equivalent population from human embryos only took place 17 years later (Thomson et al., 
1998). 
 
Under appropriate conditions, mESCs can be maintained indefinitely in culture without 
losing pluripotency and can be directed to fates from all three germ layers via appropriate 
stimuli allowing development to be studied at the cellular and molecular level (Nishikawa et 
al., 2007; Yu and Thomson, 2008). Once differentiation protocols have been developed to a 
degree of sufficient purity, ideally mESCs could be used for regenerative medicine. In 
addition to directed differentiation in vitro, mESCs can be reincorporated into the ICM of 
developing mouse blastocysts to generate chimaeras with contribution to all embryonic 
tissues, including germ cells and therefore progeny (Bradley et al., 1984).  This allows in vivo 
studies of transgenic mice with targeted inherited mutations and markers (Raymond and 
Soriano, 2006).   
  
1.2.2 Extrinsic Regulators of mESC Self-Renewal 
 
Cell fate during development is determined by repression or activation of transcription factors 
in response to extrinsic cues produced by surrounding cells and microenvironment.  In culture 
conditions, extrinsic cues are added to the culture media and produced by surrounding cells 
as well as the coating of the cell culture plates.  As a consequence the culture conditions for 
maintaining mESCs have been progressively defined since their derivation allowing better 
understanding of how pluripotency and self-renewal are controlled.   The first mESCs were 
cultured on layers of “feeder cells” – mitotically inactive fibroblasts and serum.  Feeder cell 
layers serve the dual purpose of providing an adhesion surface as well as producing a signal 
that inhibits mESC differentiation (Smith and Hooper, 1987).  Subsequent analysis identified 
Leukaemia Inhibitory Factor (LIF) – a member of the IL6 family of cytokines, as required for 
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self-renewal.  LIF binds the transmembrane receptor gp130 (Heinrich et al., 2003).  The 
LIF/gp130 complex activates downstream tyrosine phosphorylation, and eventual nuclear 
translocation of the Janus Kinase signal transducer and activator of transcription3, 
(Jak/STAT) (Matsuda et al., 1999; Niwa et al., 1998).  LIF/STAT3 signalling activates 
downstream pluripotency targets, including a known pluripotency inductive factor cMyc 
(Cartwright et al., 2005).   
 
In serum-free medium LIF/STAT3 alone is not sufficient to prevent mESC differentiation.  In 
LIF alone mESCs differentiate to a neural fate (Ying et al., 2003).  In addition to LIF without 
serum, BMPs are required to maintain mESC self-renewal.  BMPs induce the expression of 
inhibitor of differentiation (Id) proteins via the SMAD signalling pathway and suppress 
neural differentiation.  Upon LIF withdrawal, Id-expressing mESCs differentiate to non-
neural fates suggesting that Id genes block lineage-specific transcription factors and therefore 
mESC self-renewal in response to LIF/STAT (Ying et al., 2003).  Qi and co-workers have 
made an alternative argument that exogenous BMP signals act to inhibit p38 and ERK 
signalling to maintain mESC self-renewal independent of SMAD signalling and can be 
replaced with MAPK inhibitors (Qi et al., 2004). 
 
1.2.3 Intrinsic Regulation of mESC Self-Renewal 
 
In response to extrinsic cues, cell fate during development is determined by transcription 
factors which activate or repress specific gene expression programmes.  In addition, changes 
in their organisation orchestrate germ layer fate selection (Thomson et al., 2011). Three main 
transcription factors; Oct4; the homeodomain DNA-binding protein Nanog and SOX-family 
transcription factor Sox2 are expressed highly in the ICM and epiblast of the mouse embryo 
and in undifferentiated mESCs (Avilion et al., 2003; Chambers et al., 2003; Loh et al., 2006; 
Nichols et al., 1998; Niwa, 2007).   
 
Oct4 expression in the mouse is restricted to blastomeres, pluripotent early embryo cells, the 
ICM and epiblast and the germ cell lineage.  In vitro cultured pluripotent cell lines – 
embryonic carcinoma; ES and embryonic germ cells express Oct4 (Chambers and Smith, 
2004).  Within the embryo levels of Oct4 are tightly regulated as specific levels of expression 
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are required to maintain pluripotency.  Repression or deletion of Oct4 within the ICM or its 
in vitro counterpart leads to a lack of ICM specification and consequently differentiation to 
trophectoderm tissue whereas a less than two-fold increase causes differentiation to PrE and 
mesoderm (Nichols et al., 1998; Niwa, 2007).  Oct4 was shown to act specifically to induce 
PrE fate triggered by FGF4 produced by neighbouring epiblast cells (Frum et al., 2013).  
 
Nanog was identified as part of a screen for critical factors that can maintain mESC 
pluripotency independently of LIF/STAT3 signalling.  Nanog expression in pluripotent cell 
lines and the early mouse ICM and epiblast is similar to Oct4 (Chambers et al., 2003; Mitsui 
et al., 2003).  Nanog null mutants can form ICM but fail to develop epiblast.  Nanog-/- mESCs 
can be derived but do not give rise to germ cells and tend to differentiation into extra 
embryonic endoderm (Chambers et al., 2003; Mitsui et al., 2003).  Conversely 
overexpression of Nanog was capable of maintaining mESC self-renewal independently of 
LIF/STAT3 (Chambers et al., 2003; Mitsui et al., 2003; Pan and Thomson, 2007).  
 
Unlike Oct4 and Nanog, Sox2 expression is not restricted to pluripotent lineages.  Sox2 is 
first expressed in the morula and blastocyst before being restricted to the ICM and epiblast 
(Avilion et al., 2003).  At post-implantation stages expression of Sox2 becomes restricted to 
presumptive anterior neurectoderm and is used throughout development; in the adult and 
during differentiation protocols as a marker for multipotent neural stem cells (Ellis et al., 
2004).    As with Oct4, Sox2 null embryos have abnormal ICM and fail to specify epiblast 
(Avilion et al., 2003).  In the absence of Sox2 mESCs differentiate into trophectoderm cells 
(Masui et al., 2007).     
 
Several genes associated with pluripotency, including Oct4; Sox2 and Nanog, contain 
enhancer binding sites for Oct4 and Sox2, and it was previously though that as the two were 
transcription factor partners, both bind to these enhancers and regulate their expression 
(Chew et al., 2005; Kuroda et al., 2005; Nishimoto et al., 1999; Tomioka et al., 2002; Yuan et 
al., 1995).  However analysis of Sox2 null mESCs shows that regulation of Oct4-Sox2 
enhancers can occur in the absence of Sox2.  Masui and co-workers conclude that the 
essential role of Sox2 is to stabilize mESCs in a pluripotent state by maintaining a specific 
level of Oct3/4 expression (Masui et al., 2007).   
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1.2.4 The Ground State of Embryonic Stem Cells 
 
In order for ES cell therapy to be used in clinical treatments, they must be able to be 
maintained in conditions free of animal products.  Conventional mESC culture requires 
Foetal Calf Serum (FCS) which contains secreted BMPs and exogenous LIF to be added to 
cultures to maintain mESCs in an undifferentiated state. Culture requirements such as FCS 
needed to be replaced with synthetic counterparts.  Furthermore analysis of culture conditions 
used to maintain mESCs in culture have given valuable insight into the cues that induce 
differentiation.  These studies raised the prospect that mESCs could intrinsically maintain an 
undifferentiated state if protected from external differentiation-inducing cues - a “ground 
state” of embryonic self-renewal (Ying et al., 2008).  Oct4 induces paracrine FGF4 secretion 
by undifferentiated mESCs and activates ERK signalling.  FGF induced ERK signalling in 
combination with other signalling factors primes mESCs to exit self-renewal and become 
responsive to lineage induction cues (Kunath et al., 2007; Stravidis et al., 2007). Inhibition of 
ERK signalling maintains mESC self-renewal and pluripotency (Burdon et al., 1999).  Ying 
and co-workers suppressed ERK signalling at the FGF receptor and ERK kinase levels (using 
SU5402 and PD184352 (PS media) respectively) and showed that this could maintain 
undifferentiated mESCs in the absence of FCS with occasional neuronal differentiation.  
Further refinement of serum free culture conditions replaced PS media with the more potent 
MEK1/2 inhibitor PD0325901 and added a GSK3 inhibitor to suppress the remaining neural 
differentiation and promote mESC viability. The resultant media combination was termed 2i 
and was sufficient to maintain and propagate mESCs at low clonal density (Ying et al., 2008).    
 
1.2.5 Epiblast Stem Cells  
 
A second population of pluripotent stem cells can be derived from the epiblast of the late 
blastocyst of E5.5 to 6.5 post-implantation mouse embryos.  EpiSCs express transcription 
factors known to regulate pluripotency (namely Oct4; Sox2 and Nanog), maintain their 
genomic integrity and differentiate into derivatives of the three germ layers as well as 
primordial germ cells (Brons et al., 2007; Tesar et al., 2007).    However, ES and EpiSCs 
depend upon different signal transduction pathways to maintain their pluripotent state.  Using 
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culture conditions designed for maintenance of human ESCs, EpiSCs can be maintained in 
chemically defined medium containing Activin A and FGF2 (Brons et al., 2007; Tesar et al., 
2007).  On a molecular level EpiSCs express different marker genes to mESCs, rather than 
Rex1 or Gbx2, EpiSCs express markers found in the in vivo epiblast – including FGF5 and 
Nodal (Brons et al., 2007).  Lastly, analysis of their capacity for integration into pre-
implantation-stage mouse embryos (both the morula and blastocyst stage) suggests that 
EpiSCs may either be unable to develop into the early cell lineages, such as the ICM or that 
the pre-implantation embryo is not a compatible environment for EpiSCs (Brons et al., 2007; 
Tesar et al., 2007).  However, EpiSCs readily form chimaeras when introduced into 
postimplantation epiblast, if introduced prior to E8.5, a stage where epiblast pluripotency is 
lost (Huang et al., 2012).  Differentiation of EpiSCs is also different to mESCs.  Inhibition of 
Activin/Nodal signalling results in cells adopting neurectoderm lineage (Tesar et al., 2007).  
Addition of BMPs, extrinsic signals in mESC maintenance, results in specification of EpiSCs 
into primordial germ cells (Bao et al., 2009; Chenoweth and Tesar, 2010).   
 
1.3 TGFβ Signalling 
 
The TGFβ super-family signalling pathway is divided into two subfamilies.  The first is 
comprised of BMP (Bone Morphogenetic Protein)/GDF (Growth and Differentiation 
Factor)/MIS (Muellerian Inhibiting Substance) subfamily and the second is the TGF-
β/Activin/Nodal subfamily.  Subfamilies are defined by sequence similarity and activation of 
specific downstream signalling pathways.  The TGF-beta signalling superfamily is illustrated 
in Figure 1.2 below (Shi and Massague et al., 2003). 
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TGF-β signalling ligands form a dimer which bind to a receptor complex composed of two 
Type I and two Type II receptors to activate downstream signalling (Heldin et al., 1997; 
reviewed by Shi and Massague, 2003).   Due to the range of members of the TGF-β 
superfamily, various nomenclature have been used for the different ligands and receptors 
involved. Alternative nomenclature used for TGF-β Type I receptors are summarized in the 
table below: 
 
 
Acvr1 ALK1 
Actr1 ALK2 
Figure 1.2 The TGF-β Superfamily of Signalling (Shi and Massague., 2003). 
Figure showing the TGF-beta superfamily of signalling.  Ligands (red) bind to receptor 
heterodimers comprised of Type I/Type II receptors.  Once bound, receptors phosphorylate 
specific downstream SMADs, which form a complex with Co-SMAD-4 and translocate to the 
nucleus to affect target gene transcription.  Figure taken directly from Shi and Massague, 2003. 
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Table 1.  Alternative nomenclature used in TGFβ Signalling. 
Table summarising alternative nomenclature used in TGFβ signalling (Shi and Massague, 2003; 
Tsuchida et al., 2004). 
 
 
BMP ligands have high affinity for Type I receptors; upon binding these facilitate binding to 
type II receptors.  In contrast, members of the TGF-b/Activin/Nodal subfamily ligands have 
higher binding affinity to Type II receptors.  Ligand binding to the Type II receptor allows 
recruitment and subsequent binding of the Type I receptor (Massague et al., 1998).  The 
specific Type I/Type II receptors bound by each ligand are illustrated in Figure 1.3.1.  
Interaction between Type I and Type II receptors upon ligand binding results in the 
phosphorylation of the GS-box region of the Type I receptor by the constitutively active Type 
II receptor. Once activated these phosphorylate intracellular signalling proteins called 
SMADs.   TGF-β; Activin/Nodal and Inhibin signal downstream receptor phosphorylation of 
(R-) SMADs 2/3, whilst BMP/MIS/GDF related ligands signals are mediated via R-SMADs 
1/5/8.  All SMADs form complexes with Co-SMAD 4 prior to nuclear translocation to affect 
transcription.  Inhibitor SMADs 6 and 7 act as negative regulators of these signalling 
pathways, either through directly binding to activated Type I receptors and preventing their 
phosphorylation (reviewed by ten Djike  et al., 2000; Yan et al., 2009) or through competitive 
binding for receptor Smads with Co-Smad 4 (Hata et al., 1998). 
 
1.3.1 BMP Signalling 
 
BMPs were originally identified in bone and comprise a large subgroup within the 
transforming growth factor-β (TGFβ) family.  There have been around 20 BMP ligands 
identified (Bragdon et al., 2011); which can be further subdivided into functional subgroups 
based on sequence similarity and downstream activity.  One subgroup is comprised of BMP2; 
Bmpr1a ALK3 
Actr1b ALK4 
TβR1 ALK5 
Bmpr1b ALK6 
Acvr1c ALK7 
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BMP4 and the Drosophila Decapentaplegic (Dpp) gene which have known roles in 
development and bind mainly to the type 1 BMP receptor (BMPR) 1a and 1b. Other 
subgroups include the OP-1 group, which is comprised of BMP5/6/7/8a and the Drosophila 
gbb-60A; and then the growth differentiation factor-5 (GDF) group made up of GDF5/6 and 
7.   Due to the variety of BMPRs and their binding affinities; posttranslational modifications 
and expression patterns, BMPs have diverse biological functions throughout development; 
adult tissue homeostasis and disease (Miyazono et al., 2010; Shi and Massague, 2003). 
 
BMP receptors (BMPRs) are located at the cell surface and are serine/threonine kinase 
receptors.  They are composed of a short extracellular domain, a transmembrane domain and 
the intracellular serine/threonine kinase domain.  These fall into two subgroups, type I and 
type II.  Five BMP type I receptors have been identified: Acvr1; Actr1; Bmpr1a; Actr1b and 
Bmpr1b (alternative nomenclature is summarised in Table 1). In addition to these there are 
three type II BMP receptors: Bmpr2; ActrIIa and ActrIIb.  Further complexity arises with 
BMP ligand binding to these receptors, as different receptors bind with different affinities to 
different ligands and other Type I/Type II receptors (Bragdon et al., 2011; Heldin et al., 
1997). 
 
BMP ligand binding to BMPRs activates the specifically via phosphorylation of R-SMADs 
1/5/8 which bind to the co-receptor (Co-) SMAD4 and translocate to the nucleus to activate 
downstream transcription factors.    In addition to signalling through SMADs, BMP 
signalling interacts with many other signalling pathways such as Nodal; Wnt; Hedgehog and 
the MAPK cascades (Guo and Wang, 2009). 
 
1.3.1.1BMP signalling in early mouse development and mESCs 
 
In mESCs, BMP signals act in conjunction with LIF to maintain self-renewal and 
pluripotency by upregulating expression of Id genes (Ying et al., 2003). BMP4 has also been 
shown to specifically maintain mESC self-renewal by inhibiting MAPK signalling (Qi et al., 
2004). 
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BMPs play a variety of roles throughout mouse development.  BMP4 is essential for 
gastrulation and embryos lacking both alleles die between E6.5 and 9.5 many arresting at the 
egg cylinder stage (Winnier et al., 1995). Homozygous mutations in the closely related BMP2 
ligand are also embryonic lethal, although embryos develop further and are able to undergo 
gastrulation, mutants die due to defects in heart formation and proaminotic canal closure 
(Zhang and Bradley, 1996).  Closer analysis of Bmp2-/- embryos reveal heart and foregut 
tissues are specified properly but display perturbed morphogenesis that can be rescued by 
restoring BMP2 signalling in the epiblast (Madabhushi and Lacy, 2011).   
 
 Due to the redundancy of BMP ligands, mutants for the BMPRs display more severe 
phenotypes.  BMPR2 is the type II receptor that specifically binds BMP ligands. During early 
development BMPR2 is expressed in the one, two-cell and blastocyst stage embryos and 
throughout the embryonic and extraembryonic tissues of E6.0 to E7.5 embryos (Beppu et al., 
2000; Roelen et al., 1997).  BMPR2-/- mice arrest at the egg cylinder stage, show growth 
abnormality by E6.5 and are reabsorbed by E9.5. Analyses of these mutants show that they 
fail to pattern the epiblast, do not gastrulate or form mesoderm, although display no defects in 
VE differentiation (Beppu et al., 2000).  Embryos null for  either of the other Type II 
receptors ActRIIa or ActRIIb develop to term, although both receptors may rescue the 
phenotype of the other (Chang et al., 2001; Song et al., 1999). 
 
Analysis of the Type I BMP receptors expression patterns shows that they are temporally 
regulated which may suggest specificity of BMP ligand binding during development.   
BMPR1b is not expressed earlier than E9.5 so is unlikely to have roles in early embryonic 
development (Dewulf et al., 1995).  Acvr1 is expressed in extraembryonic tissues such as the 
VE and later also in extra-embryonic mesoderm and ectoderm as well as the mesoderm.  
Mutants lacking Acvr1show defects in gastrulation, with abnormal VE and mesoderm 
formation as well as defects in formation of the L-R axis, indicating roles for BMP signalling 
in patterning extraembryonic tissues as well as the epiblast (Gu et al., 1999; Kishigami et al., 
2004).   
 
Bmpr1a is first detected in the blastocyst, but remains ubiquitously expressed throughout 
both extra- and embryonic tissues (Mishina et al., 1995; Roelen et al., 1997).  Similar to 
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BMPR2-/- mice, BMPR1a homozygous mutants are smaller by E7.0, and are reabsorbed by 
E9.5 with defects in mesoderm formation (Mishina et al., 1995). Later it was demonstrated 
that Bmpr1a signalling functions during gastrulation to guide AVE migration through 
regulation of Dkk1 expression, an attractive cue that guides the AVE to the anterior side of 
the embryo (Miura et al., 2010).  Analysis of a conditional Bmpr1a-/- mutant, which lacks 
expression in the epiblast reveal that Bmpr1a-/- mESCs are not restricted to any cell fate in 
chimaeric embryos, but play a role in regulating signalling sources that promote anterior cell 
fates (Davis et al., 2004).  Further analysis of Bmpr1a-/- mutants showed that BMP signalling 
via the BMPR1a receptor is required to promote epiblast proliferation prior to gastrulation, by 
suppressing premature neural differentiation (Di-Gregorio et al., 2007). 
 
Surprisingly the Smads which transduce BMP signals also have specific functions during 
mouse development.  Smad1 is specifically required for formation of extra-embryonic 
tissues, and Smad1-/- mutants die due to lack of formation of chorioallanotoic fusion 
(Lechleider et al., 2001).  Smad5-/- mutants are also embryonic lethal, and die during mid-
gestation with heart gut and amnion defects, and defects in patterning anterior structures 
(Chang et al., 1999).  Like BMP2 mutants, mesoderm derivatives are formed but incorrectly 
patterned leading to defects in their formation.  Unlike Smads1 and 5, Smad8 homozygous 
mutants are viable and fertile.  In addition to specific roles, Smads show cooperative 
signalling, where heterozygous mutants for single Smad alleles can partially rescue defects in 
others (Arnold et al., 2006).  
 
1.3.2 Nodal Signalling 
 
Nodal signalling is part of the TGF-/Activin/Nodal subfamily of ligands and part of the 
TGF- superfamily of signalling proteins.  Like BMPs, Nodal signals are transduced via 
heterodimers of serine/threonine kinases at the cell surface.   Nodal precursor ligands are 
secreted from cells and processed by proprotein convertases such as Pace4 and Furin into 
functional ligands in a complex at the cell surface (Beck et al., 2002; Blanchet et al., 2008; 
Mesnard et al., 2006).  Once at the cell membrane Nodal signals are transduced via the type 1 
receptor Actr1b or the Nodal-specific Acvr1c in a complex with Type II receptor ActRIIB 
(Reissmann et al., 2001; Shen, 2007; Shi and Massague, 2003).  Once activated the 
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serine/threonine kinase heterodimers phosphorylates SMAD2/3, which bind to receptor 
SMAD4 and translocate to the nucleus (Kishigami and Mishina, 2005).  At the nucleus the 
SMAD complex interacts with winged-helix transcription factor FoxH1 and the Mixer 
subclass of homeodomain proteins to activated target genes (Shen, 2007).   
 
Transduction of Nodal signals also requires the EGF-CFC family of co-receptors/ligands.  In 
the mammalian genome two of these receptors are present: Cripto and Cryptic (Schier and 
Shen, 2000; Shen et al., 1997; Yan et al., 2002).   Cripto acts via recruiting Furin and 
PACE4, two proteases which cleave Nodal precursor ligands (Blanchet et al., 2008).   Also at 
the receptor level extracellular inhibitors Lefty1/2 act as competitive inhibitors of Nodal by 
binding to its serine/threonine kinase receptors and preventing ligand binding (Meno et al., 
1999; Sakuma et al., 2002; Shen, 2007).   
 
1.3.2.1 Nodal Signalling in early mouse development and mESCs 
 
Nodal signalling has multiple evolutionally conserved roles during embryogenesis.  In vitro 
studies of Nodal signalling in embryonic stem cells revealed that Activin/Nodal signalling is 
not required for self-renewal or pluripotency of mESCs but may promote BMP signalling by 
repressing Smad7.  This stimulates BMP signalling to promote self-renewal (Galvin et al., 
2010).  However, Activin/Nodal signalling is required at later stages of development to 
maintain self-renewal and pluripotency of later derived EpiSCs and induction of mesoderm 
and endoderm cell fates (Brons et al., 2007; Fei et al., 2010; Mesnard et al., 2006; Takenaga 
et al., 2007). 
 
Mutants lacking Nodal or its intracellular signal transducer Smad2 fail to form mesoderm or a 
primitive streak and are embryonic lethal around E8.5 (Conlon et al., 1994; Nomura and Li, 
1998; Zhou et al., 1993).   Surprisingly mice mutants lacking the Nodal specific type I 
receptor Acvr1c are viable and fertile, showing no defects during development whilst Actr1b-
/- phenocopy Nodal and Smad2 knockout mice suggesting Acvr1c mutations can be rescued 
by Acvr1c (Gu et al., 1998; Jornvall et al., 2004).   Unlike Smad2, Smad3 knockout mice are 
fertile and viable with no overt defects during embryogenesis, suggesting Activin/Nodal 
signals during development are mediated by Smad2 (Zhu et al., 1998).  Embryonic lethality 
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in Nodal signalling pathway mutants are due to a failure to pattern the epiblast in conjunction 
with BMP and Wnt signals.  These signals specify the DVE and thus establish the proximal-
distal axis, and its later migration to form the AVE and specify the anterior-posterior axis in 
conjunction with p38 signalling (Brennan et al., 2001; Chu and Shen, 2010; Clements et al., 
2011; Lu et al., 2001; Varlet et al., 1997).   
 
1.4 FGF Signalling 
 
The fibroblast growth factor family is a diverse evolutionally conserved family of secreted 
proteins which are required to activate multiple signalling pathways.  They are present in 
Drosophila melanogaster and C.elegans but are most diverse in vertebrates. In mouse there 
have been 22 ligands identified – FGF1-18; FGF20-23.  FGF ligands are secreted into the 
extracellular environment and create a binding complex with FGF tyrosine kinase receptors 
and heparin sulphate proteoglycans (HSPGs) to activate a variety of downstream signalling 
cascades.   The FGF ligands all share a similar conserved internal core of 28 amino acid 
residues and proteins range in molecular weight from 17 to 34kDa in vertebrates (Ornitz et 
al., 2000).  Most FGF ligands have a secretory sequence at the N terminus, a heparin binding 
site and a distinct FGFR binding site.   
 
FGF receptors (FGFRs) are intracellular tyrosine kinases (Thisse and Thisse, 2006).  These 
are encoded by four FGFR genes to produce a variety of splice variants.  FGFRs diversify the 
ability of FGFs to activate different signalling pathways through modifications to their 
extracellular ligand binding domains, ability to bind to FGFs and heparin sulphate 
proteoglycans (HSPGs) and binding to other FGFRs.  Once a complex has been established 
between FGFs; FGRs and HSPGs it results in phosphorylation of tyrosines in the intracellular 
domain of the FGFR leading to activation of downstream signalling pathways.   
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Figure 1.3 Overview of the FGF-FGFR signalling pathway (Lanner and Rossant, 2010) 
FGF ligands bind to FGFRs in a complex with heparin sulphate proteoglycans.  This results in 
activation of the FGFR receptor complex and activation of downstream signalling events.  The FGFR 
complex can activate a number of downstream signalling targets: 1. the JAK/STAT signalling pathway; 
2. The PLCγ/Ca2+ sensing pathway; 3. The PI3K/AKT signalling pathway, and lastly 4. The Ras/MAPK 
signalling pathway which leads to activation of effector MAPKs - p38; JNK and ERK1/2 (figure taken 
directly from Rossant and Lanner, 2010).  Reagents used during experiments to affect this signalling 
pathway in mESCs are indicated on the figure. 
FGF-ligand complexes usually signal via the Ras/MAP kinase pathway.  Other signalling 
pathways activated via FGFRs include the PCP pathway; PLCγ/Ca2+; JAK/STAT and 
PI3K/AKT pathways.  In addition to ERK, the Ras/MAPK pathway also activates the JNK 
and p38 kinases illustrated in Figure 1.3 (Lanner and Rossant, 2010; Villegas et al., 2010). In 
activation of the ERK1/2 MAPKs, once the FGF ligand is bound the activated FGFR 
interacts with FGFR substrate 2α (FRS2α), allowing Grb2/Son of Sevenless (Sos) binding.  
Sos catalyzes the exchange of GDP for GTP on Ras and Ras activation of downstream 
MAPKs leading to ERK1/2.  These enter the nucleus and phosphorylate target transcription 
factors.    
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FGF signalling is tightly regulated at multiple levels to determine the timing duration and 
spread of the signal.  A growing number of proteins have been identified that regulate the 
activity of FGF signalling pathways both at the extracellular and intracellular level.  The first 
identified inhibitors of FGF signalling were the 4 secreted extracellular Sprouty and the 2 
related Spred proteins (Hacohen et al., 1998; Wakioka et al., 2001; Yu et al., 2011).  Other 
intracellular modulators of FGF signalling are the dual specificity phosphatases (DUSPs) 
(Alonso et al., 2004; Li et al., 2007) and Sef (Il7rd – Mouse Genome Informatics), an 
intracellular regulator that targets the FGFR1 and 2 receptors during development (Tsang et 
al., 2002).      
 
1.4.1 FGF Signalling in early mouse development and mESCs 
 
In vitro Kunath and co-workers showed that ERK signalling in the ICM acts as a cue priming 
mESCs to differentiate (Kunath et al., 2007).  This was confirmed by Ying and colleagues 
who demonstrated that inhibition of ERK signalling by small chemical inhibitors, in 
conjunction with GSK3β inhibition could maintain mESC self-renewal and pluripotency 
indefinitely (Ying et al., 2008).   FGF/ERK signalling promotes competency of mESCs to 
differentiate towards EpiSCs, and neural fate (Stravidis et al., 2007).   
 
In vivo FGF signalling is required progressively throughout development.  The earliest 
requirements have been shown in maintenance of trophoblast cells (Georgiades and Rossant, 
2006).  FGF4 acting via ERK signalling has been shown to act as an auto-inductive cue for 
ICM differentiation and lineage commitment to PrE fate (Frum et al., 2013; Kunath et al., 
2007).  Analysis of mutants null for members of the FGF signalling pathway during early 
development confirms this requirement.  Mice mutant for FGF4/FGFR2 or Grb2 fail to 
specify PrE (Arman et al., 1998; Chazaud et al., 2006; Feldman et al., 1995).    Further work 
has also shown that the requirement for FGF signalling for specification of PrE fate may not 
be due to ERK signalling alone.  Plusa and colleagues have also seen a requirement for PI3K 
signalling in specification of PrE cell fate, an alternative target of FGF-FGFR signalling 
(Plusa et al., 2008).  Due to the requirement of FGF signalling in specifying PrE, FGF mutant 
mESCs differentiated in vitro as EBs also fail to develop VE.  As a consequence of this, these 
mutants also fail to cavitate (Chang et al., 2001; Esner et al., 2002).  The PI3K signalling 
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Figure 1.4 Overview of the Wnt signalling pathway (Pinto and Clevers, 2005) 
(A) In the absence of Wnt signalling, the Wnt degradation complex phosphorylates β-catenin which leads to its 
degradation in the cytoplasm.  (B)  Wnt ligand binding to its receptors Fz and LRP5/6 causes translocation of 
Wnt degradation complex proteins to the membrane.  This allows β-catenin to accumulate in the cytoplasm and 
translocate to the nucleus, and transcription of Wnt target genes by binding to transcription factors of the 
TCF/LEF family. 
pathway may also have a role in cavitation as some FGF mutant defects can be rescued via 
forced induction of PI3K signalling (Li et al., 2001).  FGF signalling is also required during 
gastrulation, as loss of function mutations in FGFR1 result in embryonic lethality around 
E7.5 to E9.5 due to defects in paraxial mesoderm formation and movement of the primitive 
streak (reviewed by Dorey et al., 2010; Deng et al., 1994; Yamaguchi et al., 1994).   
 
1.5 Wnt Signalling 
 
The Wnt signalling pathway is an evolutionally conserved signalling pathway with diverse 
roles in cell polarity; differentiation and embryogenesis (Logan and Nusse, 2004).  There are 
two main signalling pathways which utilise Wnt signalling components, the canonical 
pathway, which involves Wnt signalling via Frizzled receptors (Fz) and β -catenin and the 
non-canonical pathway signals independently of β -catenin but has equally diverse roles in 
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cell behaviour and development (Strutt, 2003; Veeman et al., 2003).  This work will focus on 
the canonical Wnt signalling pathway as described in Figure 1.4 (Pinto and Clevers, 2005). 
 
Wnt ligands are defined by amino acid sequence and 19 members are expressed in the mouse 
genome.  All Wnt proteins include a secretion signal sequence, several charged amino acid 
residues and an abundance of potential glycosylation sites (Mikels and Nusse, 2006).  Upon 
synthesis Wnt proteins undergo extensive posttranslational modifications, including 
palmitoylation; glycosylation and lipid modifications (Sengupta et al., 2010; Tanaka et al., 
2000; Willert et al., 2003).  One particular protein which plays an essential role in Wnt 
posttranslational modification is porcupine (porc) which was first discovered in Wg 
processing in Drosophila (Kadowaki et al., 1996; Tanaka et al., 2000).  Mutants lacking porc 
activity produce Wnt signals normally but fail to be secreted from producing cells 
significantly reducing Wnt signalling activity (Biechele et al., 2011; Zhai et al., 2004).  Once 
modified, Wnt proteins are transported to the apical cell surface and secreted. 
Secreted Wnt ligands bind to a Fz/low density lipoprotein (LDL) receptor-related protein 
(LRP5/6) complex on the extracellular surface of neighbouring cells (Bhanot et al., 1996).  
Fzds are a family of seven transmembrane spanning receptors, with a cysteine-rich domain 
(CRD) in the ligand binding extracellular N-terminus.   It is the CRD domain which mediates 
Wnt ligand binding at the extracellular surface (Wang et al., 1996). The C-terminus of the Fz 
receptor activates the canonical Wnt signalling pathway via a conserved Lys-Thr-X-X-X-Trp 
sequence which relocates to the membrane and phosphorylates Dishevelled (Dvl) (Chen et al., 
2003; Huang and Klein, 2004; Umbhauer et al., 2000).  LRP5/6 acts as a co-receptor in Wnt 
signalling with Fz and is also essential for Wnt signalling by recruiting Axin, a negative 
regulator of Wnt signalling, to the membrane when in a complex with Fz and a Wnt ligand 
(Mao et al., 2001; Tolwinski et al., 2003; Wehrli et al., 2000).   
 
In the absence of a Wnt ligand the intracellular Wnt signalling co-activator non membrane 
bound β-catenin is sequestered in the cytosol and phosphorylated by a protein complex 
comprised of Dvl; glycogen synthase kinase-3β (GSK3 β); Axin; Adenomatous Polyposis 
Coli (APC); Caesin Kinase1 (CK1) and protein phosphatase 2A (PP2a) (Kimelman and Xu, 
2006) leading to β-catenin degradation.  Upon Wnt ligand binding, Dvl and Axin are 
relocalised to the membrane and the β-catenin degradation complex is destabilised. β-catenin 
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accumulates within the cytosol and translocates to the nucleus where it acts as transcriptional 
coactivator (Itoh et al., 1998; Liu et al., 2002; Mao et al., 2001; Rubinfeld et al., 1996; 
Tolwinski and Weischaus, 2004). The main signalling targets of nuclear β-catenin are the 
TCF/LEF family of transcription factors.  In vertebrates the TCF/Lef family of transcription 
factors has four paralogues TCF1,3,4 and Lef1 in addition to splice variants (Archbold et al., 
2012; Hoppler and Kavanagh, 2006; Valenta et al., 2012).   
 
Extracellular antagonists of the Wnt signalling pathway prevent ligand-receptor interactions 
by two different mechanisms. Extracellular signalling molecules can bind to Wnt receptors 
and prevent Wnt ligand binding, examples of these molecules include Frzb (also known as 
sFRP3) and its four homologues (sFRP1/2-4/5) form the sFRP (secreted Frizzled Receptor 
Protein) family;  Wnt inhibitory factor 1 (Wif1) (Hsieh et al., 1999) and Cerberus (Katoh and 
Katoh, 2006; Kawano and Kypta, 2003) .  The second family of Wnt receptor antagonists 
bind and cause internalisation of Wnt receptor LRP5/6, including Wise (Lintern et al., 2009) 
and the Dikkopf family of proteins (Dkk1-4) (Mao et al., 2002).   
 
Intracellular modulation of Wnt signalling can be achieved through modulating movement of 
Wnt signalling components within the cell (Fu et al., 2009), availability of receptors at the 
cell surface (Yamamoto et al., 2005) and availability of “free” cytosolic pool of β-catenin 
(Orsulic et al., 1999) among other mechanisms.  
 
1.5.1 Wnt Signalling in early mouse development and mESCs 
 
Wnt proteins have important roles in embryonic development as well as in tissue homeostasis 
and stem cell maintenance after birth (Clevers, 2006; Logan and Nusse, 2004).   In addition 
Wnt signalling acts as a morphogen so signalling intensity and duration affect different cell 
fates.  Wnt knockout mice models have been developed to study the role of specific ligands 
during mouse development, and phenotypes range from embryonic lethality to no 
morphological changes (van Amerongen and Berns, 2006).  Wnt expression in the embryo is 
first detected in the mouse blastocyst with Wnt9a expressed within the TE (Kemp et al., 
2005; Pfister et al., 2007).    Canonical Wnt signalling has roles in specifying the primitive 
streak.  Mutants in components of Wnt signalling; Wnt3; β-catenin and Porc mice fail to 
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form the primitive streak and eventually undergo apoptosis and are reabsorbed (Biechele et 
al., 2011; Huelsken and Birchmeier, 2001; Liu et al., 1999).  Conversely mutants lacking 
negative regulators of the Wnt signalling pathway Axin1; Tcf3; Dkk1 develop ectopic axial 
structures and posteriorization of the embryo and lose neural structures (Kim et al., 2000; 
Merrill et al., 2004; Mukhopadhyay et al., 2001; Zeng et al., 1997). This suggests that Wnt 
signalling is not required for formation of anterior, head structures and is required to specify 
posterior cell fates.  
 
Wnt signalling is required in mESCs to maintain cell viability in the absence of other 
extrinsic factors (Ying et al., 2008).  However the role of transcriptional Wnt signalling is 
controversial.  In the absence of Wnt signalling, mESCs differentiate more quickly to an 
EpiSC fate (ten Berge et al., 2011).  However further analysis of β-catenin in self-renewal 
and pluripotency reveals that β-catenin maintains self-renewal and pluripotency through two 
separate mechanisms , reprieve of Tcf3 mediated repression of pluripotency required genes 
(Wray et al., 2011) and modulation of membrane bound pluripotency factor Oct4 (Faunes et 
al., 2013).   
 
1.6 Cell Competition 
 
Cell competition is a phenomenon where the coexistence of two cell populations with 
different metabolic properties or growth rates results in growth of the stronger population 
(termed “winners”) at the expense of the weaker one (“losers”) (Baker and Li, 2008; de Beco 
et al., 2012; Diaz and Moreno, 2005).  Later models of cell competition also included the 
concept of “supercompetition”, where cells that obtain a growth advantage, through randomly 
acquired mutations, are able to eliminate their surrounding wild-type neighbours. A model of 
cell competition and ‘supercompetition’ is illustrated in Figure 1.5 (Moreno, 2009).  This 
process of recognition and elimination of vulnerable, mispatterned or abnormal cells during 
tissue growth has demonstrated important roles in tissue homeostasis; organ size control; 
stem cell maintenance and cancer.   
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Figure 1.5 Cell Competition (Moreno et al., 2009) 
Suboptimal cells grown in a monotypic environment survive.   When suboptimal cells are introduced against 
a wild-type background, they are eliminated by cell competition.  When a wild-type cell is introduced 
against a back-ground of cells with a growth advantage (supercompetitors) wild-type cells are eliminated by 
cell competition 
Cell competition was first described in Drosophila melanogaster in 1975 in flies 
heterozygous for Minute mutations, which affect ribosomal protein-encoding (Rp) genes.  
Whilst flies homozygous for these mutations are lethal, heterozygous Minute mutants (M/+) 
flies are slow-growing but viable (Lambertsson, 1998).  In their paper Morata and Ripoll 
induced M/+ clones against a wild-type background in the developing epithelia of the wing 
and discovered these cells were eliminated during development despite their viability in 
homozygous M/+ flies.  The loss of an otherwise viable population of cells in a heterozygous 
population was termed cell competition (Morata and Ripoll, 1975). 
 
Since being first described further hallmarks of cell competition have been identified; first 
that although mutant cells are lost by apoptosis or delamination from competing populations, 
winner cells over-proliferate to maintain organ size (de la Cova et al., 2004). Furthermore, 
cell competition is determined by compartment boundaries, with competition occurring only 
in the posterior portion of the wing disc and not the anterior compartment (Simpson and 
 39 
 
Morata, 1981).   A number of factors have also since been identified as sufficient to induce 
cell competition in various models.  
 
1.6.1 Cell Competition induced by differences in Dpp signal transduction 
 
M/+ mutants transduce lower amounts of decapentaplegic (dpp) compared to their 
surrounding wild-type neighbours due to their slower proliferation rate (Moreno et al., 2002). 
In response to lower levels of dpp M/+ cells upregulate expression of the transcriptional 
repressor brinker and its co-activator dNAB followed by upregulation of the JNK pathway 
and apoptosis (Moreno et al., 2002; Ziv et al., 2009).  Conversely, constitutive activation of 
the dpp pathway in M/+ cells promoted their survival (Burke and Basler, 1996).  Therefore, 
Dpp signalling may be a general mechanism of monitoring cell fitness to identify abnormal 
cells.   
 
1.6.2 Cell Competition induced by relative differences in Myc expression 
 
Myc is a transcription factor involved in regulating the expression of many genes across a 
range of cellular processes affecting cell growth; apoptosis and ribosome biogenesis. 
Hypomorphic alleles of dMyc are not embryonic lethal but result in reduced body size, cell 
size and viability (Johnston et al., 1999).  Similar to Minute mutants, clones of cells 
expressing hypomorphic dMyc alleles are eliminated from the developing drosophila wing 
disc during development (Johnston et al., 1999).  Like M/+ induced competition, dMyc 
hypomorphic cells are protected by compartment boundaries (de la Cova et al., 2004). 
Moreno and Basler (2004) introduced dMyc overexpressing clones with 4x and 2x 
endogenous dMyc levels.  Analysis of their behaviour against a wild-type background 
showed that these clones were able to overtake large areas of the wing disc similar to regular 
cell competition (Moreno and Basler, 2004).  These experiments identify dMyc 
overexpressing cells as ‘supercompetitors’ and highlight the importance of relative 
expression levels in competing cultures.     
 
1.6.3 Cell competition induced by differences in Wingless signalling 
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Vincent et al., (2011) investigated the role of wingless (Wg – a Drosophila homologue of 
Wnt signalling) in cell competition (Vincent et al., 2011).  Similar to Dpp; signalling via the 
Wnt pathway is a major regulator of development in Drosophila and functions as a survival 
factor in the developing wing disc.   Wg insensitive cells, deficient in either of the Wg 
receptors Frizzled (Fz/Fz2) or the co-receptor arrow, are viable in a homogenous 
environment, however when introduced against a wild-type background Wg signalling 
mutants are eliminated by apoptosis dependent cell competition.  Conversely over-expressing 
mutants, for example those lacking components of the β-catenin destruction complex APC 
(adenomatous polyposis coli) or Axin are able to eliminate their wild-type neighbours.  
Further analysis of Wg-induced cell competition revealed that it is Myc; and Minute 
independent.  This suggests that cell competition is a general mechanism that can be triggered 
by multiple signalling pathways leading to apoptosis of loser cells. 
 
1.6.4 Fitness modulators in Cell Competition 
 
Salvador-Warts-Hippo pathway 
Identifying changes in Dpp; Wg and dMyc as cell competition triggers garnered interest into 
identifying other signalling pathways sufficient to induce cell competition.  Primarily Tyler et 
al., (2007) performed an unbiased genetic screen for mutations sufficient to rescue 
haplosufficient RpL36 mutant clones against a wild-type background in Drosophila  (Tyler et 
al., 2007).  This screen identified members of the Salvador-Warts-Hippo pathway as 
sufficient to both rescue mutant clones, and transform these cells into ‘supercompetitors’ 
capable of eliminating their wild-type neighbours.    This pathway plays a major regulatory 
role in controlling cell-cycle progression; growth and apoptosis as well as defining the fate of 
pre-implantation mESCs in the mouse embryo (Nishioka et al., 2009; Pan, 2010).    
 
Cell Polarity pathways 
 
Cell polarity refers to the specialized localisation of specific proteins at the cell membrane, 
such as the apical or basal surfaces.  This sequestering of specific proteins are required for 
cells  to interact with each other and their microenvironment   Mutations in central regulators 
of apico-basal polarity Lethal giant larvae (Lgl) and Disc large (Dlg); Scribble and Crumbs, 
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as well as Lgl interaction partner Mahjong have all been related to cell competition (Hafezi et 
al., 2012; Menendez et al., 2010; Norman et al., 2011; Tamori et al., 2010).  These models of 
cell competition differ from the original Dpp; Wg and Myc models as homozygous mutants 
for these genes are non-viable.  Homozygous mutant flies for these genes form neoplastic 
tumours during development as cells overproliferate and do not regulate organ size.  Whilst 
these mutant cells are viable and able to proliferate rapidly, tumour formation eventually 
leads to death of the fly larvae.  These cell polarity genes are of interest as models of cell 
competition as in the presence of wild-type cells, lgl and scrib knockout mutant clones do not 
form tumours and are instead eliminated by apoptosis (Menendez et al., 2010).  When 
mutants for cell polarity genes interact with wild-type neighbours, these cells undergo 
apoptosis and are extruded from the tissue.  Models of cell polarity mutants in cell 
competition have been observed both within the Drosophila wing disc and in mammalian 
Madin-Darby Canine Kidney (MCDK) cells (Hafezi et al., 2012; Menedez et al., 2010; 
Norman et al., 2011).   
 
1.6.5 Recognising mutant cells during Competition 
 
Secreted Factors 
Cell competition has been shown to be partly mediated by secreted factors.  S2 Drosophila 
cells grown in culture media conditioned by heterogeneous cell populations with different 
dMyc expression levels can induce competition in naïve homogenous cultures.  This suggests 
that during competition Drosophila epithelial S2 cells secrete an unknown “killing signal” 
which is selectively transduced by the weaker population (Senoo-Matsuda and Johnston, 
2007).  Conversely mutant cells can also secrete a “survival protein” which allows them 
temporary protection against cell death.  Portela et al., 2010 identified dSPARC, a secreted 
glycoprotein that acts as a protective barrier against competition-induced apoptosis (Portela et 
al., 2010).  Ectopic expression of dSPARC is sufficient to prevent Minute and dMyc 
competition induced apoptosis.  dSPARC secretion may therefore be a general response to 
apoptotic signals to allow cells time to recover after damage.   
 
The Flower code 
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Changes in cell surface protein expression have also been demonstrated to be involved in cell 
competition.  Rhiner and co-workers describe Flower (Fwe) an ubiquitously expressed 
extracellular surface protein, posttranslationally modified into different isoforms in response 
to cell metabolic rate (Rhiner et al., 2010).  Cells expressing the same isoform of Fwe do not 
compete.  In Minute mediated cell competition, mutant cells express one of two truncated 
forms of Fwe termed FweloseA or FweloseB whilst winner cells express an isoform termed 
Fweubi.  Ectopic expression of either truncated isoform results in loss of otherwise wild-type 
cells whereas expression of the ubiquitous isoform is sufficient to rescue a mutant cell from 
being eliminated (Rhiner et al., 2010).   
 
The Flower code is particularly interesting as it provides a “read-out” for cell viability.  Of 
interest is whether this read-out using alternative isoforms of Fwe could be applicable to 
mammalian systems, such as cell competition in the epiblast or in other systems.  Further 
evidence of the role of Fwe in competitive interactions between cells was described within 
the developing Drosophila retina, were loser isoforms of Fwe are expressed at the surface of 
stunted photoreceptors prior to induced apoptosis (Merino et al., 2013; Pichaud et al., 2013). 
This suggests that the role of Fwe in identifying cells as suboptimal is conserved throughout 
different tissue types.  
 
To determine whether Fwe is also conserved in other species, Fwe was assessed in mouse 
models.    In mice, Fwe has a single predicted homologue termed mFwe and is spliced into 
four separate isoforms. Expression of mFwe was also analysed in adult tissues and found to 
have the highest expression in the eyes and brain, similar to Drosophila Fwe. Interestingly, 
when different isoforms of Fwe  were expressed within these tissues, apoptosis was not 
triggered as would have been expected in cell competition,  However when transfected into 
Drosophila models of cell competition,expression of mFwe isoforms 1 or 3is sufficient to 
trigger apoptosis in the expressing cell  (Petrova et al., 2012).  This discrepancy may be 
related to cell competition being active within different developmental boundaries or times 
between Drosophila and mice.  This data suggests that Fwe and its role in cell competition is 
evolutionarily conserved between species, and highlights changes in Fwe isoforms as a 
potential bio-marker for early changes in cancer progression.    
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1.6.6 Cell Competition – apoptosis and engulfment 
 
Cell competition is limited mostly by compartment boundaries, and is modulated partially by 
secreted factors and cellular distances.  Once identified as “losers” these cells are removed 
from competing environments.  TUNEL or activated caspase-3 staining co-localises with 
“loser” cells confirming that “loser” cells are eliminated by apoptosis.  However, the 
signalling pathways preceding apoptosis vary dependent upon the model of cell competition 
(de la Cova et al., 2004; Moreno and Basler, 2004; Moreno et al., 2002).   
In addition to apoptosis, engulfment may play a role in removing loser cells.  Li and Baker 
(2007) observed that winner cells actively eliminate loser cells during competition (Li and 
Baker, 2007).  As they examined the boundaries of wild-type and M/+ cells in Minute 
mediated cell competition they observed wild-type cells in the process of engulfing mutant 
cell debris.  These studies showed that the ability to engulf loser cells is required for cell 
competition and sufficient to induce competition where no growth difference is present.  
However, the role of engulfment during cell competition is controversial as a later paper was 
unable to replicate these results, and concluded that “winner” cells were still able to induce 
apoptosis in “loser” cells in M/+ mediated competition, despite lacking genes required for 
engulfment such as drpr and wasp.  Instead, they observed that apoptotic “loser” cells were 
extruded from the basal epithelium and the resultant cellular debris was engulfed by 
circulating haemocytes (Lolo et al., 2012).  
 
1.6.7 Mammalian models of cell competition 
 
Cell competition has also been described in various mammalian systems.  Some evidence 
suggests that cell competition may also occur in the mouse for example; Belly spot and tail 
(Bst) heterozygote cells are defective in ribosomal protein L24 and behave similarly to 
Drosophila Minutes.  When injected with R26-lacZ mESCs, Bst/+ blastocysts retain a greater 
contribution of R26-lacZ cells at E12.5 when compared to similarly injected wild-type 
blastocysts, suggesting defects in Bst/+ cells’ ability to contribute to chimaeras (Oliver et al., 
2004).  Competitive-like interactions have also been described between donor wild-type and 
diseased host liver hepatocytes during liver regeneration in rats (Oertel et al., 2006).  
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Tamori et al., (2010) were the first authors to describe cell competition in a mammalian 
epithelial model using Martin Canine-Darby Kidney (MCDK) epithelial cells deficient in a 
scaffolding protein Mah-jong  (Tamori et al., 2010).  Mah-jong deficient MCDK cells (Mahj-
/-) grow normally and show no defects.  However when they are grown in apposition with 
wild-type MCDK cells Mahj-/- cells upregulate JNK signalling and undergo elimination by 
apoptosis. This model adheres most strenuously to cell competition hallmarks described in 
Drosophila as mutant cells are viable in homogenous culture and are eliminated by apoptosis 
in heterogeneous populations.   
 
Also in 2010, two papers were published describing p53-mediated hematopoietic stem cell 
and progenitor cells as a model of cell competition (Bondar and Medzhitov, 2010; Green, 
2010; Marusyk et al., 2010).  Bondar and Medzhitov, (2010) irradiated haematopoietic stem 
and progenitor cells and introduced them with wild-type progenitors into lethally irradiated 
recipients.  Whilst irradiated HSPCs could repopulate bone marrow as a homogenously 
treated population, in the presence of non-irradiated progenitors treated HSPCs contributed a 
significantly lower proportion to later HSPC population than non-irradiated HSPCs.  In this 
model outcompeted irradiated cells undergo p53 mediated senescence and do not proliferate. 
Loss or reduction in p53 in irradiated HSPCs eliminated the competitive advantage of wild-
type HSPCs as irradiated HSPCs no longer induced senescence in response to the presence of 
wild-type neighbours. 
 
Most recently, cell competition in mouse models of development have been described.  The 
first paper, from Claveria et al., (2013) describes a super-competition model using a genetic 
mosaic model to induce relative expressions of Myc in the mouse epiblast.  In this model, 
alleles with differential Myc expression where expressed under EYFP or EGFP in the 
epiblast, and the ratio of fluorphore expression analysed (Claveria et al., 2013).  Using this 
model, the authors show that cell competition occurs in the epiblast, results in and that cell 
competition is dependent upon apoptosis  in loser (relatively lower Myc expressing) cells.  
This paper is of particular interest as it describes cell competition in vivo as a normally 
occurring phenomenon during development to eliminate lower Myc-expressing cells in the 
epiblast.   
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The second paper, by Sancho et al., (2013) also describes cell competition during mouse 
development.  In this work a series of mutant cell lines (Bmpr1a-/-; Atg5-/- and 4n) mESCs as 
well as Myc over-expressing mESCs are competed in co-culture against wild-type mESCs.   
The authors go on to show that during differentiation in culture over a four-day period, wild-
type mESCs eliminate neighbouring mutant cell lines and are out-competed by Myc over-
expressing mESCs (Sancho et al., 2013; and this work).  The authors go on to show that this 
elimination of neighbouring cells in co-culture is apoptosis dependent and mediated by 
secreted factors.   Additionally, the authors go on to show that prior to elimination of the 
loser population, Myc is upregulated in the winner population, suggesting that relative 
expression of Myc is the driving force behind cell competition.  These results are also 
demonstrated in vivo using the mouse epiblast at E5.5 to E7.5 similar to work shown by 
Claveria et al., (2013) (Claveria et al., 2013; Sancho et al., 2013; and this work).    
 
 
1.6.8 Roles for cell competition 
 
Quality control 
Cell competition has been proposed to have three roles, the first as a quality control 
mechanism.  During development, cell populations, such as the Drosophila imaginal disc or 
eye, proliferate and differentiate rapidly in response to various environmental changes.  Cell 
competition would ensure that suboptimal, mispatterned or abnormal cells undergo apoptosis 
during development and not contribute to the adult tissue (Moreno and Basler, 2004; Moreno 
et al., 2002; Tyler et al., 2007). 
 
Cancer 
Cell competition may also be involved during cancer development, as a tumour promoter 
mechanism.  “Field cancerization” is a term used to describe a possible early event in cancer 
where mutant cells proliferate rapidly without inducing morphological changes due to 
compensatory loss of surrounding wild-type cells, as described in cell competition (Moreno, 
2009). 
Conversely, cell competition could also act as a tumour suppressing mechanism depending 
on context.  Cells which acquire a mutation in a tumour suppressor gene against a wild-type 
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background would be eliminated by apoptosis.  Examples of both models of cell competition 
have been described earlier in addition to the known oncogene Myc being identified as 
sufficient to induce competitive behaviour (de la Cova et al., 2004; Menendez et al., 2010; 
Moreno and Basler, 2004; Tamori et al., 2010). 
 
Regeneration 
The third proposed role for cell competition is in regeneration.  In response to tissue damage, 
tissues able to regenerate proliferate rapidly, differentiate to replace lost tissue and return to 
quiescence when appropriate organ size is restored.  However if cells from a healthy donor 
are transplanted near the damaged area, “suboptimal” host cells undergo apoptosis and donor 
cells proliferate to replace the damaged organ.  During this process a large area of host tissue 
is overtaken in the process, yet organ size is still maintained and the replaced tissue is 
functional (Bondar and Medzhitov, 2010; Oertel et al., 2006).   This has clinical applications 
as non-functional tissues and organs could be damaged and then replaced with functional 
donor tissue at the expense of host cells.     
 
1.7 Autophagy 
 
Autophagy is a process by which cytoplasmic components, including organelles are degraded 
by the lysosome. Macroautophagy (hereafter referred to as “autophagy”) is of particular 
interest as it is through this method that cytosolic contents are delivered to the lysosome by 
specialised compartments called autophagosomes.  Autophagy has physiological and 
morphological roles in the cell.  It acts as an adaptive response to starvation or stress to 
breakdown excess proteins back into their amino acid components and provide energy when 
needed.  Due to this autophagy is closely coupled to the nutrient-sensing metabolism 
pathway, regulated by mammalian target of rapamycin (mTOR) (Lum et al., 2005, Yang and 
Klionsky, 2010).  
 
Autophagy also acts as a quality control mechanism for intracellular proteins and organelles, 
where long-lived or excess cytosolic components are trafficked into the autophagosome 
pathway and degraded.  This allows the cell to ‘refresh’ its cytosolic contents and to remove 
damaged or misfolded organelles and proteins which would otherwise remain.  Lastly, 
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autophagy has roles during development, the earliest of which acts to convert the fertilised 
oocyte to an unpatterned totipotent cell.    Many components of the autophagy pathway are 
required at different points of embryogenesis emphasising the importance of autophagy in 
development (reviewed by Mizushima and Levine, 2010).  
 
Autophagy is regulated by a central ‘master’ regulator called TOR, a serine-threonine kinase.  
TOR is highly conserved and as illustrated in Figure 1.6 incorporates signals from both 
growth factors and nutrient signals and the energy status of the cell (Yang and Klionsky, 
2010).  Although TOR serves as the central component in two complexes in mammals; 
mTORC1 and mTORC2, Whilst both complexes are involved in autophagy,  only mTORC 1 
is directly involved in the regulation of autophagy. mTORC1 comprises of mTOR; raptor 
(regulatory associated protein of mTOR) which regulates autophagy inhibition on addition of 
rapamycin (Oshiro et al., 2004) ; GβL (also known as mLST8) and PRAS40 (proline-rich Akt 
substrate of 40kDa (reviewed by Ravikumar et al., 2010).   
 
In response to low levels of nutrients or high amounts of abnormally-folded proteins in the 
cell the autophagy pathway degrades these components back into its constituent parts in order 
to be recycled.  This occurs via a series of sequential steps involving components of the 
autophagy pathway which mark components for degradation.  These components are then 
encompassed into vesicles called autophagosomes.  These eventually fuse with lysosomes 
within the cell containing enzymes which degrade their contents allowing them to be reused 
to form further proteins or provide energy for the cell. 
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Figure 1.6  Overview of the signalling pathways regulating autophagy (Yang and 
Klionsky, 2010). 
Figure showing an overview of the signalling pathways which affect autophagy.  Growth 
factors; cell stress and nutrients all feed into autophagy pathway which is involved in 
regulating cell growth and energy status (Yang and Klionsky, 2010).  
Both ATG5 and Beclin1 are components of the autophagy pathway in mammalian systems. 
ATG5 forms a conjugate complex with ATG12, which is required for formation of the 
autophagosome isolation membrane where cytosolic components are degraded (Mizushima et 
al., 2001).  Beclin1 acts in a variety of roles, some autophagy-independent and regulates 
autophagy through interaction with class I PI3K kinases.   The class I PI3K kinase complex 
made up partly of ATG14 and Beclin-1 mediate localisation of autophagy components to the 
preautophagosome site (PAS) (reviewed by Cao and Klionsky, 2007).  It is worth mentioning 
a third component of the autophagy machinery LC3 which is expressed at the surface of the 
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autophagolysosome where unwanted components are degraded.  In response to increased 
levels of autophagy, LC3 is cleaved from its original state LC3-I to a smaller fragment LC3-
II and this conversion serves as a marker for levels of autophagy (reviewed by Tanida et al., 
2004).   
 
Qu et al., 2006 used an LC3-GFP reporter line as a marker for autophagy, and found this 
process to be clearly occurring within wild-type mESCs.  They then used two separate cell 
lines, atg5 and beclin1 null ESCs to analyse an additional role for autophagy during 
cavitation in development.  Embryoid bodies (EBs) comprised of either atg5 or beclin-1 
ESCs fail to cavitate.  This failure to cavitate differs from S2 EBs which do not respond to 
BMP mediated cell death signals from the visceral endoderm (VE) (Coucouvanis and Martin, 
1999).  Qu, et al., (2006) observe apoptosis, suggesting these cells are responsive to BMP 
signalling, but cell corpses are not cleared and remain within the EB. These experiments 
indicated that autophagy is required for cell engulfment. ES cells are highly proliferative and 
long-lived so it is highly plausible that autophagy is required as a cell homeostasis 
mechanism not only to remove mis-folded proteins and supply energy within the cell but also 
to remove dead cells from the environment.  
 
Autophagy has a debated role within cell competition.  Engulfment of neighbouring loser 
cells during cell competition within the Drosophila wing disc was observed by Li and Baker 
(2007).  They went on to hypothesise that winner cells “eat” their way through the 
neighbouring loser population to perpetrate cell competition (Li and Baker, 2007).  However, 
this view was later challenged by Lolo and colleagues who could not recreate these 
experiments and hypothesised that loser cells were actually extruded from the basement 
membrane and engulfed by circulating hemocytes (Lolo et al., 2012).  Whilst the exact 
method of removal of loser cells from a competing environment is still under debate, models 
of cell competition using mESCs and in vivo mouse studies have also observed winner cells 
engulfing their losing neighbours during competition (this work, Sancho et al., 2013; Claveria 
et al., 2013).  Whether this is an active part of cell competition or a mechanism to remove 
loser cell debris is unknown and requires further investigation. 
 
1.8 Apoptosis in mESCs 
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Apoptosis occurs throughout the life of an organism.  It can be triggered by a variety of 
causes, such as a reduction in growth factor binding, withdrawal of non-apoptotic factors or 
excessive cell stress.   All cell types undergo apoptosis, although the stimuli and sensitivity of 
response depends upon cell type.  In response to such stimuli, a variety of changes occur 
within the cell.  Morphologically, cells, including mESCs, undergoing apoptosis show certain 
features, such as blebbing; cell swelling; vacuole formation and disruption of the cell 
membrane (Elmore, 2007; Lawen, 2003).  The cell eventually disintegrates and in some 
cases, including cell competition, the debris is engulfed into neighbouring surviving cells 
(Claveria et al., 2013; Li and Baker, 2007; Sancho et al., 2013).  These morphological 
changes are accompanied by changes at the cell surface, due to disruption of the cell 
membrane.  Markers staining for inner cell membrane residues, in particular AnnexinV which 
binds to phosphatidylserine at the cell surface can be used to assess levels of apoptosis.    
 
In response to stimuli apoptosis signals via extrinsic and/or intrinsic initiator pathways.   The 
extrinsic pathways regulating apoptosis involves the binding of extracellular ligands to “death 
receptors” at the cell surface causing activation of downstream caspases (Elmore et al., 2007).  
Interestingly mESCs do not express any members of the extrinsic apoptotic pathway and 
therefore initiate apoptosis only through intrinsic signalling pathways (Khromov et al., 2012; 
Nishitai et al., 2004).    The intrinsic pathways that trigger apoptosis are also diverse.  As 
mentioned earlier, these can be triggered by a variety of stimuli.  All of these stimuli cause 
changes in the inner mitochondrial membrane and cause release of pro-apoptotic factors 
contained therein (Saelens et al., 2004).  These factors, such as Cytochrome-c and DIABLO, 
form complexes with other proteins such as Apaf-1 and subsequently recruit and activate the 
intrinsic initiator procaspase-9 to its cleaved active form, caspase-9 (Elmore et al., 2007). 
 
Both the extrinsic and intrinsic apoptosis pathways culminate in activation of executor 
caspases, caspase3,6-7.  Expression of activated, (cleaved) caspase-3 can also be used as a 
late non-reversible marker to assess apoptosis. Activation of these executor caspases leads to 
disassembly of the cell structure, DNA fragmentation and death of the cell, where the 
remaining debris is engulfed by neighbouring cells (Lawen et al., 2003) 
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1.9 Aims of this Study 
 
A mammalian model of cell competition was developed using mESCs null for Bmpr1a 
(Sancho et al., 2013). These cells do not express the type I BMP receptor and transduce a 
lower level of BMP signal. When grown in co-culture with wild type mESCs in conditions 
where growth factors are limiting, Bmpr1a null cells are rapidly out-competed. This model 
has been used in this study to further elucidate mammalian cell competition.    
 
This study focuses on different aspects of cell competition. First the report describes how 
BMPR1a null cells are removed from competing co-cultures with wild-type mESCs by 
analysing proliferation; apoptosis and upstream signalling cascades known to be activated in 
response to stress.  This study goes on to address is if the elimination of Bmpr1a-/- mESCs 
depends on cell-cell contact or is mediated by secreted factors, using a transwell assay 
system.  This same model is also used to test whether cell competition is a conserved 
mechanism by investigating how wild-type mutant mESCs interact.  Lastly this study 
investigates cell competition at the molecular level by studying the signalling pathways 
which affect the elimination of Bmpr1a-/- cells. For this the ERK and WNT signalling 
pathways are analysed.   
 
This work will help demonstrate that cell competition is a conserved mechanism involved in 
embryonic stem cell fitness and begin to investigate how embryonic stem cells interact with 
each other to determine fitness levels. 
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Chapter 2 – Materials and Methods 
 
2.1 Tissue Culture Methods 
 
All reagents used in tissue culture were from Gibco (Invitrogen) unless otherwise stated. 
 
2.1.1 mESC Lines 
 
E14Tg2a.IV mESCs were a gift from Austin Smith (Nichols et al., 1990).  Bmpr1a-/- FR124 
cell line were generated from Oct4-GFP 129_SvEv  transgenic mice a gift by Yuji Mishina 
(Qi et al., 2004). Atg5-all-/-ftftx  mESCs were generated from an R1 ES parent cell line (129 ES 
background) gifted by Mizushima’s lab (Mizushima et al., 2001). Bmpr1a-/- mESC line C1 
were derived from Bmpr1a-/- mice maintained on a 129SvCC background and established 
from blastocyst outgrowths maintained by Margarida Sancho (Mishina et al., 1995; Sancho et 
al., 2013).  4n (tetraploid) mESC cell line were generated by Margarida Sancho from 
E14Tg2a.IV mESCs during GFP electroporation experiments and were determined to have 
80 chromosomes by karyotyping (Sancho et al., 2013).  E14-gfp8; C1-gfp6 and 4n-GFP 
mESC lines were stably transfected with eGFP under the control of the CAG promoter by 
Margarida Sancho (Sancho et al., 2013). 
 
2.1.2 mESC Maintenance 
 
mESCs were maintained as undifferentiated cells on 0.1% gelatine-coated flasks (Nunc, 
Thermo Fisher).  Cells were grown in Glasgow’s Modified Eagle Medium (GMEM) 
supplemented with 10% (v/v) foetal calf serum (FCS), 1X non-essential amino acids 
(NEAA), 1x Sodium Pyruvate; 2mM L-glutamine, 0.1mM β-mercaptoethanol and 1:500 LIF 
(produced in house by Sara Pozzi and Kim Smith).  Cell washes were done with phospho-
buffered saline (PBS).  mESCs were routinely dissociated with trypsin-EDTA and passaged 
1:8 every 2-3 days.  For future use cells were frozen in media containing 10% tissue-culture 
grade dimethyl sulfoxide (DMSO, Sigma) and 90% FCS, and stored in liquid nitrogen.  All 
cells were cultured at 37⁰C in 5% C02. 
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2.1.3 Cell Competition Assays 
Confluent mESCs were dissociated with Trypsin-EDTA and counted using a Neubaur 
improved cell counting chamber. 4.2x104 cells/cm2 were plated onto 0.1% gelatin-coated 6 
well plates (Nunc, Thermo Fisher).  Cells were plated as each genotype separately or in co-
culture as a mixture of control and mutant mESCs at either 50:50 or 40:60 ratios depending 
on cell genotype.  After plating cells were maintained in ES media without LIF and changed 
daily thereafter for the duration of the experiment.    
 
E14-GFP8 and FR124 Bmpr1a-/- mESCs were used in cell competitions to determine if GFP 
loss was responsible for the loss of GFP +ve mESCs during cell competition (Figure 3.2B).  
E14-gfp8 cells were used in competition with ATG5-/- mESC competitions.  Tetraploid 
mESCs generated from GFP electroporated E14Tg2a.IV mESCs were used as the mutant cell 
line for tetraploid experiments (Sancho et al., 2013).  Wild-type E14-gfp8 and FR124 
Bmpr1a-/- cells were also used to confirm results for pancaspase inhibition experiments 
(Figure 3.4H). For all other experiments E14tg2a.IV mESCs were used as wild-type controls.  
Unless stated otherwise C1-gfp6 Bmpr1a-/- mESCs derived mice maintained on a 129SvCC 
background and established from blastocyst outgrowths maintained by Margarida Sancho 
were used as the mutant mESCs in all other experiments (Sancho et al., 2013). 
 
For transwell cell competition assays 4.2x104 cells/cm2 control or mutant cells were plated 
onto wells of a 6 well plate coated with 0.1% gelatin.  In a separate 6 well plate transwells 
(Millipore) were also coated with 0.1% gelatin and 4.2x104 cells/cm2 control or mutant cells 
were plated onto them.  Cells were left for 4-5 hours before cells in transwell were placed 
overlying those plated directly onto the plate.   
 
 For growth curve analysis cells were plated for separate and co-cultures and then counted 
daily.   The cell count graphs represent the total cell number of each genotype counted.  For 
cells grown in co-culture, the total number of cells was counted and the relative proportion of 
each genotype present was determined by flow cytometry (FACs). This proportion was then 
multiplied by the total cell number in co-culture to determine the cell number of each 
genotype present. As control and mutant cells represent a proportion of the total cell number 
in co-cultures, these numbers are often lower than those grown in separate cultures. 
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The bar graphs represent the ratio of control to mutant cells in separate and co-culture.  This 
was determined by FACs analysis of each culture.  For co-cultures the population was 
analysed as a whole population.  For analysis of separate cultures, each population was 
trypsinised and mixed in equal volumes before analysis by FACs.    
 
2.1.4 Growth Rate Analysis 
 
Growth rates were calculated for each cell type in each condition daily.  The growth rate (cell 
doublings per day) for each cell type was calculated as equals natural logarithm, (LN) (final 
number/initial number) divided by Ln (2).  Unless stated otherwise a minimum of three 
independent experiments were performed and the average±s.e.m plotted. 
 
2.1.5 Growth Factor/Inhibitor Treatments 
 
Cell competition assays were set up as described in 2.1.3.  All growth factors/inhibitors are 
listed in Table 1 below, in order and concentration used.  1ug/ml heparin was used as a 
vehicle control for FG4 and FGF5 experiments (Sigma).  Unless stated otherwise DMSO was 
used as a vehicle control.  Inhibitors were added either 4-5 hours after plating, with fresh 
media, or 2 days after plating.  Unless stated otherwise, a minimum of three independent 
experiments were performed and average±s.e.m plotted. 
 
Reagent Concentration Target Company 
 
Z-VAD-FMK 100µM Caspases R&D Systems 
SP600125 5µM JNK Sigma 
SB203580 20µM p38 Merck 
Rapamycin 10ng/ml mTOR Cayman Chemicals 
LY294002 25µM PI3K Cayman Chemicals 
Wortmannin 1µM PI3K Sigma 
SB431542 10µM ALK5/4/7 Cayman Chemicals 
PD0325901 1µM MEK1/2 Cayman Chemicals 
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Table 2.  Reagents used during Cell Competition Assays 
Reagents used to modify cell behaviour during cell competition listed in order of use.  Reagents are 
described at the concentration used to affect cell competition dynamics and the company supplier. 
 
 
 
 
Reagent Concentration Target Company 
PD184352 2µM  MEK1/2 Santa Cruz 
PD98059 12.5µM MEK1/2 Cell Signalling 
U0126 10µM MEK1/2 Cell Signalling 
PD173074 100ng/ml FGFR1/3 Cayman Chemicals 
FGF4 5ng/ml FGFR1c/2c R&D Systems 
FGF5 10ng/ml FGFR1c/2c R&D Systems 
IWR-1 2µM Axin1/2 Calbiochem 
IWP-2 2µM  Porcupine Calbiochem 
CHIRON99201 3µM GSK3β Sigma 
 
2.2 Flow Cytometry (FACs) Analysis 
 
2.2.1 GFP and PI analysis of live cells 
 
All FACs analysis was performed on a BD LSR2 cytometer with FlowJo software.  For GFP 
expression analysis in separate and co-cultures, mESCs were washed with PBS, trypsinised, 
pelleted and resuspended in FACs buffer (3% FCS in PBS).  For exclusion of dead cells, cells 
were stained with propidium iodide (PI). 3µl of 1mg/ml PI solution (Sigma) was added per 
500µl of cell suspension prior to FACs analysis.  PI+ve cells were excluded prior to analysis of 
GFP expression ratios. Fluorophore expression channels GFP <525/50 B-A> channel PI 
<610/20 B-A> channel. 
 
2.2.2 AnnexinV/PI staining for early/late apoptotic cells 
 
AnnexinV is used as an early marker of apoptosis by staining exposed phosphatidylserine 
caused by disruption of cell membranes.  PI is used as a late marker of apoptosis by binding 
to exposed nucleic acids.  Cells in separate or co-culture were harvested and pelleted.  Cell 
pellets were resuspended in 100µl AnnexinV binding buffer (0.1% BSA in 10mM HEOES, 
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140mM NaCl, 2.5mM CaCl2, pH7.4) with 3µl of APC-conjugated AnnexinV (Molecular 
Probes).  Cell pellets were incubated at RT in the dark for 15 min.  5µl of 1mg/ml PI was 
then added to the cell suspension and cells incubated at RT in the dark for a further 5min.  
After this incubation period, 400µl of annexin-binding buffer was added to each sample and 
immediately analysed.  AnnexinV-APC fluorescence was detected in the APC channel < 
APC-A>, in correlation with PI and GFP. 
 
2.3 Live Cell Imaging 
 
Cells were plated as described during cell competition assays.  Cells were grown for 2 days 
before 6ml of media was added to each well.  Cells were then transferred to a humidified 
chamber set at 37⁰C and 5% C02 connected to an Ultraview microscope and Hamamatsu 
software.  Cells were imaged every 5 minutes using both brightfield phase contrast and GFP 
channels.  Data was correlated and analysed using Velocity 6.1 software to generate short 
time-lapse movies. 
 
2.4 Protein Analysis 
 
2.4.1 Western Blot 
 
4x105 cells were plated onto gelatin coated 6-well plates and grown for 2 days in 
GMEM+Serum.  Inhibitors were then added at increasing concentrations per well for 24 
hours.  PD0325901 (Cayman Chemicals) added at 1;2;5;10 and 20µM; PD184352 (Santa 
Cruz) added at 2;5;10;20 or 50µM; PD98059 (Cell Signalling) added at 12.5;25;37.5;50 and 
75µM; U0126 (Cell Signalling) added at 10 and 20µM; PD173074 added at 
100;200;500;1000 and 2000ng/ml.      
 
Cells were washed with ice-cold PBS before being lysed on ice with RIPA buffer (150mM 
NaCl; 50mM Tris pH8; 0.5% sodium deoxycholate, 0.1% SDS, 1% NP-40) containing 
Complete Mini Protease Inhibitors (Roche) and Phosphatase Inhibitors Set II (Calbiochem). 
Protein extracts were quantified using the Bradford method (reagent from Biorad).  After 
denaturation (10min at 95⁰C) 5-40µg of protein were loaded and separated in a 12% pre-
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made acrylamide gel (XT-Criterion, Biorad) in 1x XT-MOPS Buffer (Biorad).  Proteins were 
then transferred onto a PVDF membrane (Amersham) using vertical wet transfer for 1hour at 
100V at 4⁰C.  Membranes were blocked in 5%milk in TBS/0.1% Tween (TBST) containing 
protease inhibitors at RT for 1 hour before incubation with primary antibody in 5% 
BSA/TBST overnight at 4⁰C.  Primary antibodies used were mouse anti phospho-ERK 
(1:10,000 Sigma) and rabbit anti α-tubulin (1:5000 Cell Signalling). 
 
The following day membranes were washed in TBST and incubated in peroxidase-conjugated 
secondary antibody (anti-mouse 1:5000 or anti-rabbit 1:2000, from Santa Cruz) in 5% 
milk/TBST at RT for 1h.  Membranes were washed again in TBST and rinsed in PBS and 
chemiluminescence assayed using ECL-Plus Western blotting detection system (Amersham 
Biosciences).  Blots were visualised on a Hyperfilm ECL X-ray film (Amersham 
Biosciences). 
 
2.4.2 Immunofluorescence 
For immunofluorescences analysis cells were grown on glass coverslips coated with 10ng/ml 
human plasma fibronectin (Millipore). 
 
Coverslips were washed in PBS and fixed in 4% paraformaldehyde (PFA) in PBS for 10min.  
Fixed cells were washed again with PBS and permeabilized with 0.4% Triton-X100 in PBS 
for 5min, before washing with PBS.  Samples were then incubated in blocking solution (10% 
BSA, 0.1% Triton-X100 in PBS) for 30min.  This was followed by incubation in primary 
antibody: rabbit anti-cleaved caspase3 (1:100 Cell Signalling); rabbit anti-GFP (1:400 
Molecular Probes) was diluted in blocking solution o/n at 4⁰C in a humid chamber.  
Coverslips were then washed with PBS and incubated with secondary antibodies coupled to 
appropriate fluorophores (1:300 Molecular probes) diluted in blocking solution for 45min at 
RT in the dark. 
 
Cells were washed 2x more in PBS.  For some experiments cells were then incubated in 
Phalloidin-TRITC (1:1000/diluted in PBS) for 40min at RT in the dark.  Finally cells were 
washed twice in PBS before being mounted in Vectashield with DAPI (Vector).  Samples 
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were visualised using an SP5 Leica laser-scanning confocal microscope.  Images were 
processed using Leica confocal software and Adobe Photoshop CS4. 
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Chapter 3 - Characterisation of Cell Competition between wild-type 
and Bmpr1a-/- mESCs 
 
3.1 Introduction 
 
Cell competition is a type of cell-cell interaction where the co-existence of two cell 
populations with differing growth or metabolic properties results in the loss of the weaker 
‘loser’ population and a compensatory increase in proliferation of the stronger ‘winner’ 
population (Levayer and Moreno, 2013; Wagstaff et al., 2013).  In addition to other factors, 
differences in signal transduction of BMP homologue in Drosophila Dpp have been shown to 
induce cell competition in the epithelial wing disc of developing flies (Burke and Basler, 
1996; Moreno and Basler, 2004; Moreno et al., 2002).    However, the mechanisms 
underlying cell competition are not universal with different models triggered and resolved in 
a context-dependent manner. 
 
Cell competition has been shown to have multiple roles, in tissue homeostasis, repair, organ 
size and stem cell maintenance and is a conserved mechanism that is present in mammalian 
models in addition to Drosophila (de la Cova et al., 2004; Jin et al., 2008; Oertel et al., 2006; 
Rhiner et al., 2009; Tamori et al., 2010).   The hypothesis that cell competition acts as a 
protective mechanism against “unfit” cells is intriguing in the context of stem cells which are 
required to proliferate and self-renew over long time periods, yet still remain competent to 
differentiate into specialised cell types.  In the mouse embryo, two pluripotent stem cell 
populations are generated, the earlier derived ICM, from which mESCs are obtained from 
and the later forming and more specialized epiblast, from which EpiSCs are derived from.  
Both populations are highly proliferative, and subject to random mutations that could 
immediately affect their viability or that may damage the organism only at later stages of 
development.   
 
The majority of competitive interactions are resolved by apoptosis of the weaker population 
of cells and compensatory proliferation of the stronger ‘winner’ cell population (Abrams, 
2002; Morata and Ripoll, 1975). However, the mechanism to induce apoptosis differs 
between systems such as induction of JNK-dependent apoptosis in the Drosophila imaginal 
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Figure 3.1 Bmpr1a-/- mESCs are out-competed when co-cultured with wild-type mESCs 
Time-lapse imaging of co-cultured wild-type and Bmpr1a-/- -GFP ESCs.  Wild-type and Bmpr1a-/--GFP 
ESCs were mixed together at a 40:60 ratio and the two cell types were co-cultured in GMEM + Serum 
media.  Represented are overlapping fluorescence (GFP) and brightfield images of the co-cultures. t= 
time in hours (hrs.). 
disc (Menendez et al., 2010; Moreno and Basler, 2004; Moreno et al., 2002; Portela et al., 
2010; Tamori et al., 2010) or induction of pro-apoptotic genes such as hid in the developing 
Drosophila wing disc (de la Cova et al., 2004).  Other models have been shown to be non-
apoptosis dependent such as the mouse haematopoietic system where loser cells undergo p53-
induced senescence (Bondar and Medzhitov, 2010) or the Drosophila germ stem cell niche 
where cells are displaced and differentiate (Jin et al., 2008; Rhiner et al., 2009).    
 
Primarily, this chapter introduces the model used to investigate cell competition in 
mammalian pluripotent stem cells and for this uses mESC cultures. The purpose of this 
chapter is to determine how competing wildtype and Bmpr1a-/- mESCs interact. This chapter 
also investigates the growth rate of competing and monotypic cultures and how competition 
is resolved by investigating some of the cellular pathways involved in cell stress and 
apoptosis.   
 
3.2 Results 
 
3.2.1 Bmpr1a-/- mESCs are progressively lost upon coculture with wild-type mESCs 
 
Cell competition is a biological phenomenon where suboptimal cells are eliminated by 
apoptosis when confronted with a faster growing or fitter population (Levayer et al., 2013).  
In 
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Drosophila, differences in being able to transduce Dpp have been shown to induce cell 
competition between populations within the same wing disc (Burke and Basler, 1996; 
Moreno and Basler, 2004; Moreno et al., 2002). The mammalian homologues of Dpp are 
BMP2/4, which signal via the Bmpr1a receptor in the early mouse embryo (Di-Gregorio et 
al., 2007; Mishina et al., 1995).  Previous work in the lab and by other groups isolated and 
established Bmpr1a-/- mESCs as cell lines that could be maintained in conventional culture 
conditions (GMEM supplemented with LIF and FCS) (Qi et al., 2004; Sancho et al., 2013). 
 
Further analysis show that Bmpr1a-/- mESCs display lower levels of BMP signalling than 
wild-type cells and do not respond to BMP2/4. However although these cells exhibit 
premature neural differentiation in the epiblast, mosaic knockout mice have shown Bmpr1a-/- 
cells present in tissues  derived from all the germ layers, in a similar manner to wild-type 
controls (Davis et al., 2004; Di-Gregorio et al., 2007; Sancho et al., 2013).  Using these 
mutant cells, a co-culture system was set up by the lab to examine the behaviour of Bmpr1a-/- 
mutant cells when coexisting with wild-type cells.  In this system Bmpr1a-/- mESCs were co-
cultured with wild-type E14 mESCs in GMEM plus serum and the relative proportion of each 
cell type in the culture analysed (Sancho et al., 2013).  In order to visualise this process a 
time-lapse experiment was set up of Bmpr1a-/- mESCs labelled with GFP in co-culture with 
wild-type E14 mESCs. Figure 3.1 shows the overlap of brightfield and fluorescent images at 
various time-points illustrating the gradual loss of GFP+ve mESCs from co-culture.  As the 
experiment progresses, areas of previous high GFP expression are replaced with large 
numbers of rounded pro-apoptotic mESCs.  Whilst this experiment allows us to visualise cell 
competition in real-time as active cells rather than fixed images it does not allow 
quantification of the loss of Bmpr1a-/- mESCs from co-culture.  This experiment also does not 
explain how Bmpr1a-/- mESCs are lost from co-culture, although judging by the rounded cell 
morphology it is suggestive that Bmpr1a-/- mESCs are subject to apoptosis.     
 
3.2.2 Loss of Bmpr1a-/- mESCs from co-culture with wild-type mESCs is not due to 
GFP expression 
 
To allow for a quantitative representation of cell competition the ratio of wild-type to  
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Figure 3.2 Flow cytometry data of wild-type and Bmpr1a-/- mESCs during cell competition 
(A) Wild-type and Bmpr1a-/--GFP mESCs at day 0 of cell competition, cells plated as co-culture, 
flow cytometry data of total population, gated for mESCs, then gated again to exclude (dead) 
propidium iodide positively stained cells (red box) before analysis as a histogram. (B) Flow 
cytometry data showing proportion of wild-type and Bmpr1a-/--GFP mESCs after 4 days of 
culture in GMEM+Serum.  Data highlights the different contribution of each cell type in separate 
and co-culture. (C) Wild-type and Bmpr1a-/- -GFP mESCs at day 0 and day 4 of cell competition 
to demonstrate how many cells have a high enough GFP expression to be easily distinguished 
from unlabelled cells in culture. 
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Figure 3.3 Cell Competition between wild-type and Bmpr1a-/- mESCs is not affect by GFP 
expression 
Wildtype and Bmpr1a-/- mESCs were grown in GMEM+Serum in separate and co-culture for four days and 
the ratio of GFP positive to negative mESCs in each condition was analysed by flow cytometry.  Graphical 
representation of FACs data of (A) wild-type E14 and C1-gfp6 Bmpr1a-/- mESCs and (B) wild-type E14-
GFP and FR124-lacZ Bmpr1a-/- mESCs in separate and co-cultures.  All numbers are normalised to the 
starting population ratio (40:60 wild-type to    Bmpr1a-/-) n=3 average±s.e.m p ≤0.01 
Bmpr1a-/- - GFP mESCs was analysed by flow cytometry (FACs) daily and normalised to the 
original ratio of cells seeded at day 0 (40:60 unless otherwise stated to correct for the slight  
proliferation defect shown in Bmpr1a-/-  mESCs in culture) (shown as flowy cytometry data 
in Figure 3.2).  By day 4 of co-culture, Bmpr1a-/- mESCs contribute a significantly lower 
proportion of cells in co-culture compared to separate culture, suggesting they have been 
outcompeted (at day 4 co-culture ratio of wild-type mESCs to Bmpr1a-/- -GFP mESCs = 
5.48±1.08 compared to separate culture ratio 1.68±0.27 n=3 p≤0.01). This data is shown in 
graphical form in Figure 3.3A.  To exclude a possible effect of GFP expression affecting 
competition wild-type E14 mESCs expressing GFP under the CAG promoter (E14-GFP) and 
FR124-lacZ Bmpr1a-/- mESCs were also analysed in the same manner. After 4 days of co-
culture, the ratio of wild-type/Bmpr1a-/- mESCs was significantly higher in co-cultures 
compared to separate cultures, as shown in Figure 3.3B (ratio wild-type/ Bmpr1a-/- co-culture 
5.26±0.4 compared to separate culture ratio 2.14±0.54 average ±s.e.m n=3 p≤0.01 students t-
test). Analysis of the contribution of competing cultures results in a significant proportion of 
co-cultures consisting of wild-type mESCs compared to monotypic cultures. 
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Figure 3.4 Wild-type cells over-proliferate when co-cultured with Bmpr1a-/-  mESCs 
(A) Total number of cells in separate (top) and co-culture conditions (bottom) grown in GMEM+Serum.  
Number of cells in co-culture populations is derived from the total number of cells multiplied by the 
percentage of GFP+ve cells in that population as analysed by FACs on a daily basis. Data shown n=3, 
average±s.e.m.  (B) Differences in growth rate between wild-type and Bmpr1a-/-ESCs – growth rate is 
calculated as Ln (final cell number/initial cell number)/Ln (2) n=3 average±s.e.m *=p≤0.05  
3.2.3  Wild-type cells proliferate significantly faster upon co-culture with Bmpr1a-
/- mESCs  
 
One of the hallmarks of cell competition is the over-proliferation of the stronger ‘winner’ 
population in competitive cultures, to maintain organ size and compensate for the loss of the 
loser population (de la Cova et al., 2004).  In order to address whether changes in cell growth 
rate occur during competition between mESCs, wild-type and Bmpr1a-/- mESCs were plated 
and the total number of cells in cultures were counted daily and shown for separate and co-
culture, Figure 3.4 A.  In separate cultures, both wild-type and Bmpr1a-/- mESCs show 
similar growth curves.  Observation of wild-type and Bmpr1a-/- mESC co-cultures shows that 
Bmpr1a-/- mESCs appear to undego growth arrest around day 2-3 of co-culture and are 
actively lost from co-culture by day 4.  To investigate further, the growth rate of wild-type 
and Bmpr1a-/- mESCs was investigated by analysing population doubling times in separate 
and co-cultures, using the following equation Ln(final cell number/initial cell number)/Ln(2).  
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By day 4 of co-culture, there is a significant increase in proliferation of wild-type cells in co-
culture when compared to separate culture conditions with a corresponding decrease in the 
growth rate of Bmpr1a-/- mESCs, shown in Figure 3.4B (wild-type growth rate separate 
0.40±0.1 co-culture 0.62±0.07 n=3 Bmpr1a-/- growth rate separate 0.35±0.12 co-culture -
0.37±0.18 average±SEM p≤0.05).  Therefore, in response to cell competition wild-type 
mESCs overproliferate compared to mono-typic cultures.  This is a similar to cell behaviour  
seen in Drosophila models of cell competition (de la Cova et al., 2004).     
3.2.4  Bmpr1a-/- mESCs are lost from competing cultures by apoptosis  
 
A second hallmark of cell competition is that loser cells in a population are eliminated by 
apoptosis  (Abrams, 2002; de la Cova et al., 2004; Moreno et al., 2002).  To investigate if 
higher levels of apoptosis were visible in co-cultures compared to separate monocultures of 
wild-type and Bmpr1a-/- mESCs, two methods of analysing apoptosis were used.  Primarily 
separate and co-cultures of mESCs were fixed and stained  at day 3 of culture for cleaved-
caspase3, a late apoptotic marker, Figure 3.5A-C. Unfortunately it is difficult to qualitively 
state that any condition has a higher level of cleaved caspase3 staining.  In addition, caspase3  
cleavage and activation is a late stage in apoptosis, by this stage many pro-apoptotic mESCs 
may have detached and lost before analysis.   
 
AnnexinV staining is also used to identify pro- apoptotic cells before caspase activation by 
identifying cells whose phospholipid cell membrane is disrupted.   The percentage of 
AnnexinV+ve/PI-ve mESCs in separate and co-cultures of wild-type and Bmpr1a-/- mESCs 
were analysed by flow cytometry but no significant differences in the percentage of pro-
apoptotic cells in each population were observed (Figure 3.5 D). 
 
Previous reports in the literature have investigated whether inhibiting apoptosis in competing 
cultures is sufficient to rescue loser cells (Abrams, 2002; de la Cova et al., 2004; Moreno et 
al., 2002).  To test if this was the case for competing mESC cultures these were treated from 
the second day of co-culture with a DMSO control or 100µM pan-caspase inhibitor Z-VAD-
FMK and stained with anti-GFP; Phalloidin and DAPI to visualise individual cells (Figure 
3.5E, F).   Inhibition of caspase activity was confined to the latter half of the experiment to 
minimise non-apoptotic cell death in response to caspase inhibition and DMSO uptake. This 
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analysis revealed that competing cultures treated with DMSO contained large amounts  of 
Bmpr1a-/--GFP+ve cellular debris (highlighted by white arrows) suggesting that mutant cells 
were dying in these cultures. In  contrast to this pan-caspase inhibtor treated cultures showed 
low amounts of cellular debris and a higher proportion of  GFP+ve mESCs in comparison.  To 
quantify if inhibition of apoptosis was sufficient to prevent competition between wild-type 
and Bmpr1a-/- mESCs, competing and separate cultures of wild-type and Bmpr1a-/- mESCs 
were treated with 100µM of pan-caspase inhibitor Z-VAD FMK from the second day of co- 
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Figure 3.5 Cell competition between wild-type and Bmpr1a-/- mESCs is apoptosis dependent  
(A) wild-type (B) Bmpr1a-/- and (C) co-cultures of mESCs fixed and stained for cleaved-caspase3 at day 3 of 
culture. Cell nuclei are visualised with Dapi. (D) Graphical representation of the percentage of AnnexinV+ve/PI-ve 
mESCs in separate and co-cultures of wild-type and Bmpr1a-/- mESCs (average±s.e.m n=3). (E) Comparison of 
fixed competing cultures when treated with DMSO (control) or (F) 100uM Z-VAD-FMK at day 3 of culture.  
Cell nuclei were stained with DAPI, Bmpr1a-/- mESCs were labelled with GFP and cell actin stained with 
Phalloidin-TRITC. White arrows highlight Bmpr1a-/--GFP cellular debris in cultures treated with DMSO that is 
absent in pan-caspase inhibitor treated cultures. (G) Ratio of wild-type/Bmpr1a-/- mESCs in separate and co-
culture analysed by FACs after 3 days of co-culture shows a significant rescue of cell competition between wild-
type and Bmpr1a-/- mESCs by addition of 100uM Z-VAD-FMK pan-caspase inhibitor from day 2 of culture 
(average±s.e.m n=5 p≤0.01).  (H) Flow cytometry data showing wild-type-GFP transfected cells co-cultured with 
Bmpr1a-/- ESCs treated with pancaspase inhibitor or DMSO control at day 0 and 3 days after co-culture. 
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culture and the ratio of wild-type to Bmpr1a-/- mESCs was calculated and normalised to the 
the first day of treatment.   Inhibition of caspase activity was sufficient to rescue Bmpr1a-/- 
mESC elimination during competition, shown in Figure 3.5G (Z-VAD-FMK co-culture 
1.98±0.17 separate 1.74±0.35; DMSO control co-culture 4.08±0.31 separate 1.59±0.48 data 
shown as average±SEM n=5 p≤0.01). Analysis of competing cultures reveals GFP+ve 
Bmpr1a-/- mESC debris and a significant reduction in the proportion of Bmpr1a-/- mESCs in 
competing cultures, both of which are rescued in the presence of the pan-caspase inhibitor Z-
VAD-FMK suggesting Bmpr1a-/- mESCs are eliminated by apoptosis upon co-culture with 
wild-type mESCs. 
 
This data is also represented directly asanalysed by flow cytometry  in Figure 3.5H.  In this 
experiment, wildtype-GFP mESCs and Bmpr1a-/- mESCs are plated either separately or in co-
culture at a 40:60 wild-type to Bmpr1a-/- mESCs and treated with either pan-caspase inhibitor 
or DMSO for 2 days and analysed on the third (3) day of co-culture, similar to data 
represented graphically in Figure 3.5G.  As also seen with wildtype and Bmpr1a-/-- GFP 
mESC cell competition experiments, cell competition was significantly reduced upon 
addition of pancaspase inhibitor ZVAD-FMK compared to DMSO controls.   
 
3.2.5 Inhibition of JNK or p38 signalling is insufficient to rescue Bmpr1a-/- mESCs 
from cell competition  
 
Caspase activation is one of the last steps to occur during the apoptotic process.  Upstream 
signalling cascades respond to cellular stresses and if unresolved, lead to apoptosis. It is of 
interest to identify which signalling pathways mediate competitive stress upstream of caspase 
activation and apoptosis, as this would help elucidate how cells sense changes in ‘fitness’ and 
trigger competition.  It is likely that a variety of triggers exist to mediate competition, which 
signals via diverse pathways before converging on caspase activation and apoptosis, as seen 
in other cell competition models (Levayer and Moreno, 2013; Wagstaff et al., 2013).  
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In previous studies of competing cultures, JNK signalling and activation of downstream pro- 
apoptosis signals were found to be a common response to cell stress (Weston and Davis, 
2007), and is described in both Drosophila and mammalian models of cell competition (de la 
Cova et al., 2004; Moreno and Basler, 2004; Tamori et al., 2010).  To investigate if JNK 
signalling also affects competiton between Bmpr1a-/- and wild-type mESCs, 5µM of JNK 
inhibitor SP600125 (Bennett et al., 2001) was added from the initial day of culture and 
replaced daily. As a separate target of interest the p38 pathway was also investigated.   Like 
JNK signalling, activation of p38 is also induced in response to cellular stress (Ono and Han, 
2000).  Therefore competing cultures were treated from the initial day of competition with 
20µM of p38 inhibitor SB203580  and replaced daily with fresh media (Clements et al., 2011; 
Cuenda et al., 1995).  DMSO was added to control cultures as a vehicle control in both 
experiments. Growth curves of separate and co-cultured wild-type and Bmpr1a-/- mESCs 
were counted daily and plotted, shown in Figure 3.6.   
 
Wild-type mESCs treated with 5µM SP600125 resulted in a profound reduction in cell 
number of wild-type cells, although it is unclear whether this is due to higher levels of 
apoptosis or growth arrest. This effect is not seen in co-cultures or in monocultures of 
Bmpr1a-/- mESCs (Figure 3.6).  Due to this change in growth upon JNK inhibition 
specifically in wild-type mESCs it is difficult to analyse the involvement of JNK signalling in 
cell competition.  The ratio of wild-type to Bmpr1a-/- mESCs in separate compared to co-
cultures is significantly higher in co-culture due to the very low number of wild-type mESCs 
upon separate culture, suggesting that cell competition still occurs although not to the same 
extent (JNK inhibitor treated co-culture 1.98±0.03 separate 0.63±0.11 p≤0.05, DMSO control 
co-culture3.08±0.10 separate 1.09±0.07 data shown as average±sem n=2 representative 
experiment shown).  Reports in the literature show that mESCs which lack JNK isoforms 1 
and 2 proliferate significantly faster than wild-type mESCs, so it is possible that the growth 
defect observed may be due to the cytotoxicity of the inhibitor SP600125 (Davies et al., 
2000; Xu and Davis, 2010). Other JNK inhibitors are described in the literature which could 
be investigated and target individual JNK isoforms (Bogoyevitch et al., 2010).  However, it is 
interesting to note that Bmpr1a-/- mESCs display no growth rate phenotype in response to 
compound JNK signalling inhibition. 
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Wild-type and Bmpr1a-/- mESCs grown with p38 inhibitor were cultured as separate and co-
cultures of both genotypes.  Growth curves were similar in separate cultures of wild-type and 
Bmpr1a-/- mESCs.  The growth curves of wild-type mESCs in co-culture was similar to that 
of separate cultures, but Bmpr1a-/- mESCs undergo growth arrest and are progressively lost 
from co-culture, shown in Figure 3.6D-E. Inhibition of p38 signalling has no significant 
effect on wild-type or Bmpr1a-/- mESC cell growth or cell competition as shown in Figure 
3.6(D-F) suggesting that it is not involved in cell competition (p38 inhibitor co-culture 
6.97±0.77 separate 2.95±0.5 compared to DMSO co-culture 4.57±1.25 separate 2.33±0.40 
data shown as average±sem n=3, Figure 3.6F). This data indicates that JNK or p38 signalling 
pathways are not required during competition between wild-type and Bmpr1a-/- mESCs 
though this may be due to redundancy between the different signalling pathways mediating 
competition (de la Cova et al., 2004; Tamori et al., 2010).    
 
3.3 Discussion 
 
The model described throughout the majority of this work investigates competitive 
interactions between wild-type and Bmpr1a-/- mESCs.  This mutation was investigated due to 
previous observations in Drosophila cell competition models in the epithelial wing disc of 
developing flies (Burke and Basler, 1996; Moreno and Basler, 2004; Moreno et al., 2002).  In 
these experiments, differences in signal transduction of Dpp (Decapentaplegic) the 
Drosophila homologue of BMP 2 and 4 is sufficient to induce these cells to be outcompeted 
by neighbouring wild-type cells.   Bmpr1a-/- is the mammalian receptor for BMP2 and 4 and 
Bmpr1a-/- mESCs have been shown to have reduced pSMAD 1/5/8 compared to wild-type 
cells in response to BMP 2 or 4 (Sancho et al., 2013).  Morphologically, Bmpr1a-/- mESCs are 
similar to wild-type cells and show similar abilities to self-renew and growth rates both as 
mESCs and during the four days of differentiation, when grown separately (Sancho et al., 
2013 and this work).  These features, similar to that seen in Drosophila models of cell 
competition, suggest that the interaction of Bmpr1a-/- mESCs upon co-culture with wild-type 
cells is a good mammalian model for studying cell competition. 
 
Analysis of differentiation of wild-type and Bmpr1a-/- mESCs upon separate and co-culture at 
day 0 and day 4 do not show significant differences in gene expression for specific germ 
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layers (Sancho et al., 2013 supplemental data).  Additionally, in vivo whilst Bmpr1a-/- 
embryos  the epiblast undergoes premature neural differentiation (Di-Gregorio et al., 2007) 
this defect is not seen in mosaic Bmpr1a-/- embryos, where mutant cells can contribute to all 
three germ layers (Davis et al., 2004; Di-Gregorio et al., 2007).  These data do not suggest 
that a deficiency in acquiring particular cell fates cause Bmpr1a-/- mESCs to undergo 
apoptosis upon co-culture with wild-type counterparts. 
 
 To determine whether the loss of Bmpr1a-/- mESCs from co-culture with wild-type cells was 
the sole cause determining their elimination, Bmpr1a-/- mESCs were re-transfected with 
Bmpr1a (termed Bmpr1aGOF mESCs).  Bmpr1aGOF mESCs were cultured separately or in 
co-culture with either Bmpr1a-/- mESCs or wild-type mESCs. After 4 days of co-culture the 
ratio of each cell type per culture condition was analysed by FACs.  Interestingly 
Bmpr1aGOF mESCs were able to out-compete Bmpr1a-/- mESCs upon co-culture but showed 
no competitive behaviour when co-cultured with wild-type mESCs (Sancho et al., 2013).    
This data shows that loss of Bmpr1a-/- in mESCs triggers cell competition and results in the 
elimination of this mutant population when confronted with wild-type mESCs or mESCs 
where Bmpr1a function is restored. 
 
This chapter has shown that by inhibiting caspase activity the elimination of mutant cells is 
recued and therefore that in mESCs cell competition is resolved by apoptosis of Bmpr1a-/- 
cells.  It is therefore likely that the attempts to analyse cell death in competitive cultures by 
AnnexinV staining (an early apoptotic marker of cell phospholipid membrane 
disorganisation) and activated (cleaved) caspase 3 analysis described in this chapter were 
both inconclusive due to loss of GFP expression in mutant cells and detachment of apoptotic 
cells from culture as shown in Figure 3.1.  In addition cleaved caspase3 staining was difficult 
to quantify, as positively stained debris could not always be identified as belonging to one or 
more cells.  The choice to prevent caspase activation was aimed at minimising loss of GFP 
expression and delamination of apoptotic mESCs to ensure an accurate analysis of the 
proportion of wildtype and Bmpr1a-/- mESCs.   
 
The addition of pancaspase inhibitor ZVAD-FMK was sufficient to significantly rescue the 
elimination of Bmpr1a-/- mESCs from cell competition upon co-culture with wild-type 
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mESCs, regardless of GFP expression (similar results observed with both wild-type-GFP 
+Bmpr1a-/- mESCs and wild-type +Bmpr1a-/- -GFP mESCs).  Interestingly the data indicated 
that despite the inhibition of caspase activation a non-significant proportion of Bmpr1a-/- 
mESCs were still being lost upon co-culture with wild-type mESCs.  This data suggests that 
Bmpr1a-/- mESCs are also eliminated by other methods in addition to caspase activation, such 
as delamination, engulfment or necrosis (non-caspase dependent cell death).  A second 
possible explanation could be due to the increase in growth rate of wild-type mESCs upon 
co-culture with Bmpr1a-/- mESCs.  Although, this increase in growth rate is not sufficient to 
result in a significantly higher proportion of wild-type cells without also triggering apoptosis 
in neighbouring Bmpr1a-/- mESCs  
 
In response to cell competition analysis of growth rate changes in cells upon competition 
show that wild-type mESCs exhibit higher growth rates upon co-culture compared to separate 
cultures.  This has also been observed in previous models of cell competition as a mechanism 
to ensure reproducible organ size and to maintain total cell number (de la Cova et al., 2004; 
Norman et al., 2011).  During development the epiblast is a rapidly proliferating mass of cells 
and is required to increase in cell number by upto 5-fold between E5.5 to E6.5dpc in the 
mouse embryo and commence gastrulation (Snow, 1977; Stuckey et al., 2011a).  This time-
frame prior to gastrulation and posterior patterning in the epiblast around E6.5 coincides with 
the developmental state of competing mESCs in vivo (Claveria et al., 2013; Sancho et al., 
2013).  This suggests that cell competition promotes higher proliferation in winner cells upon 
competition and maintains rapid proliferation in the epiblast so loss of mutant cells in the 
epiblast doesn’t result in developmental delay or differences in patterning the epiblast. 
 
Whilst it has been shown that ultimately Bmpr1a-/- mESCs are lost from competing cultures 
by apoptosis, the upstream signalling pathways that induce cell death were not identified.   In 
some Drosophila models of cell competition, a reduction in levels of Dpp signal transduction 
has been shown to result in upregulation of JNK signalling leading to apoptosis (Moreno et 
al., 2002).  Furthermore extensive reports in the literature highlight multiple roles in JNK 
signalling in mediating cell stress; apoptosis and during mammalian development, including 
during cavitation, making it a logical target of investigation (Barr and Bogoyevitch, 2001; 
Maekawa et al., 2005; Sabapathy et al., 1999; Xu et al., 2010).  
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However, it has been difficult to analyse the role of JNK signalling in cell competition 
between mESCs due to the effects of JNK inhibitor SP600125 on wild-type mESCs.  In 
mESCs only the JNK 1 and 2 isoforms are present as the third isoform JNK3 is restricted to 
the brain and neural tissue (Davis, 2000). Furthermore mESCs can be derived from JNK1; 2 
and compound JNK1/2 knockout mice which exhibit no self-renewal or proliferation defects 
(Xu et al., 2010).  These data indicate that the cytotoxicity observed in wild-type mESCs is 
due to the inhibitor used and not the lack of JNK signalling, although this does not address 
why this cytoxicity is not present in Bmpr1a-/- mESC mono-cultures.Another possible 
explanation for the cytotoxicity of wild-type but not Bmpr1a-/- mESCs could be due to the 
changes in differentiation ability.  JNK1/2-/- mESCs are defective in mesoderm 
differentiation, a trait shared by Bmpr1a-/- mESCs (Xu et al., 2010).  It could be that this 
inability to differentiate into mesodermal lineages triggers apoptosis in wild-type mESCs 
upon JNK inhibition, but Bmpr1a-/- mESCs may have adapted in culture to adopt other fates, 
thus escaping apoptosis.  Other methods to inhibit JNK signalling, including non-
anthropyrazole inhibitors could be used, or target the downstream JNK signalling substrate c-
Jun to perturb JNK signalling with fewer cytotoxic side effects (Bogoyevitch et al., 2010).    
 
p38 signalling has also been linked to apoptosis in response to cell stress and cell competition 
(Kyriakis et al., 1997; Norman et al., 2011; Ono and Han, 2000).  In addition the p38 MAPK 
pathway is involved in embryonic development and inhibition of the p38 MAPK pathway 
allows maintenance of embryonic stem cells and derivation of embryonic stem cells from 
recalcitrant cell lines (Natale et al., 2004; Qi et al., 2004; Zohn et al., 2006).  Whist the 
Bmpr1a-/- mESCs used in this work can be maintained in the absence of p38 inhibition, it was 
hypothesised that this pathway may trigger apoptosis in these cells in response to competitive 
stress.   However, treatment of cultures with a p38 inhibitor has no effect on the dynamics of 
cell competition, suggesting that imbalances in p38 signalling between wild-type and 
Bmpr1a-/- mESCs are not the driving force for competition. 
 
This chapter has begun to investigate the signalling pathways that may be involved in cell 
competition, however further investigation is needed.  Within the embryo there are a variety 
of interacting signalling pathways acting to pattern the epiblast and surrounding tissues, such 
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as Nodal; Wnt; FGF (Tam and Loebel, 2007; Tam et al., 2006).  An inability to transduce 
such signals or differential responses to such signals in a single mutated cell surrounded by 
wild-type cells could trigger cell competition, rendering such signalling pathways targets of 
future investigation.   
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Chapter 4 – Investigating the Signalling factors involved mediating cell 
competition between wild-type and Bmpr1a-/- mESCs 
4.1 Introduction 
 
One of the fundamental questions invoked during studies of cell competition is how do cells 
sense their relative fitness levels, particularly what marks a cell as a “loser” or a “winner” 
during competition, and what if any response can be used to mark the change in cell identity 
prior to apoptosis.   Two possible mechanisms have been suggested by which cells interact, 
cell-cell contact-mediated communication and uptake of unknown signalling factors.   
 
Senoo-Matsuda and Johnston first demonstrated the existence of secreted factors mediating 
cell behaviour in cultures of Drosophila epithelial S2 cells with differing levels of dMyc.   In 
their experiments, naïve cultures of control or dMyc overexpressing cells were treated with 
media from control and dMyc overexpressing cells. In response wild-type cells underwent 
apoptosis whilst dMyc overexpressing cells overproliferated (Senoo-Matsuda and Johnston, 
2007).  These experiments suggest the presence of unknown secreted factors that mediate cell 
competition.  This mechanism has been postulated to be a part of cell competition in 
mammalian systems, although it is thought to be a short ranged mechanism (Claveria et al., 
2013).  
 
Rhiner et al., also investigated how cells sense each other’s’ relative fitness and described the 
existence of the Flower (Fwe) code that could also explain how cells respond differently to 
the same stimulus.  Using the Drosophila wing imaginal disc model, Rhiner and coworkers 
showed that winner and loser cells display different isoforms of Flower, an ubiquitous protein 
expressed at the cell membrane.  In this model winner cells displayed a full-length isoform of 
the protein termed fweubi whilst loser cells expressed a truncated form of the protein fwelose-
A/fwelose-B.  Forced expression of either loser isoforms of fwe in non-competing populations is 
sufficient to induce apoptosis in those cells.  However, interpretation of the fwe code required 
direct cell-cell contact and therefore is likely to involve a different mechanism to that 
described in Drosophila epithelial cells (Rhiner et al., 2010).   
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During early development, the vertebrate body plan is laid down.  Through inductive 
interactions that are mediated by intracellular signalling factors, such as Wnt, FGF and TFGβ 
family members. These cues serve to pattern the embryo and direct cell fate.  Differences in 
these signalling pathways may serve as a “read-out” of cell viability and thus may be 
involved during cell competition (Tam et al., 2006).   
 
In this chapter we first investigate whether secreted factors are required for cell competition 
to occur using a transwell assay that prevents cell-cell contact. This chapter then goes on to 
investigate the role of some of the signalling pathways involved during embryonic 
development.  In particular LIF; Nodal; Wnt and FGF signalling pathways were investigated 
due to their roles in patterning the early embryo.  Through a series of inhibition assays, the 
roles of various signalling pathways were perturbed during the co-culture of wild-type and 
Bmpr1a-/- mESCs and their effects on cell competition dynamics investigated.    
 
4.2 Results 
 
4.2.1 Bmpr1a-/- mESCs are lost from co-culture with wild-type mESCs despite no 
cell-cell contact 
  
In order to investigate whether cell-cell contact was required for cell competition between 
mESCs we utilised a transwell system.  In this system, shown in Figure 4.1A, cells are grown 
on the base of the well; whilst another group of cells are grown on the transwell filter lying 
1.2mm above. In separate cultures, cells are grown with cells of the same genotype grown in 
the overlying transwell, and in co-culture, cells of another genotype are used.  Cells were 
grown in this way for 4 days and the number of cells in the base of the 6 well plate were 
counted daily, and shown in Figure 4.1B.  The genotype of cells grown in the base of the well 
are listed first and the genotype of those grown in the transwell filter is shown in brackets.    
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Growth rate is calculated as the natural log (final number/initial number)/Ln (2) to account 
for exponential growth or mESCs, in each case data is shown as average±s.e.m.  Analysis of 
growth rates between days 2 and 3 of culture show a marked reduction in the growth rate of 
Bmpr1a-/- mESCs when grown with overlaying wild-type cells Bmpr1a-/- (control) 0.11±0.08 
compared to separate Bmpr1a-/- mESC culture; Bmpr1a-/- (Bmpr1a-/-) 0.76±0.20 (data shown 
as average cell number  n=2).  This reduction is similar to what is observed when analysing 
the growth curves of wild-type/Bmpr1a-/- mESCs co-cultured in the same well (Appendix 
Table 1).  Interestingly, there is also a reduction in the growth rate between wild-type cells 
grown with overlaying Bmpr1a-/- mESCs (co-culture)  compared to wild-type cells with cells 
of the same genotype in the transwell above (separate).  The growth rate of cells grown in 
Figure 4.1 Cell-cell contact is not required for out-competition of Bmpr1a-/- mESCs upon co-
culture with wild-type mESCs  
(A)  Model of the transwell system.  Cells of one genotype are grown at the base of a 6 well plate (green circles) 
whilst those of another genotype (grey circles) are grown atop a filter situated 1.2mm above the base of the well.  
(B) Growth curves showing cell number per day.   Cells are grown as shown in (A) with the genotype grown on 
the filter shown in brackets.  (Data shown as average cell number.  At 4 days of culture n=3 p≤0.01; for previous 
days’ growth n=2) (C) Changes in growth rate in cultures between days 2 and 3 of culture. (D) Percentage of 
AnnexinV+ve/PI-ve cells grown for 3 days in culture.  In both experiments, cells grown in the base of the well are 
listed first.  The genotypes of the cells grown in transwells are listed in brackets. (data shown as average cell 
number as n=2).   
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transwell are shown in Figure 4.1C (control (control) 0.85±0.33; control (Bmpr1a-/-) 
0.56±0.18; Bmpr1a-/- (Bmpr1a-/-) 0.76±0.20; Bmpr1a-/- (control) 0.11±0.08; data shown as 
average±s.e.m n=2).  As the growth rate has only been calculated for two experiments, 
further work is needed to confirm if any of these changes in growth rate are significant. This 
experiment suggests that secreted factors are involved in inducing apoptosis and growth 
arrest of competing mESCs.  
 
Following the observation that no cell-cell contact is required for the elimination of Bmpr1a-/- 
mESC when in co-culture with wild-type mESCs, the question of how Bmpr1a-/- mESCs are 
lost upon co-culture with wild-type mESCs arose.  Primarily this was thought to be due to 
secreted factors from wild-type cells triggering apoptosis in neighbouring Bmpr1a-/- mESCs.  
To investigate this, the number of apoptotic cells in various culture conditions was analysed.  
To quantify levels of apoptosis occurring in each growth condition, cells were grown for 3 
days in transwell culture.  Cells grown in the base of the well were stained and analysed by 
FACs for AnnexinV+ve/PI-ve to determine the percentage of pro-apoptotic cells in each 
population.  There are no significant changes in the percentage of pro-apoptotic cells in each 
condition, data shown in Figure 4.1D (%AnnexinV+ve/PI-ve mESCs at day 3 co-culture with 
the same genotype: wild-type 6.03±1.29 Bmpr1a-/- 7.30±2.10; co- culture with cells of 
different genotype wild-type 5.97±0.87 Bmpr1a-/-7.63±2.22 data shown as average±s.e.m n=3 
p≤0.05). Given that caspase inhibition blocks the elimination of Bmpr1a-/- mESCs when in 
co-culture with control cells (chapter 3), this observation suggests in the transwell assays 
Bmpr1a-/- mESCs could be extruded from the mESC colonies very early on during the 
apoptotic process. Alternatively the growth arrest observed in these assays could be due to 
secreted factors mediating a cell cycle block in loser cells and cell-cell contact being 
necessary for their elimination.  Further work is required to investigate these aspects. 
 
4.2.2 Activin/Nodal Signalling is not involved in mediating cell-competition 
between wild-type and Bmpr1a-/- mESCs. 
 
In mouse development Nodal signalling is required for maintenance of EpiSCs and for the 
formation of mesoderm and endoderm (Chenoweth and Tesar, 2010; Fei et al., 2010; 
Mesnard et al., 2006; Takenaga et al., 2007). The involvement of Activin/Nodal signalling 
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during cell competition was investigated by using SB431542, a chemical inhibitor against the 
serine/threonine kinase receptors involved in transducing these signals – ALK5; the activin 
type I receptor ALK4 and the nodal specific type I receptor ALK7 (Clements et al., 2011; 
Inman et al., 2002; Laping et al., 2002).  
 
First, Activin/Nodal signalling was inhibited from the onset of cell competition. Co-cultures 
of Bmpr1a-/- and wild-type mESCs were plated as a 40:60 ratio as Bmpr1a-/- mESCs have a 
slight grown defect in culture.  All cultures had media replaced daily supplemented with 
either 10µM SB431542 or an equal volume of DMSO.  Analysis of the growth curves of 
separate cultures of wild-type and Bmpr1a-/- mESCs in inhibitor treated cultures shows that 
addition of 10µM SB431542 daily to cultures was not cytotoxic to mESCs compared to 
DMSO controls.  In separate cultures both wild-type and Bmpr1a-/- mESCs show similar 
growth curves.  In co-cultures of Bmpr1a-/- and wild-type mESCs in DMSO, Bmpr1a-/- 
mESCs undergo growth arrest after two days and are progressively lost from culture.  In 
contrast co-cultures treated daily with 10µM SB431542 show similar growth curves to 
separate cultures.  These data are shown in Figure 4.2A-B. After four days of culture the ratio 
of wild-type to Bmpr1a-/- mESCs in separate and co-cultures of 10µM SB431542 or DMSO 
treated were analysed by FACs to determine the ratio of wild-type cells to Bmpr1a-/- mESCs 
in separate and co-cultures.  The ratio of wild-type to Bmpr1a-/- mESCs after 4 days of culture 
in 10µM SB431542, shown in Figure 4.2C, shows significant rescue of Bmpr1a-/- mESCs 
compared to DMSO treated cells (ratio of wild-type/Bmpr1a-/- mESCs in 10µM SB431542 
treated co-culture 1.52±0.32 separate 1.20±0.15 DMSO co-culture 10.66±3.17 separate 
2.01±0.24 n=3 p≤0.05).  This suggests that addition of SB431542 to competing cultures is 
sufficient to rescue cell competition if added from day 0 of culture. 
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Within this model of cell competition wild-type and Bmpr1a-/- cells are plated as mESCs and 
then grown in GMEM+Serum, which allows undirected differentiation of mESCs.  Cell 
competition is generally induced around the second day of culture in our model.   By day 2 of 
culture, mESCs have begun to differentiate (Sancho et al., 2013).  Nodal has been implicated 
in maintaining pluripotency in mESCs, by preventing inhibition by Smad7 of BMP-mediated 
signalling (Galvin et al., 2010).  To determine if Activin/Nodal signalling is sufficient to 
prevent cell competition once mESCs have begun to differentiate cultures were treated from 
day 2 with 10µM SB431542.  Analysis of growth curves of separate wild-type and Bmpr1a-/- 
mESCs showed no differences in the growth of either cell population.  In contrast analysis of 
the growth curves of wild-type and Bmpr1a-/- mESC co-cultures (Figure 4.2C-D) showed that 
Bmpr1a-/- mESCs underwent growth arrest from day 2 of co-culture despite inhibition of 
Nodal/Activin signalling. The ratio of wild-type to Bmpr1a-/- mESCs in treated cultures 
compared to DMSO controls were also investigated by FACs analysis. These ratios were 
normalised to the ratio at day 2. Analysis of ratios of wild-type to Bmpr1a-/- mESCs in culture 
when Activin/Nodal signalling was inhibited from day 2 of culture was not significantly 
different from DMSO controls, (ratio of wild-type to Bmpr1a-/- mESCs treated with 10µM 
SB431542 from day 2 co-culture 5.64±0.12 separate 1.31±0.27 compared to DMSO control 
co-culture 6.02±0.06 separate 1.18±0.16 average±s.e.m n=3 p≤0.05 shown in Figure 4.2F).    
This experiment shows that inhibition of Activin/Nodal signalling is insufficient to rescue 
Bmpr1a-/- mESCs from cell competition once cells have initiated differentiation. 
 
4.2.3 LIF mediated signalling is not involved in cell competition between wild-
type and Bmpr1a-/- mESCs. 
 
LIF signalling is essential for the maintenance of mESC pluripotency via activation of the 
Jak-Stat3 signalling pathway resulting in Tbx3-mediated activation of Sox2 and Klf4-
mediated activation of Oct3/4 (Niwa et al., 2009).  Previous work in Drosophila showed that 
differences in STAT signalling, a downstream target of LIF in mESCs, is sufficient to trigger 
competition in the wing disc of developing larvae (Rodrigues et al., 2012).  Recently 
published work by Sancho et al., and Claveria et al., have highlighted the importance of cMyc  
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in mediating cell competition in mESCs and c-Myc is a known target of LIF (Cartwright et 
al., 2005; Claveria et al., 2013; Sancho et al., 2013).   
 
The role of LIF mediated signalling in cell competition was investigated. Separate and co-
cultures of wild-type and Bmpr1a-/- mESCs were plated, as previously described (chapter 3).  
LIF was added with fresh media daily, to all cultures of Bmpr1a-/- and wild-type mESCs from 
the onset of the experiment.  Total cell numbers of separate and co-cultures of wild-type and 
Bmpr1a-/- mESCs were counted daily and compared with control cultures were LIF was not 
added.  In separate cultures for both LIF supplemented and control treated conditions, both 
wild-type and Bmpr1a-/- mESCs show similar growth curves .  In co-cultures of wild-type and 
Bmpr1a-/- mESCs treated with LIF from day 0 of competition, no growth arrest or loss of 
Bmpr1a-/- mESCs is observed (Figure 4.3A-B).  
 
When the ratio of wild-type to Bmpr1a-/- mESCs in separate and co-cultures are quantified by 
FACs analysis, after 4 days of culture it could be observed that there is a significant rescue of 
Bmpr1a-/- mESCs in LIF treated cultures compared to untreated controls, shown in Figure 
4..3C  (LIF treated co-culture 0.76±0.07 separate 0.86±0.17 untreated co-culture 6.94±1.29 
separate 1.88±0.0.29 data shown as average±s.e.m n=3 p≤0.05).  This suggests that LIF 
rescues Bmpr1a-/- mESCs from out-competition by wild-type mESCs. 
 
mESCs cultured in GMEM supplemented with Serum and LIF can be maintained indefinitely 
as a pluripotent undifferentiated population in culture.  To investigate if addition of LIF is 
sufficient to rescue Bmpr1a-/- mESCs from competition once cells have started to 
differentiate, LIF was added to separate and co-cultures of wild-type and Bmpr1a-/- mESCs 
from day 2 of culture.  As shown in Figure 4.3D-E the growth curves of separate wild-type 
and Bmpr1a-/- mESCs are similar. In co-cultures of wild-type and Bmpr1a-/- mESCs where 
LIF is only added from the second day of culture, Bmpr1a-/- mESCs behave similarly to 
untreated cultures, therefore undergo growth arrest at day 2 and are progressively lost from 
culture thereafter. When the proportion of each genotype to the total cell population is 
quantified by FACs analysis and the ratio of wild-type to Bmpr1a-/- mESCs plotted 
normalised to day 2, it could be observed that cultures treated with LIF from day 2 show no 
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significant change compared to untreated controls, Figure 4.3F (co-culture 4.61±0.41 separate 
1.18±0.05 compared to untreated control co-culture 7.38±1.01 separate 1.65±0.15 
average±s.e.m n=3 p≤0.05).  This indicates that once mESCs have initiated differentiation 
LIF mediated signalling is unable to prevent cell competition between wild-type and Bmpr1a-
/- mESCs, suggesting this pathway is not involved in cell competition. 
 
4.2.4 Inhibition of FGF/ERK signalling prevents cell-competition between wild-
type and Bmpr1a-/- mESCs 
 
Similar to Nodal; FGF/ERK signalling is essential throughout mouse development.  Null 
mutations in FGF signalling members are embryonic lethal as early as E4.0 whereupon Fgf4 
mutants die due to defects in PrE and TE formation (Feldman et al., 1995; Goldin and 
Papaioannou, 2003; Yamanaka and Ralson, 2010).  Furthermore, FGF mediated activation of 
ERK1/2 acts as an auto-inductive cue for mESCs to initiate differentiation (Kunath et al., 
2007). To investigate the role of FGF/ERK signalling in cell competition, separate and co-
cultures of wild-type and Bmpr1a-/- mESCs were plated in a 40:60 ratio. 1µM of MEK1/2 
inhibitor PD0325901 or an equivalent volume of DMSO was added to cultures with fresh 
media daily.  Shown in Figure 4.4 are the growth curves of separate and competing cultures 
of wild-type and Bmpr1a-/- mESCs treated with 1µM PD0325901 or DMSO added from day 
0.   In separate cultures wild-type and Bmpr1a-/- mESCs show similar growth curves, and this 
is also reflected by the analysis of growth rates, in Appendix Table.1 (growth rate separate 
wild-type 1.17±0.10; Bmpr1a-/- 1.48±0.25 average±s.e.m n=3 p=0.62).  In competing cultures 
of wild-type and Bmpr1a-/- mESCs treated with DMSO, Bmpr1a-/- mESCs growth arrest by 
day 2 and are progressively lost from culture between days 3 and 4.  This growth arrest and 
removal of Bmpr1a-/- mESCs from co-culture with wild-type cells is not observed in cultures 
treated with 1µM PD0325901.  This observation is confirmed when the ratios of wild-type 
and Bmpr1a-/- mESCs in separate and co-culture conditions are quantified by FACs analysis 
and normalised to the day 0.   The ratio of wild-type/Bmpr1a-/- mESCs from day 0 in 1µM 
PD0325901 treated co-culture was similar to the ratio of PD0325901 treated separate cultures 
and significantly lower than that of DMSO treated co-cultures (ratio of wild-type/Bmpr1a-/- 
mESCs from day 0 in 1µM PD03259011.08±0.17 separate1.78 ±0.06 compared to DMSO 
control co-cultures 6.92 ±0.80 separate 2.40±0.16 data shown as average±s.e.m n=3 p≤0.05).   
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Given that Lif and inhibiting Nodal signalling only blocked cell competition of pluripotent 
mESCs, it is possible that similar may occur with FGF/ERK signalling.  To investigate this 
competing and separate cultures of wild-type and Bmpr1a-/- mESCs were grown in 
GMEM+Serum for 2 days, therefore allowing cells to differentiate.  After 2 days of culture 
the media was supplemented with 1µM PD0325901 or DMSO.  Under these conditions wild-
type and Bmpr1a-/- mESCs in separate cultures show similar growth curves and growth rates 
(between day 2 and 3 ) upon addition of 1µM PD0325901 compared to DMSO controls, 
shown in Figure 4.4 and Appendix Table 1. In contrast to this Bmpr1a-/- mESCs in co-culture 
did not undergo growth arrest when treated with Bmpr1a-/- mESCs, as occurred with DMSO 
controls. Analysis of the ratio of wild-type to Bmpr1a-/- mESCs treated with 1µM 
PD0325901 normalised to day 2 co-culture confirms that this inhibitor rescues the 
elimination of Bmpr1a-/- mESCs (ratio of wild-type to Bmpr1a-/- mESCs, 1µM PD0325901 
from day 2 co-culture 1.23±0.08 separate 0.85±0.10 compared to DMSO control co-culture 
4.47±0.49 separate 1.92±0.03 average±s.e.m n=3 p≤0.05; Figure 4.4F).   This suggests that 
even if added after the onset of differentiation, inhibition of FGF/ERK signalling is sufficient 
to rescue Bmpr1a-/- mESCs from competition.     
 
As described, PD0325901 prevented the elimination of Bmpr1a-/- mESCs by wild-type 
mESCs even when added after the onset of differentiation (day 2 of cell competition) and 
western blot analysis shows that 1µM PD0325901 is sufficient to completely inhibit ERK1/2 
phosphorylation.     
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Figure 4.5 Complete suppression of ERK1/2 phosphorylation is required to 
prevent cell competition between wild-type and Bmpr1a-/- mESCs   
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Figure 4.5 Complete suppression of ERK1/2 phosphorylation is required to prevent cell 
competition between wild-type and Bmpr1a-/- mESCs 
Wild-type and Bmpr1a-/- ESCs were cultured separately or in co-cultures and the ratio of wild-type/Bmpr1a-/- 
mESCs after four days of culture was normalised back to the first day of inhibitor treatment and plotted 
compared to equivalent DMSO controls.  As an indication of inhibitor potency the levels of phosphorylated 
ERK1/2 were determined by western blot and quantified with α-tubulin used as an indicator of protein content. 
Effect of (A) 100ng/ml of FGFR inhibitor PD173074 (B) 10uM MEK1/2 inhibitor U0126  (C) 12.5uM 
PD98059  (D) 1uM PD0325901 (E) 2uM PD184352 on the ratio of wild-type/Bmpr1a-/- ESCs during cell 
competition when added at day 0; day2 and day3 of culture; and ERK1/2 phosphorylation.  (Data shown as 
average±s.e.m n=3 p≤0.05) 
 
 
 
 
 
To further test if FGF/ERK signalling was sufficient to rescue cell competition between wild-
type and Bmpr1a-/- mESCs, a second inhibitor, PD184352, was investigated.  In Figure 4.5B 
Western blot analysis of PD184352 showed that 2µM PD184352 is sufficient to block 
pERK1/2 as previously described (Kunath et al., 2007).   Comparison of the ratio of wild-
type to Bmpr1a-/- mESCs in cultures supplemented daily with 2µM PD184352 from day 0 of 
competition found it to be significantly lower than DMSO control co-cultures and similar to 
separate cultures (ratio of wild-type to Bmpr1a-/- mESCs 2µM PD184352 day 0 co-culture 
1.33±0.30 separate 1.22±0.08 DMSO control 5.95±1.21 separate 1.76±0.19 data shown as 
average±s.e.m n=3 p≤0.05). When 2µM PD184352 was added from day 2 of culture, after 
mESCs had begun to differentiate, the ratio of wild-type to Bmpr1a-/- mESCs was also 
significantly lower than DMSO control co-cultures (day 2 treated co-culture 3.35±0.31 
separate 1.14±0.12 DMSO control 5.39±0.41 separate 1.51±0.19 (average±s.e.m n=3 
p≤0.05).  
 
PD98059 has a similar mode of action to PD184352, acting by preventing ERK1/2 activation, 
but is not as effective at suppressing FGF/ERK signalling (Davies et al., 2000).   12.5µM 
PD98059 was added to separate and co-cultures of wild-type and Bmpr1a-/- mESCs from day 
0 of cell competition and replaced daily with fresh media.  After 4 days of culture the ratio of 
wild-type to Bmpr1a-/- mESCs in cultures treated with 12.5µM PD98059 or DMSO was 
quantified by FACs and normalised.  As shown in Figure 4.5C although treatment of wild-
type and Bmpr1a-/- mESC co-cultures with 12.5µM PD98059 did not completely rescue the 
elimination of Bmpr1a-/- mESCs it leads to a significantly lower ratio of wild-type to Bmpr1a-
/- mESCs compared to DMSO treated co-cultures (ratio wild-type/Bmpr1a-/- mESCs 12.5µM 
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PD98059 day 0 co-culture 4.61±0.22 separate 1.52±0.09 DMSO control co-culture 9.91±0.59 
separate 2.07±0.06 (average±s.e.m n=3 p≤0.05).  12.5µM PD98059 was also added to 
separate and co-cultures of wild-type and Bmpr1a-/- mESCs after 2 days of culture in 
GMEM+SeruM.  However under these conditions no significant differences could be 
observed in the ratio of wild-type to Bmpr1a-/- mESCs in co-culture compared to DMSO 
(ratio wild-type/Bmpr1a-/- mESCs treated co-culture 6.22±0.51 separate 1.20±0.11 DMSO 
control co-culture 7.46±0.96 separate 1.39±0.16).    Analysis of the efficiency of PD98059 to 
block ERK1/2 revealed that 12.5µM only led to a partial blockage of ERK1/2 
phosphorylation (fold change wild-type 0.6X reduction compared to control; Bmpr1a-/- 0.5X 
reduction, Figure 4.5C). This suggests that partial suppression of ERK signalling is not 
sufficient to rescue Bmpr1a-/- from cell competition in co-culture with wild-type mESCs.  
 
Next U0126, a chemical inhibitor of MEK1/2 signalling but with fewer non-specific effects 
than PD98059 (Davies et al., 2000) was tested.   The effect of U0126 on ERK1/2 
phosphorylation was analysed by western blot (Figure 4.5D) and it was observed that 10µM 
only caused 0.5 fold reduction in ERK1/2 phosphorylation. To analyse the effects of this 
level of pERK1/2 inhibition on mESCs separate and co-cultures of wild-type and Bmpr1a-/- 
mESCs were plated (starting ratio 40:60 wildtype:Bmpr1a-/- mESCs).  10µM U0126 was 
added daily from the onset of cell competition and the ratio of wild-type to Bmpr1a-/- mESCs 
analysed after 4 days of culture in each condition.  As observed with PD98059, partial 
suppression of FGF/ERK signalling from the onset of culture was sufficient to partially 
rescue Bmpr1a-/- mESCs from elimination compared to DMSO controls (ratio wild-
type/Bmpr1a-/- mESCs 10µM U0126 day 0 co-culture 1.65±0.13 separate 1.41±0.20 DMSO 
control co-culture 8.39±0.38 separate 2.12±0.04).   The effect of PD98059 on the co-culture 
of wild-type and Bmpr1a-/- mESCs once they had started differentiate was also analysed. 
When co-cultures treated 2 days after culture with 10µM U0126 were compared to DMSO 
controls, no significant difference in ratio of wild-type/Bmpr1a-/- mESCs was observed (day 2 
treated co-culture 6.15±0.29 separate 1.78±0.29 DMSO control co-culture 6.82±0.34 separate 
1.51±0.14 all data shown as average±s.e.m n=3 p≤0.05).   These data suggest that complete 
suppression of FGF/ERK signalling is required to prevent cell competition between wild-type 
and Bmpr1a-/- mESCs after the onset of differentiation. 
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PD173074 acts as a small chemical inhibitor of FGFR1 by preventing its autophosphorylation 
(Bansal et al., 2003).   PD173074 therefore acts by suppressing the response to FGF ligand 
binding to its receptor rather than acting on ERK1/2 phosphorylation.  To determine the 
concentration of PD173074 required to suppress ERK1/2 phosphorylation wild-type and 
Bmpr1a-/- mESCs were treated with increasing concentrations of inhibitor. The level of 
pERK1/2 at each concentration in both cell lines was analysed by western blot, Figure 4.5E.  
Surprisingly PD173074 affected wild-type and Bmpr1a-/- mESCs differently.  In wild-type 
cells addition of increasing concentrations of PD173074 resulted in an increased reduction in 
PD173074.  In contrast, when treated with lower concentrations of PD173074 Bmpr1a-/- 
mESCs show higher levels of pERK1/2.   
 
Next the effect of PD173074 on competition was analysed. Adding 100ng/ml PD173074 to 
separate and co-cultures of wild-type and Bmpr1a-/- mESCs allowed  to analyse the effect of 
suppression of FGF/ERK signalling in wild-type mESCs, whilst upregulating it in Bmpr1a-/- 
mESCs.  Separate and co-cultures of wild-type and Bmpr1a-/- mESCs were plated and treated 
from day 0 with 100ng/ml PD173074, replaced daily with fresh media.  After 4 days of 
culture the ratio of wild-type and Bmpr1a-/- mESCs in co-culture was significantly lower 
compared to DMSO controls (Figure 4.5E 100ng/ml PD173074 day 0 co-culture 1.37±0.32 
separate 2.15±0.49 DMSO control 10.05±2.19 separate 2.69±0.51).   As with previous 
experiments the effects of adding the inhibitor from day 2 was analysed by studying the ratio 
of wild-type to Bmpr1a-/- mESCs in separate and co-culture.  The ratio of wild-type to 
Bmpr1a-/- mESCs co-cultured from 2 day with PD173074 was compared to similarly treated 
DMSO controls, and found to be significantly lower in treated cultures (day 2 treated co-
culture 3.37±0.58 separate 1.17±0.23 DMSO control co-culture 6.83±0.96 separate 1.63±0.24 
data shown as average±s.e.m n=3 p≤0.05).  This data suggests that a change in FGF/ERK 
signalling in ‘winner’ cells mediates cell competition in wild-type and Bmpr1a-/- mESCs.   
 
The effect of each inhibitor was determined by their ability to significantly alter the ratio of 
wild-type to Bmpr1a-/- mESCs after 4 days of culture.  As with both Activin/Nodal and LIF 
experiments, the effect of FGF/ERK inhibition on cell competition was investigated at two 
different time points, from the onset of competition (cells are mESCs - inhibitor from day 0) 
or after 2 or 3 days of culture to allow mESCs to initiate differentiation (day 2/ day 3 
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inhibitor).  In each case, the ratio of wild-type to Bmpr1a-/- mESCs were normalised to the 
population ratio at the onset of inhibitor treatment.  Once normalised, ratios of wild-type to 
Bmpr1a-/- mESCs were compared by students’ t-test to DMSO controls cultured at the same 
time to determine whether changes were significant.  To establish the efficiency of each 
inhibitor western blot for ERK1/2 phosphorylation was used as an indicator of their ability to 
prevent ERK1/2 phosphorylation.  In all cases, addition of inhibitor from day 3 of culture was 
never sufficient to rescue cell competition (shown in Figure 4.5 ratios shown in Appendix 
Table 2). It is likely that by that point the process is too far along to be efficiently reversed. 
 
4.2.5 Addition of FGF ligands to competing cultures does not promote cell 
competition between wild-type and Bmpr1a-/- mESCs 
 
In early murine development, FGF4 is paracrine factor produced by cells of the ICM and acts 
as an autoinductive cue to promote differentiation and specific PrE cell fate (Kunath et al., 
2007; Frum et al., 2013).  As mESCs differentiate and become EpiSCs, FGF4 is 
downregulated in favour of FGF5, which is often used as a marker of EpiSCs (Hebert et al., 
1994; reviewed by Rossant and Lanner, 2010).  Both FGF4 and FGF5 have different 
affinities for the FGFRs.  These differences in receptor binding affinity are likely to reflect 
specificity activation of ligand targets.   
 
Inhibition of FGF/ERK signalling, as analysed by western blotting for pERK, was able to 
block cell competition, at both the mESC state and after the onset of differentiation.    To 
investigate if promoting FGF signalling was sufficient to promote cell competition, FGF4 or 
FGF5 was added to separate and co-cultures of wild-type and Bmpr1a-/- mESCs.  FGF4 or 
FGF5 was added to cultures daily at 5ng/ml and 10ng/ml daily in the presence of 1ug/ml 
heparin (Kunath et al., 2007).  1ug/ml heparin was used as a volume control for these 
experiments.   
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In separate cultures treated with 5ng/ml FGF4 and 1ug/ml heparin wild-type and Bmpr1a-/- 
show similar growth curves (Figure 4.6).   However, in co-culture with wild-type cells, 
Bmpr1a-/- mESCs growth arrest after 2 days and are progressively lost from culture.  After 4 
days of culture, separate and co-cultures of wild-type and Bmpr1a-/- mESCs were analysed by 
FACs.  This was to quantify if the loss of Bmpr1a-/- mESCs from co-culture with wild-type 
mESCs was more pronounced in the presence of excess FGF, shown in Figure 4.6.  When the 
ratio of wild-type and Bmpr1a-/- mESCs in co-cultures grown with additional FGF4 was 
compared to heparin treated controls, no significant difference was observed (ratio wild-
type/Bmpr1a-/- mESCs 5ng/ml FGF4 co-culture 7.62±0.25 separate 1.67±0.40; 1ug/ml 
heparin only 8.01±1.25 separate 2.04±0.48; average±s.e.m n=3 p≤0.05).   
 
Similar to FGF4- treated cultures, wild-type and Bmpr1a-/- mESCs grown separately 
supplemented with 10ng/ml FGF5 also show similar growth rates.  When cells of both 
genotypes are grown in co-culture, Bmpr1a-/- mESCs growth arrest and are progressively lost 
from culture, similar to FGF4-treated and 1ug/ml heparin control cultures.  After 4 days of 
culture, the ratio of wild-type and Bmpr1a-/- mESCs in separate and co-cultures were 
quantified by FACs analysis (shown in Figure 4.6F).  However, when these ratios were 
compared to 1ug/ml heparin control cultures no significant difference in these ratios was 
observed  (ratio wild-type/Bmpr1a-/- mESCs 10ng/ml FGF5 co-culture 10.82±2.63 separate 
2.01±0.23; 1ug/ml heparin co-culture 7.62±0.81 separate 2.15±0.46 data shown as 
average±s.e.m n=3 p≤0.05).  These data show that addition of excess FGF4 or FGF5 does not 
promote cell competition in cultures of wild-type and Bmpr1a-/- mESCs.   All FGF/ERK 
signalling modulation experiments are summarized in Table 3. 
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Table 3.  Summary of Results of FGF/ERK modulation experiments on Cell Competition 
between wild-type and Bmpr1a-/- mESCs. 
The table above summarises the results seen when the FGF/ERK signalling pathway was perturbed 
using different small molecule signalling molecules to affect activation of the FGF/ERK signalling 
pathway.   
  
 
4.2.6 Inhibition of Wnt signalling is sufficient to significantly promote cell  
competition dynamics between wild-type and Bmpr1a-/- mESCs. 
 
Wnt signalling is required throughout development in addition to Activin/Nodal; BMP and 
FGF signalling pathways.  In mESCs, Wnt signalling is required to maintain mESC self-
renewal and pluripotency, in part by alleviating Tcf3-mediated repression of core 
pluripotency transcription factors (Niwa, 2011; ten Berge et al., 2011).  However in EpiSCs,  
Reagent Concentration  Effect on Cell 
competition              at 
day 0 
Effect on Cell 
competition              
at day 2 
PD0325901  
MEK 1/2 inhibitor 
1µM Rescue Rescue 
 
PD184352 
MEK 1/2 inhibitor 
2µM Rescue  Rescue 
 
PD98059 
MEK ½ inhibitor 
12.5µM Rescue No Rescue 
U0126 
MEK1/2 inhibitor 
10µM Rescue No Rescue 
PD173074 
FGFR inhibitor 
1000ng/ml Rescue Rescue 
FGF4 
FGFR1c/2c ligand 
5ng/ml No change N/A 
FGF5 
FGFR1c/2c ligand 
10ng/ml No change N/A 
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Wnt signalling is required for both differentiation and pluripotency.  Nuclear transduction of 
β-catenin in EpiSCs promotes differentiation, whilst retention of high levels of β-catenin in 
the cytoplasm maintains pluripotency (Kim et al., 2013).    
 
To first investigate whether perturbing Wnt signalling would affect cell competition 
dynamics, two recently developed Wnt signalling inhibitors IWR-1 and IWP2 were utilised 
(Chen et al., 2009).  IWR-1 is a tankyrase inhibitor, which prevents the degradation of 
Axin1/2, members of the β-catenin proteasome.  Treatment of cells with IWR-1 significantly 
reduces β-catenin mediated Wnt signalling (Huang et al., 2009). Separate and co-cultures of  
Bmpr1a-/- mESCs were plated, (with a starting ratio of 40:60 Bmpr1a-/- mESCs in co-culture) 
and 2µM IWR-1 was added daily.  As Wnt signalling has been shown to affect mESCs and 
mEpiSCs differently the effect of perturbing Wnt signalling was investigated both in mESCs 
and after cells had begun to differentiate.  
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Addition of 2µM IWR in separate cultures of wild-type and Bmpr1a-/- mESCs did not affect 
cell growth; either by comparison of growth curves or analysis of growth rates (Appendix, 
Figure 1).  However, in wild-type and Bmpr1a-/- mESCs in co-cultures shows that after two 
days of culture, Bmpr1a-/- mESCs are progressively lost from culture, reflected by a 
significant reduction in their growth rate compared to separate cultures.  After 4 days of 
culture analysis of the ratio of wild-type/Bmpr1a-/- mESCs in separate and co-culture 
compared to DMSO controls revealed is a significantly higher proportion of wild-type 
mESCs in co-cultures treated with 2µM IWR-1 compared to DMSO treated cultures, Figure 
4.7 (ratio wild-type/Bmpr1a-/- mESCs IWR-1 co-culture 11.91±1.89 separate 2.37±0.33 
DMSO control co-culture 7.75±1.13 separate 1.68±0.20).  
 
To investigate if inhibiting Wnt signalling promotes cell competition after cells have begun to 
differentiate separate and co-cultures of wild-type and Bmpr1a-/- mESCs were cultured for 2 
days in GMEM+Serum.  After 2 days of culture 2µM IWR-1 was added daily to these 
cultures with DMSO treated cultures used as a vehicle control.  Analysis of the growth curves 
and growth rates of wild-type and Bmpr1a-/- mESCs shows that inhibition of Wnt signalling 
after cells have started to differentiate does not affect cell growth in separate culture 
conditions (growth rate wild-type treated 0.64±0.10; DMSO 0.44±0.04 p=0.91 Bmpr1a-/- 
treated 0.35±0.11; DMSO 0.39±0.12 p=0.74 average±s.e.m n=3 shown in Appendix Table 1).    
In contrast when the growth curves of wild-type and Bmpr1a-/- mESCs in co-culture were 
analysed, it could be observed that Bmpr1a-/- mESCs are also progressively lost from culture.  
Analysis of growth rates shows that Bmpr1a-/- mESCs are not lost faster in co-cultures treated 
with IWR-1 compared to DMSO controls, Figure 4.7C (growth rate Bmpr1a-/- co-culture 
treated -0.37±0.08; DMSO -0.33±0.15 average±s.e.m n=3 p=0.74). However when the ratio 
of wild-type to Bmpr1a-/- mESCs in treated co-cultures are compared to DMSO controls, 
there is  a significant increase in the proportion of wild-type mESCs, Figure 4.7F (day 2 
treated 7.35±0.10 separate 1.29±0.08 DMSO co- culture 5.77±0.45 separate 1.18±0.10;  data 
shown as average±s.e.m n=3 p≤0.05).   This suggests that Bmpr1a-/- mESCs are being lost 
more quickly in IWR-1 treated cultures compared to DMSO controls, but that this is due to 
differences other than cell growth. 
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To confirm these results a second Wnt signalling inhibitor, IWP-2 which targets Porcupine 
(Porc), was used. Porc encodes a protein which modifies Wnt ligands post-transcriptionally 
by adding a palmitoyl group to ligands (Kadowaki et al., 1996; Tanaka et al., 2000).  This 
modification renders Wnt ligands soluble and thus able to travel through the extracellular 
space.  In contrast to IWR-1 inhibition, treatment of cells with IWP-2 would also help to 
investigate if changes in Wnt signalling are due to β-catenin mediated signalling or non-
canonical effects of Wnt binding to receptor ligands.  
 
Wild-type and Bmpr1a-/- mESCs were plated in separate and co-cultures at a starting ratio of 
40:60 and 2µM IWP-2 was added from day 0, data shown in Figure 4.8.  Comparison of the 
growth curves shows similar growth between wild-type and Bmpr1a-/- mESCs when grown 
separately, reflected by growth rates (wild-type 0.66±0.26; Bmpr1a-/- 0.20±0.17 
average±s.e.m n=3 p=0.08 shown in Appendix Table 1).  In co-cultures wild-type mESCs 
Bmpr1a-/- mESCs growth arrest and are progressively removed from culture, as shown by a 
significant reduction in the growth rate of Bmpr1a-/- mESCs after 3 days in co-culture 
(growth rate between day 2 and day 3 separate 0.20±0.17 co-culture -0.38±0.17 
average±s.e.m n=3 p≤0.05 shown in Appendix 1).  After 4 days of culture supplemented with 
2µM IWP-2 the ratio of wild-type to Bmpr1a-/- mESCs in treated cultures were compared to 
DMSO controls.  Data shown in Figure 4.8 shows that in co-cultures of wild-type and 
Bmpr1a-/- mESCs there is a significantly higher proportion of wild-type mESCs when Wnt 
signalling is inhibited compared to controls (ratio of wild-type/Bmpr1a-/- mESCs normalised 
back to the first day of treatment, day 0 2µM IWP-2 co-culture 11.34±2.13 separate 
1.95±0.17 DMSO control co-culture 7.78±1.03 separate 1.76±0.11).  
 
A second experiment was performed to investigate if IWP-2 inhibition of Wnt signalling was 
also sufficient to affect cell competition dynamics after the onset of differentiation.  Separate 
and co-cultures of wild-type and Bmpr1a-/- mESCs were plated and allowed to differentiate in 
GMEM+Serum for 2 days.  After 2 days culture medium was supplemented with 2µM IWP-2 
or an equal volume of DMSO. Analysis of the growth curves of cells grown in separate 
culture show no significant differences (growth rate between day 2 and day 3 wild-type 
0.66±0.14; Bmpr1a-/- 0.36±0.11 average±s.e.m n=3 p=0.24, shown in Appendix Table 1).  
However, as with IWR-1 treated and DMSO control co-cultures, after 2 days of co-culture 
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inhibition of Wnt signalling still resulted in growth arrest and removal from culture of 
Bmpr1a-/- mESCs.  Analysis of growth rates demonstrates that this removal of Bmpr1a-/- 
mESCs compared to DMSO co-cultures is not due to changes in cell growth (growth ratio 
between day 2 and day 3 of co-culture 2µM IWP-2 -0.25±0.24 DMSO -0.20±0.22 
average±s.e.m n=3 p=0.67).To compare if the change in proportion of Bmpr1a-/- mESCs in 
culture was significantly different to DMSO controls, the ratio of wild-type to Bmpr1a-/- 
mESCs in separate and co-cultures was quantified by FACs analysis.  There is a significant  
reduction in the ratio of wild-type/Bmpr1a-/- mESCs in IWP-2 treated co-cultures compared 
to DMSO controls, once normalised to the ratio of wild-type/Bmpr1a-/- mESCs after 2 days of 
culture data shown in Figure 4.8 (ratio wild-type/Bmpr1a-/- mESCs IWP-2 day 2 treated co-
culture 7.45±0.36 separate 1.38±0.31 DMSO control 5.50±0.21 separate 1.38±0.13 
average±s.e.m n=3 p≤0.05).  
 
These data show that suppression of Wnt mediated signalling promotes cell competition 
dynamics and therefore has the opposite effect to that observed with suppressing FGF/ERK 
signalling.   Furthermore these data show that these changes are likely to be affected by 
canonical β-catenin mediated changes in Wnt signal transduction.   
 
4.2.7 Promoting Wnt signalling is sufficient to rescue Bmpr1a-/- mESCs upon 
competition with wild-type mESCs. 
 
The converse experiment, investigating the effect of promoting Wnt signalling was carried 
out using the GSK3β inhibitor CHIRON99201.  Like Axin1/2 GSK3β is also a member of 
the β-catenin proteasome.  In addition with other proteins GSK3β binds to β-catenin and 
phosphorylates it.  Phosphorylation of β-catenin targets it to the lysosome and results in its 
degradation.  Inhibition of GSK3β results in disassociation of the β-catenin phosphorylation 
complex.  In response to Wnt signals, GSK3β is inhibited and β-catenin accumulates in the 
cytoplasm and translocates to the nucleus to target transcription.   
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Separate and co-cultures of wild-type and Bmpr1a-/- mESCs were plated and 3µM 
CHIRON99201, a GSK3β inhibitor, was added from the day 0, data shown in Figure 4.9.   In 
contrast to DMSO controls where Bmpr1a-/- mESCs are lost in co-culture, wild-type and 
Bmpr1a-/- mESCs s cultured separately or together in the presence of CHIRON displayed 
similar growth curves.  Despite this wild-type mESCs show significantly higher growth rates 
in co-culture compared to separate cultures between days 2 and 3 of culture  co-culture 
0.86±0.01 separate 0.53±0.05 average±s.e.m n=3 p≤0.05).  This increase in growth rate is not 
accompanied by a significant reduction in growth rate of Bmpr1a-/- mESCs (growth rates co-
culture 0.64±0.04 separate 0.60±0.10 average±s.e.m n=3 p=0.85). To compare if this rescue 
of Bmpr1a-/- mESCs is significant the ratio of wild-type and Bmpr1a-/- mESCs in separate and 
co-culture were analysed after 4 days by FACs, Figure 4.9C. These data was normalised to 
the starting ratio of wild-type:Bmpr1a-/- mESCs (40:60) and the ratio in co-culture was found 
to be significantly lower compared to DMSO controls, data (ratio of wild- type/Bmpr1a-/- 
mESCs 3µM CHIRON99201 day 0 co-culture 1.24±0.11 separate 1.07±0.17 DMSO control 
co-culture 10.08±3.08 separate 1.97±0.47). 
 
Wnt signalling is involved in maintaining mESC self-renewal and pluripotency and therefore 
the question if promoting Wnt signalling sufficient to rescue cell competition after the onset 
of differentiation was next asked.  To investigate this separate and co-cultures of wild-type 
and Bmpr1a-/- mESCs were plated and left to differentiate in GMEM+Serum for 2 days.  
After 2 days 3µM CHIRON99201 was added daily to cultures with fresh media.  Growth 
curves of separate cultures show no changes compared to DMSO controls, shown in Figure 
4.9 and Appendix 1 (growth rate at day 3 wild-type CHIRON99201: 0.67±0.14; DMSO 
0.71±0.09 p=0.58; Bmpr1a-/- CHIRON99201 0.55±0.07; DMSO 0.47±0.13 p=24). 
Similarly, the growth curve of wild-type mESCs in co-culture with Bmpr1a-/- mESCs show 
no differences compared to DMSO controls or separate cultures (growth rate wild-type co-
culture treatment 0.88±0.23 compared to DMSO 1.24±0.11 p=0.13). However, when 
compared to the growth rate of wild-type mESCs in separate cultures treated with 
CHIRON99201, cells in co-culture grow significantly faster (separate wild-type 0.66±0.14 
average±s.e.m n=3 p≤0.05).   In contrast to this, while in DMSO controls Bmpr1a-/- mESCs 
growth arrest after two days of co-culture with wild-type mESCs and are progressively lost 
from culture after this, in co-cultures supplemented with 3µM CHIRON99201 this growth 
 104 
 
arrest only commences at day 3.  After 4 days of culture FACs analysis was used to quantify 
the ratio of wild-type to Bmpr1a-/- mESCs in separate and co-cultures.  These data were 
normalised to the ratio of wild-type/Bmpr1a-/- mESCs when the inhibitors were added (day2).  
In co-cultures of wild-type and Bmpr1a-/- mESCs supplemented for 2 days with 3µM 
CHIRON99201, there is a significantly higher proportion of wild-type cells in co-culture 
compared to separate cultures.  However, when this difference was compared to DMSO 
control co-cultures, it was significantly lower, suggesting a partial rescue of Bmpr1a-/- 
mESCs occurred (Figure 4.9F; ratio wild-type/Bmpr1a-/- mESCs day 2 treated co-culture 
3.79±0.99 separate 1.30±0.25 DMSO control co-culture 7.92±2.28 separate 1.59±0.17 (data 
shown as average±s.e.m n=3 p≤0.05).  Promoting Wnt signalling after differentiation is 
sufficient to rescue Bmpr1a-/- mESCs from cell competition with wild-type mESCs but this 
rescue is partial. 
 
4.3 Discussion 
 
What roles do cell-cell contact and signalling factors have in cell competition?  Senoo-
Matsuda and Johnston first demonstrated the role of secreted factors in cell competition in 
cultures of Drosophila epithelial cells.  Using transwell culture experiments, they showed that 
wild-type cells grown with dMyc overexpressing cells were eliminated by apoptosis even if 
these populations were not in contact with each other (Senoo-Matsuda and Johnston, 2007).    
 
A second series of experiments performed by Rhiner and co-workers seem to contradict this 
finding (Rhiner et al., 2010).  Using microarray analysis of competing dMyc over-expressing 
cells against a wild-type background, Rhiner and colleagues identified a number of genes 
differentially expressed in separate and competing populations.   One of these genes encoded 
the cell-surface receptor Flower (Fwe). Fwe is a transmembrane synaptic vesicle Ca2+ 
channel involved in endocytosis (Yao et al., 2009).  Analysis of Fwe isoform expressions 
showed that in the presence of winner cells, loser cells changed expression of full length Fwe 
receptor to a truncated form.  In large clones of FweloseA/loseB cells, apoptosis was significantly 
higher at the clone border with wild-type cells.  Similarly, FweloseA/loseB –GFP Drosophila 
epithelial cells survived in co-cultures with wild-type cells when plated at low confluencies 
where no cell contact occurred (Rhiner et al., 2010) 
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. 
In this thesis the requirement for cell-cell contact during cell competition was investigated.  
Using transwell co-cultures of mESCs with different genotypes (wild-type vs. Bmpr1a-/-/ 
Atg5-/- or 4n) it was observed that cell competition occurred without cell-cell contact. One 
possible explanation why cell competition has been shown to have different requirements for 
cell contact in different contexts is that both cell contact and secreted factors may be involved 
in cell competition.   For example it is possible that in the absence of cell-cell contact 
secreted factors alone may mediate cell competition, but when cells are grown in contact with 
each other there may be an additive effect of long and short range signals.    
 
Interestingly, analysis of growth rates of wild-type mESCs grown in transwell co-culture 
compared to physical co-culture was changed.  As shown in chapter 3 the presence of 
Bmpr1a-/- mESCs significantly increases the growth rate of wild-type mESCs in co-culture, 
where cells can communicate via cell-cell boundaries.  Similar observations have also been 
made in Drosophila models of cell competition (de la Cova et al., 2004).   However, in 
transwells with overlying Bmpr1a-/- mESCs, the growth rate of wild-type cells are lower 
compared to wild-type cells with cells of the same genotype overlying them. It could be that 
cell-cell contact with loser cells drives the proliferation of winner cells during cell 
competition, whilst secreted factors trigger their elimination.   
 
Though there are no significant changes in apoptosis using transwell co-culture, this does not 
preclude that Bmpr1a-/- mESCs are being eliminated from co-culture with wild-type mESCs 
by other mechanisms (Degterev and Yuan, 2008; Vincent et al., 2013).  An alternative 
possibility is that analysis of AnnexinV levels does not accurately reflect differences in 
apoptosis. The analysis done in this chapter was only carried out on the cells remaining 
attached to the base of the tissue culture well.  As was observed in Figure 3.1, many mESCs 
detach from culture prior to analysis.  Thus, this data may not truly reflect the actual 
percentages of apoptotic and dying cells in competing cell cultures, as a number of cells may 
have already been lost by extrusion, or engulfed by their neighbours.  Inhibition of caspase 
activation was sufficient to rescue Bmpr1a-/- mESCs from cell competition upon co-culture 
with wild-type cells (chapter 3); it may be interesting to see whether this rescue occurs in 
transwell co-culture as well.   
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Given that secreted factors were found to mediate cell competition in mESCs, this chapter 
also investigated which signalling pathways affect cell competition dynamics between wild-
type and Bmpr1a-/- mESCs.  In the literature, Nodal signalling has been shown to help 
maintain mESCs in a pluripotent state by mediating BMP signalling (Galvin et al., 2010).  
Activin/Nodal signalling is also required for EpiSC pluripotency (Brons et al., 2007; Tesar et 
al., 2007).  Interestingly, inhibition of Activin/Nodal signalling in co-cultures was sufficient 
to prevent cell competition while cells remain in the undifferentiated naïve ES state, but not 
once cells had been allowed to begin differentiating. 
 
LIF/STAT mediated signalling is also a known requirement for mESC pluripotency in 
conventional ES media (GMEM supplemented with LIF and Serum).  LIF acts by activating 
STAT3 signalling, a known target of which is c-Myc. Culture of cells in ES media completely 
rescues Bmpr1a-/- mESCs from competition with wild-type cells.  However, LIF is unable to 
rescue loser cells from competition once cells have begun differentiating.  This could be due 
to down-regulation of the LIF/gp130 receptor rendering cells less susceptible to signalling 
(Sancho et al., 2013).    
 
The role of the FGF/ERK signalling pathway in cell competition in wild-type and Bmpr1a-/- 
mESCs was also investigated. This chapter shows that inhibiting ERK signalling at different 
levels had different effects.  Complete suppression of ERK rescued cell competition after 
cells had started differentiating, but partial suppression did not. Suppression of FGF/ERK 
signalling has been shown to promote mESC self-renewal and pluripotency as part of the 2i 
culture system (Ying et al., 2008).  In this system suppressing pERK also suppresses Myc 
(Ying et al., 2008).  Further evidence that ERK signalling acts upstream of Myc stabilisation 
was presented by Sears and colleagues (2002).  In their work they describe a mechanism 
where ERK acts as a positive modulator of Myc stability via phosphorylation of the S62 
residue (Sears et al., 2002).  
 
Therefore changes in Myc stability may explain why FGF/ERK inhibition could rescue cells 
from competition. This would also provide an explanation for the cell competition rescue in 
PD173074 treated cultures where ERK phosphorylation was suppressed only in wild-type 
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cells.  Inhibition of pERK in wild-type cells would also suppress cMyc upregulation in those 
cells, thereby preventing a difference between cMyc expression between wild-type and 
mutant cells (Ying et al., 2008; Sancho et al., 2013).  Without the transient upregulation of 
cMyc in winner cells, cell competition does not occur (Sancho et al., 2013).  
 
However, experiments where additional FGF4 or FGF5 were added to cultures did not affect 
cell competition.  This could be due to the FGF concentrations used for these experiments 
being insufficient to significantly upregulate ERK signalling in wild-type cells.  
Alternatively, given that FGF signalling pathway is comprised of 22 known ligands (Villegas 
et al., 2010).  It could be that different ligands or a combination of ligands are required to 
promote cell competition. 
 
Finally the role of Wnt signalling in cell competition was also investigated.  Both inhibition 
and stimulation of Wnt signalling were able to change cell competition dynamics.  When Wnt 
signalling is inhibited, cell competition dynamics are more pronounced.  In cultures where 
GSK3β is repressed, cell competition is also inhibited.    In mESCs and mEpiSCs, Wnt 
signalling has been shown to mediate self-renewal and pluripotency via localisation of β-
catenin (reviewed by Niwa et al., 2011; Kim et al., 2013).  Wnt signalling has been shown to 
act by inhibiting GSK3β activity (Metcalf and Bienz, 2011; Wu and Pan, 2010).  GSK3β 
phosphorylates the T58 residue on cMyc, a modification that targets it for degradation.  
Therefore, like the ERK signalling pathway, modulation of the Wnt signalling pathway, and 
therefore GSK3β activity could affect Myc stability.  cMyc could either be more unstable in 
loser cells or, via repression of GSK3β activity, more stable in winner cells. 
 
Both FGF and Wnt signalling may converge on c-Myc to drive cell competition. Myc 
signalling has been reported to trigger cell competition in Drosophila (de la Cova et al., 2004; 
Moreno and Basler, 2004).  In co-cultures of wild-type mESCs with cells of mutant genotype 
(Bmpr1a-/-; Atg5-/- and 4n), cMyc is transiently upregulated in wild-type cells during 
competition (day 3-4 of co-culture) (Sancho et al., 2013).  Recently another group has also 
shown that relative differences in Myc expression can drive cell competition in vivo during 
early mouse development (Claveria et al., 2013).  
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Figure 4.10 Model for how differentiation and signalling factors may affect cell competition 
mESCs have homogenously high levels of c-Myc expression.  As cells begin to differentiate this 
level of high c-Myc expression is lost.  This rate may be dependent upon differentiation, which is 
affected by signalling factors such as members of the FGF or WNT pathways.   This results in the 
first step during cell competition where mutual sensing of c-Myc expression allows cells to 
identify neighbours cells with lower c-Myc indicating them as “unfit” or mispatterned.  In 
response to mutual sensing this establishes differential c-Myc expression between “fit” and 
“unfit” cells.  Cells continue to mutually sense the c-Myc expression levels of neighbouring cells 
leading to activation of apoptosis and elimination of “unfit” cells with relatively lower c-Myc 
expression (Sancho et al., 2013).  
One question that arises from these experiments is why are mESCs resistant to competition?  
One explanation is that this pluripotent state also has high levels of cMyc, rendering cells less 
susceptible to relative changes in expression.   In addition questions still remain as to the 
precise role of the ERK and Wnt signalling pathways in cell competition.   As both the 
FGF/ERK and WNT signalling pathways also affect differentiation of mESCs it could be that 
affecting the process of differentiation could affect cell competition. As changes in c-Myc 
expression is the common trigger of cell competition, it is likely that these factors help 
regulate the relative expression of c-Myci between winner and loser cells (Sancho et al., 
2013). FGF signalling is known to maintain mESC pluripotency, and thus, maintaining the 
relatively high c-Myc expression of that state (Kunath et al., 2007).  This could therefore 
make winner cells less able to sense the relative differences in Myc expression that would 
indicate a loser cell and trigger competition.  The converse would apply to competitions 
where WNT signalling was modified as WNTs are required to drive mESC differentiation 
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(Altasi et al., 2013).   However this explanation still leaves some questions as it is unknown if 
there are differences in signal transduction between winner and loser cells and whether this 
would directly result in upregulation of c-Myc in winner cells?  It would also be interesting to 
investigate how changes in c-Myc regulation induce apoptosis in loser cells and survival of 
winner cells.  Lastly it would be of interest to investigate if other pathways independent of c-
Myc induction affect cell competition.  This hypothesis is summarised in the chart below, 
Figure 4.10. 
 
To begin to answer these questions, first it needs to be proved that modulation of the ERK or 
Wnt signalling pathways affect c-Myc upregulation in winner cells.  Once this is established, 
the next line of questioning would be how is this change accomplished?  Does ERK and Wnt 
signalling act as described in the literature by phosphorylating specific residues on c-Myc that 
affect its stability (Cartwright et al., 2005; Sears et al., 2002)? To investigate this analysis of 
signalling activity in each cell type could be investigated at the onset of differentiation. 
 
An additional question would be whether differences in Wnt and FGF signalling in winner or 
loser cells alone are enough to prevent cell competition?  This would require the generation 
of mutant cell lines also deficient in FGF or Wnt signal transduction or investigating whether 
cells with impaired FGF/Wnt signalling could outcompete other mutant genotypes. 
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Chapter 5 – Investigating the Role of Autophagy during Cell 
Competition 
 
5.1 Introduction 
 
Autophagy is a process by which cytoplasmic components, including organelles are degraded 
by the lysosome. Macroautophagy (hereafter referred to as “autophagy”) is of particular 
interest as it is through this method that cytosolic contents are delivered to the lysosome by 
specialised compartments called autophagosomes.   Phagocytosis of neighbouring cell debris 
(also known as “engulfment”) once internalized, is degraded by the autophagy pathway. 
 
Autophagy is regulated by the serine/threonine kinase mammalian target of rapamycin 
(mTOR) (Lum et al., 2005). ATG5 and Beclin1 are also components of the autophagy 
pathway in mammalian systems.  ATG5 forms a conjugate complex with ATG12, which is 
required for formation of the autophagosome isolation membrane where cytosolic 
components are degraded (Mizushima et al., 2001).  Beclin1 acts in a variety of roles, some 
autophagy-independent and regulates autophagy through interaction with class I PI3K 
kinases.   The class I PI3K kinase complex made up partly of ATG14 and Beclin-1 mediate 
localisation of autophagy components to the preautophagosome site (PAS) (Cao and 
Klionsky, 2007).   
 
Autophagy has physiological and morphological roles in the cell. It acts as an adaptive 
response to starvation or stress to breakdown excess proteins back into their amino acid 
components and provide energy when needed.  Due to this autophagy is closely coupled to 
the nutrient-sensing metabolism pathway. In addition, autophagy acts as a quality control 
mechanism for intracellular proteins and organelles, where long-lived or excess cytosolic 
components are trafficked into the autophagosome pathway and degraded.  This allows the 
cell to ‘refresh’ its cytosolic contents and to remove damaged or misfolded organelles and 
proteins which would otherwise remain.   
 
Autophagy is active throughout embryonic development, in particular its role in clearing 
apoptotic cellular debris In Atg5 and Beclin1 null mutant EBs cavitation does not occur due 
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to the persistence of apoptotic corpses in the fluid-filled centre of the EB, suggesting the 
autophagy pathway may be involved in clearance of cellular debris (Coucouvanis and Martin, 
1999; Mizushima and Levine, 2010; Qu et al., 2007; Tsukamoto et al., 2008).   Considering 
this role in apoptotic corpse clearing and the controversial hypothesis that during cell 
competition winner cells “eat” their way through competing populations, the role of 
autophagy and its regulatory pathways were investigated in this chapter  (Li and Baker, 2007; 
Lolo et al., 2012).  
 
5.2 Results 
 
5.2.1 Cell debris in competing cultures is internalised by neighbouring wild-type 
mESCs 
 
Observation of competing wild-type and Bmpr1a-/- co-cultures show large amounts of GFP+ve 
cellular debris (see Figure 3.3).   Previous work in Drosophila illustrated that cell competition  
may progress through competing populations by wild-type neighbours “eating” their way 
through surrounding “loser” cells (Li and Baker, 2007).  To investigate whether a similar 
process was occurring during competition between mESCs, monotypic and co-cultures of 
Figure 5.1 Internalised cell debris is present in wild-type cells of competing cultures, but 
absent in monotypic cultures of wild-type and Bmpr1a-/- ESCs in the same conditions. 
(A) Monoculture of wild-type,(B) Bmpr1a-/- and (C) co-cultures of both cell lines were grown for 
3 days in GMEM+Serum, 1micron sections of colonies were examined by confocal microscopy. 
Cell nuclei were stained with DAPI, Bmpr1a-/- ESCs were labelled with GFP and cell actin 
stained with Phalloidin-TRITC. White arrows highlight Bmpr1a-/--GFP cellular debris. 
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wild-type and Bmp1a-/- mESCs were cultured for 3 days, fixed and stained.  DAPI was used 
to stain for cell nuclei, and Phalloidin-TRITC used to visualise cell actin and therefore cell 
boundaries.  To distinguish between each cell type Bmpr1a-/- -GFP mESCs were identified by 
staining for GFP.  Confocal microscopy was used to examine 1micron sections through 
colonies.   Monotypic cultures of wild-type (A) and Bmpr1a-/- (B) mESCs showed very little 
cellular debris.  However in Figure 5.1C when sections of co-cultures of wild-type and 
Bmpr1a-/- mESCs were examined we identified GFP+ve debris from Bmpr1a-/- mESCs within 
and at the cell membrane boundaries of neighbouring wild-type mESCs (white arrows). 
 
This experiment demonstrates that wild-type neighbours in competing cultures may 
internalise part of the cellular debris produced by post-apoptotic Bmpr1a-/- mESCs.  
However, there are a variety of caveats this experiment does not address such as the 
mechanisms used to internalise debris from neighbouring cells, how this debris is degraded 
and whether this is an active or passive process during cell competition.  Further experiments 
are required to co-localize debris with markers for cellular compartments, and to investigate 
how mESCs internalize neighbouring cellular debris.   
 
5.2.2 Inhibition of mTOR significantly increases cell competition  
 
The breakdown of large intracellular organelles or internalized cellular debris usually occurs 
via the autophagy pathway (Florey and Overholtzer, 2012).  One of the major regulators of 
autophagy is the serine/threonine kinase mTOR, the central component of mTORC1, a 
complex that regulates autophagy (Yang and Klionsky, 2010).    Rapamycin inhibits 
autophagy by causing disassociation of the mTORC1 complex and thus relieving inhibition 
of autophagy (Ballou and Lin, 2008; Oshiro et al., 2004; Pattingre et al., 2008).   To 
investigate whether the mTOR signalling pathway is involved in cell competition 10ng/ml 
rapamycin was added to cultures and replaced with fresh media daily.  The growth curves of 
wild-type and Bmpr1a-/- mESCs in separate and co-cultures were counted and plotted daily, 
(Figure 5.2A). In separate cultures, wild-type and Bmpr1a-/- mESCs have similar growth 
curves.   
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Figure 5.2 Inhibition of mTOR signalling significantly increases cell competition between 
wild-type and Bmpr1a-/- mESCs 
Growth curves of separate (A) and co-culture (B) wild-type and Bmpr1a-/- ESCs grown with the 
addition of 10ng/ml rapamycin to culture media compared to DMSO control separate (C) and co-
cultures (D).  (E) Ratio of wild-type to Bmpr1a-/- ESCs cultured after 4 days in the presence of 
rapamycin or DMSO and normalised to the starting ratio of cells.  In the presence of rapamycin, 
there is a significantly higher ratio of wild-type to Bmpr1a- /- ESCs (average±s.e.m n=3 p≤0.01). 
 
In co-cultures with wild-type cells, Bmpr1a-/- mESCs growth arrest after 2 days and are 
rapidly eliminated from co-cultures (Figure 5.2B).  In addition, comparison of the growth 
curves of rapamycin treated cultures compared to DMSO controls indicated a greater 
elimination of mutant cells.  After 4 days of culture the ratio of wild-type to Bmpr1a-/- mESCs 
in co-cultures was analysed by FACs. In rapamycin-treated cultures the proportion of wild-
type cells in co-culture was significantly higher than in DMSO controls shown in Figure 5.2E 
(rapamycin treated co-culture 14.36±2.09 separate 2.33±0.44 DMSO co-culture 8.74±1.15 
separate 2.37±0.26 n=3 average±s.e.m p≤0.01).   This suggests that the mTOR signalling 
pathway inhibition is sufficient to enhance cell competition, although whether it does this by 
inducing increased levels of autophagy or some other mechanism involved in nutrient or 
energy sensing is unclear. 
 
5.2.3 Inhibition of PI3K signalling to inhibit autophagy does not affect cell 
competition between wild-type and Bmpr1a-/- mESCs 
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Given the previous results, it was hypothesised that inhibition of autophagy, could prevent 
cell competition (Li and Baker, 2007).  PI3K signalling has been shown to regulate 
autophagy complexes (Blommaart et al., 1997; Yang and Klionsky, 2010).  To investigate 
whether inhibiting PI3K affects cell competition, 25µM of PI3K inhibitor LY294002 was 
added to cultures daily (Storm et al., 2007). Growth curves of separate and co-cultures treated 
with 25µM LY294002 show that LY294002 is may be highly cytotoxic to mESCs as large 
numbers of cells are lost from cultures compared to untreated DMSO control growth curves 
(Figure5.3 A-B, G-H).  Despite high numbers of cells being lost from culture, the ratio of 
wild-type to Bmpr1a-/- mESCs was analysed at day 4 of competition, but no rescue of 
Bmpr1a-/- mESCs was observed (Figure 5.3C), (ratio wild-type/Bmpr1a-/- mESCs after 4 days 
of culture LY294002 treated co-culture 13.29±0.71 separate 2.43±0.06; DMSO control 
9.44±0.34 separate 2.46±0.15 average±s.e.m n=3).  
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Due to the high levels of cell death observed in response to LY294002 addition to culture 
media, a second PI3K inhibitor, wortmannin was used (Powis et al., 1994). This was to 
determine if the lack of rescue Bmpr1a-/- mESCs was dependent on PI3K signalling inhibition 
or other non-specific effects of LY294002. Cell numbers in separate and co-cultures treated 
daily with 1µM wortmannin were counted and plotted as growth curves (Figure 5.3D-E).  In 
separate cultures wild-type and Bmpr1a-/- mESCs show similar growth curves, compared to 
DMSO controls (Figure 5.3).  However, in co-cultures, Bmpr1a-/- mESCs growth arrest after 
2 days and are gradually lost from culture. After 4 days of co-culture the ratio of wild-type to 
Bmpr1a-/- mESCs in wortmannin treated cultures was analysed by FACs and were compared 
by students’ t-test against DMSO controls. No significant differences in either separate or co-
cultures was observed, shown in Figure 5.3F (wortmannin treated co-culture 5.49±1.46 
separate 1.18±0.41 DMSO co-culture 4.18±0.53 separate 2.04±0.10 with similar ratios if just 
cell numbers are investigated and normalised back to d0 of culture co-culture 5.67±1.07 
separate 1.25±0.08 DMSO co-culture 3.71±0.48 separate 1.81±0.15 data shown as 
average±s.e.m n=3 p≤0.05).  The ratio of separate cells in DMSO cultures seems quite high 
despite similar growth curves, as cell numbers are normalised to d0, so an increase in wild-
type cell numbers compared to Bmpr1a-/- mESCs is exaggerated due to the lower starting 
proportions (40:60 wild-type/Bmpr1a-/- mESCs at d0).  However, despite higher wild-type to 
Bmpr1a-/- mESC ratios in treated cultures, PI3K signalling inhibition does not rescue of 
Bmpr1a-/- mESCs from competing cultures as there is no significant difference between ratio 
of DMSO and wortmannin treated cultures at day 4 of competition.   
 
5.2.4 Atg5-/- mESCs are out-competed upon co-culture with wild-type mESCs. 
 
AuTophaGy (ATG) proteins are major components of the autophagy pathway (Itakura and 
Mizushima, 2010).  Atg5 is required for elongation of the autophagosome membrane in 
conjunction with its partner Atg12 (Mizushima et al., 2001).  Atg5-/- mESCs were kindly 
gifted by the Mizushima lab and have been extensively characterised (Mizushima et al., 
2001).  Atg5-/- mESCs can be maintained indefinitely in culture and transgenic mice with 
random deletion of Atg5 under the control of Cre-reporter develop into neonates, suggesting 
that they can contribute to all germ layers (Mizushima and Levine, 2010; Mizushima et al., 
2001; Takamura et al., 2011) 
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Figure 5.4 Atg5-/- ESCs are lost from co-culture with wild-type ESCs 
(A) Separate and (B) co-cultures of wild-type and Atg5-/- ESCs are grown in GMEM+Serum for 4 
days and cell numbers counted daily. (C) Ratio of wild-type to Atg5-/- ESCs in separate and co-
cultures analysed daily by FACs (average±s.e.m n=3 p≤0.01). (D) Total cell number after 4 days 
of transwell co-culture.   Cells were grown as shown in Figure 4.1A with the genotype grown on 
the filter shown in brackets (n=2 average±s.e.m). 
 .  
As an alternative method of investigating autophagy in cell competition, autophagy-deficient 
Atg5-/- mESCs were competed against wild-type cells, shown in Figure 5.4. In order to 
identify each cell type, wild-type mESCs were expressing GFP. Atg5-/- and wild-type mESCS 
were cultured separately and in co-culture with cell numbers and the ratio of wild-type to 
Atg5-/- mESCs analysed daily (Figure 5.4).   
  
Wild-type and Atg5-/- mESCs grown in monoculture show similar growth curves.  However, 
in co-cultures with wild-type mESCs, Atg5-/- mESCs growth arrest and are progressively lost 
from culture  (Figure 5.4B).   To quantify the proportion of each cell type, separate and co-
cultures were analysed by FACs and the ratio of wild-type to Atg5-/- mESCs normalised to the 
starting ratio at day 0 of culture (50:50 wild-type/Atg5-/-) and plotted daily, shown in Figure 
5.4C.  By day 4 of culture, the ratio of wild-type to Atg5-/- mESCs was significantly higher in 
co-culture compared to separate cultures, indicating that autophagy-deficient Atg5-/- mESCs 
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Figure 5.5 Atg5-/- and Bmpr1a-/- mESCs do not undergo cell competition in co-culture 
Atg5-/- and Bmpr1a-/- mESCs were cultured separately and in co-culture for up to 6 days in 
GMEM+Serum.  Every 2 days the ratio of Atg5-/- to Bmpr1a-/- mESCs in separate and co-cultures 
were analysed by FACs (averages±sem n=3).   
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were out-competed by wild-type mESCs (ratio of wild-type to Atg5-/- mESCs co-culture 
5.70±1.49 separate 1.48±0.22 data shown as average±s.e.m n=3 p≤0.05).  This is similar to 
what has been observed with Bmpr1a-/- mESCs upon co-culture with wild-type cells.   It may 
be of interest to compete wild-type mESCs with other autophagy-deficient cell lines should 
also be used to investigate if this is a general response.  
 
 
Both Atg5-/- and Bmpr1a-/- mESCs are out-competed when co-cultured with wild-type cells.  
To investigate whether Atg5-/- or Bmpr1a-/- mESCs would be able to recognise each other as 
defective and therefore compete, both cell lines were cultured separately or in co-culture for 
up to 6 days in GMEM+Serum and the ratio of Atg5-/- to Bmpr1a-/- mESCs analysed every 2 
days by FACs, shown in Figure 5.5.  Interestingly, no significant difference in the ratio of 
each cell type was observed even after 6 days of co-culture (ratio of Atg5-/- to Bmpr1a-/- 
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Figure 5.6 Tetraploid (4n) ESCs are lost from co-culture with wild-type ESCs 
(A) Separate and (B) co-cultures of wild-type and 4n ESCs are grown in GMEM+Serum for 4 days and cell 
numbers counted daily. (C) Ratio of wild-type to 4n ESCs in separate and co-cultures analysed daily by 
FACs (average±s.e.m n=3 p≤0.01).  (D) Total cell number after 4 days of transwell co-culture.   Cells were 
grown as shown in Figure 4.1A with the genotype grown on the filter shown in brackets (n=2 
average±s.e.m). 
 
 
 
 
 
mESCs after 6 days of co-culture 1.27±0.06 compared to separate culture 1.12±0.10 
average±sem n=3). 
 
Previous experiments, shown in Figure 4.1, illustrated that secreted factors are involved in 
mediating cell competition between wild-type and Bmpr1a-/- mESCs.   
To investigate whether cell competition occurs between mESCs regardless of mutant 
phenotype and whether the requirement of secreted factors in mediating this process is 
general rather than genotype specific, wild-type and Atg5-/- mESCs and wild-type and 
tetraploid (4n) mESCs were investigated using the same cell competition model as wild-type 
and Bmpr1a-/- mESCs.   
 
Wild-type and Atg5-/- mESCs were grown in culture with cells of the same or different 
genotype grown in an overlying transwell to investigate the role of secreted factors during 
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competition.  Cell numbers were counted and plotted at day 4 shown in Figure 5.4D, with the 
genotype of cells in overlying transwells shown in brackets; (control (control) 30.20±1.27; 
Atg5-/- (Atg5-/-) 29.25±4.77; control (Atg5-/-) 33.90±0.21; Atg5-/- (control) 17.45±1.52 data 
shown as average±s.e.m n=2).  Despite the lack of cell-cell contract, Atg5-/- mESCs display a 
growth defect upon co-culture with wild-type mESCs suggesting wild-type mESCs release 
secreted-factor(s) that affect Atg5-/- mESC growth.  
 
Tetraploid (4n) mESCs were co-cultured with wild-type cells to observe whether they are 
also eliminated by cell competition. In separate cultures, wild-type cells have significantly 
higher cell numbers; however growth rate analysis shows no significant differences 
(Appendix Table 1).  Upon co-culture with wild-type mESCs, 4n mESCs growth arrest after 
two days and are lost from co-culture, Figure 5.6C.  This behaviour is similar to that observed 
with Bmpr1a-/- and Atg5-/- mESCs, shown in Figure 5.4.  This is reflected in a significantly 
higher ratio of wild-type/4n mESCs in co-cultures compared to separate cultures after 4 days 
of culture when populations were analysed by FACs (at day 4 of culture ratio of wild-type to 
4n mESCs co-culture 20.87±1.13 separate 8.48±2.31 average±s.e.m n=3 p≤0.05).   
 
Wild-type mESCs have been shown in this work to be able to eliminate both Bmpr1a-/- and 
Atg5-/- mESCs in the absence of cell-cell contact.  To investigate if this was also the case 
during competition between 4n and wild-type cells, cells of both genotypes were with 
transwells of the same or different genotype overlying them, as described in Figure 4.1.  After 
4 days of co-culture in transwells, cells grown in the underlying wells were counted.  
Compared to co-culture of cells with the same genotype in the overlying transwell, the 
number of 4n mESCs co-cultured with wild-type mESCs in the overlying transwell was 
lower, shown in Fig.5.6D although further experiments are required for statistical analysis 
(cell number in transwell co-culture control (control) 46.25±0.88; 4n (4n) 16.80±0.71; control 
(4n) 48.00±0.42; 4n (control) 8.85±1.31 (data shown as average±s.e.m ratios n=3 transwell 
culture n=2).  This data suggests that cell competition and the role of secreted factor(s) is a 
general mechanism between wild-type mESCs and mESCs with mutant genotypes. 
 
5.3 Discussion 
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In this chapter, the role of autophagy during cell competition was investigated. The 
observation that winner or circulating cells “eat” their surrounding loser neighbours has been 
observed in both Drosophila and mouse models of cell competition (Claveria et al., 2013; Li 
and Baker, 2007; Lolo et al., 2012; Sancho et al., 2013).  Our data confirms this as Bmpr1a-/- 
GFP+ve debris was observed within neighbouring wild-type mESCs.    This chapter aimed to 
address the role of autophagy and its regulatory pathways during cell competition between 
mESCs. 
 
Whilst mutant cell debris was observed within neighbouring wild-type mESCs during cell 
competition (Figure 5,1), this may not significantly alter the proportion of wild-type and 
mutant cells analysed by flow cytometry in separate and co-cultures.  Primarily, instances 
whereupon endocytosed cell debris was found within neighbouring cells was very rare, and 
may contribute a non-significant proportion of cells if analysed by FACs as a mutant cell 
rather than a wild-type cell.  One possible experiment to exclude the possibility of analysing 
wild-type cells with endocytosed mutant cell debris as mutant cells would be to label wild-
type and mutant cell types with separate fluorophores.  In this instance, the amount of 
endocytosed material would in most cases be much less fluorescent than the fluorophores 
expressed by the cell and would more likely result in more specific sorting by FACs. 
 
Autophagy is regulated by the mTOR signalling pathway, and acts to inhibit autophagy to 
basal levels. Rapamycin causes dissociation of the mTOR signalling complex and relieves 
autophagy from this inhibition (Ballou and Lin, 2008; Oshiro et al., 2004).  In contrast, the 
nucleation and assembly of the phagophore membrane where unwanted cellular components 
are degraded requires formation of a class III PI3K complex and PI3K inhibitors such as 
wortmannin are used to inhibit autophagy (Blommaart et al., 1997; Klionsky and Deretic, 
2010; Liang et al., 1999; Sun et al., 2008).   Whilst addition of rapamycin to competing 
cultures was sufficient to significantly increase cell competition dynamics, it was more 
difficult to interpret data from inhibiting PI3K signalling.  One of the inhibitors used, 
LY294002, was highly cytotoxic suggesting that non-specific effects could affect the 
interpretation of the data from these experiments, and no inhibition or significant reduction in 
cell competition was observed with a second inhibitor, wortmannin.   
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Two points raised in this chapter are of interest, primarily the differences in cell behaviour on 
LY294002 treatment, compared to wortmannin treatment.  Reports in the literature have 
described LY294002 non-specific effects, including affecting kinases in metabolism; DNA 
binding and transcription and ATPases, and is therefore likely to affect cell proliferation and 
survival (Gharbi et al., 2007). This data suggests that LY294002 affects cell survival in 
mESCs in a non-PI3K dependent manner, as no changes in cell growth were observed 
compared to DMSO controls when wortmannin, a second PI3K inhibitor was used.   
 
Secondly are the non-opposing effects of rapamycin induced mTOR inhibition compared to 
PI3K inhibition with wortmannin.  Ideally as they both act on opposing sides of the 
autophagy pathway, they should have opposite effects on cell competition.  However, the 
data shown in this chapter demonstrates this is not the case.  It is likely that other signalling 
pathways regulating autophagy, such as the AMPK and p53 signalling pathways are 
sufficient to mediate autophagy independent of PI3K, whereas rapamycin, which acts directly 
on mTOR, may be less susceptible to regulation by other kinases (Ravikumar et al., 2010; 
Yang and Klionsky, 2010).   
 
An alternative method to modifying the signalling pathways involved in mediating cell 
competition was to observe the behaviour of wild-type mESCs upon confrontation with 
mESCs with defective autophagy.  Upon co-culture with wild-type mESCs, Atg5-/- mESCs 
were lost from culture, reminiscent of what is observed upon Bmpr1a-/-/wild-type mESC co-
culture.  This data suggests that defects in autophagy are sufficient to induce cell competition.  
Although this experiment only partially addresses the hypothesis that autophagy is required 
for cell competition, as autophagy is required for multiple roles in the cell including energy 
homeostasis and accumulation of old or misfolded proteins (Yang and Klionsky, 2010).   
However, this experiment does begin to address the idea of cell competition as a general 
phenomenon between optimal and suboptimal cells. It begins to investigate the idea that 
differences in energy homeostasis may trigger cell competition.  As autophagy also has roles 
in energy homeostasis, it would be interesting to investigate whether differences in the 
energy-sensing machinery within cells is involved in cell competition.   This could be done 
through looking at phosphorylation of the energy-sensing kinase AMPK.  
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Interestingly, Atg5-/- mESCs were unable to recognise and out-compete Bmpr1a-/- mESCs in 
co-culture, suggesting a role for autophagy during cell competition.    This does suggest that 
components of the autophagy or energy-sensing pathways are involved in recognition of 
mutant cell lines by wild-type or winner cells during competition.  However the particular 
molecular mechanisms involved would require further study. 
   
Additionally, these experiments do not address whether winner cells in competing cultures 
“eat” their way through the losing population. Components of the autophagy machinery are 
known to be involved in phagocytosis of apoptotic corpse clearance, and this engulfment of 
neighbouring mutant neighbours has been observed during competition  (Claveria et al., 
2013; Qu et al., 2007).  It would be helpful to determine whether autophagy has an active or 
passive role during cell competition.  However, it may be that this process of eliminating 
loser neighbours during cell competition is only part of how mutant cells are removed.  It is 
likely that in addition to engulfment, loser cells are removed by apoptosis and extrusion from 
competing environments (Vincent et al., 2013).  
 
Analysis of autophagy deficient mice by development mosaic mutation models revealed that 
such mice developed multiple tumours in the liver, derived specifically from Atg5-/- 
hepatocytes, despite the presence of wild-type neighbours (Takamura et al., 2011). This is 
despite the fact that Atg5-/- cells contribute to all cell types.  There is also evidence in the 
literature to suggest that components of the autophagy pathway also function as tumour 
suppressors (Yue et al., 2003).  This suggests that competitive interactions between wild-type 
and Atg5-/- mESCs or their equivalent which could arise during development would target and 
remove these cells before they could contribute to the adult.  This would coincide with 
reports in the literature of other pro-cancerous mutations in such as Scribble; Dlg and Lgl 
mutants that are also regulated by cell competition (Chen et al., 2012; Hafezi et al., 2012; 
Menendez et al., 2010; Norman et al., 2011; Tamori et al., 2010). 
 
To continue research into the role of autophagy during cell competition it is worth 
mentioning two further components of the autophagy machinery. LC3 is expressed at the 
surface of the autophagolysosome (fusion of the autophagosome with lysosome) where 
unwanted components are degraded.  In response to increased levels of autophagy, LC3 is 
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cleaved from its original state LC3-I to a smaller fragment LC3-II and this conversion serves 
as a marker for levels of autophagy (Klionsky et al., 2008; Mizushima, 2004; Tanida et al., 
2004). Secondly p62 is a protein which recognises toxic cellular waste and is continuously 
cleared by basal levels of autophagy.   A lack of autophagy leads to accumulation of the p62 
protein therefore analysis p62 degradation is also used as a marker to examine levels of 
autophagy. (Lamark et al., 2009; Rusten and Stenmark, 2010).   Western blotting for changes 
in these markers during cell competition would be useful to discover if the autophagy 
pathways are differently regulated between winner and loser cells during competition.  
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Chapter 6 – General Discussion 
 
Cell competition has been described using a variety of model systems.  Despite the diversity 
of competition triggers, many of these models share similar hallmarks whereupon 
outcompeted cells are ultimately eliminated by apoptosis or extruded and later engulfed, and 
remaining ‘winner’ cells over-proliferate in a compensatory manner (de Beco et al., 2012; 
Levayer and Moreno, 2013; Tamori and Deng, 2011; Vincent et al., 2013).  In contrast to 
these models, other reports of cell competition, such as occupancy of the Drosophila stem 
cell niche by GSCs or of the mouse bone marrow by HSPCs do not exhibit these hallmarks.  
Instead, GSCs in the Drosophila stem cell niche become displaced and differentiate whilst 
HSPCs become senescent when outcompeted (Bondar and Medzhitov, 2010; Rhiner and 
Moreno, 2009).   
 
In the embryo, the epiblast differentiates to generate all the somatic cells of the adult and this 
process starts with formation of the three germ layers occurs during gastrulation.  Prior to 
gastrulation the epiblast rapidly proliferates to increase in cell number (Snow, 1977; Stuckey 
et al., 2011a).   During such periods of rapid proliferation the likelihood of mutated or 
mispatterned cells arising is quite high, and whilst these mutations may not be lethal, they 
could lead to defects in adult tissues or the organism.  At the onset of gastrulation, apoptosis 
in the embryo is also increased (Spruce et al., 2010).   This increase in apoptosis correlates 
with increased proliferation making it likely that cell competition is a mechanism to 
recognise and remove mispatterned or mutated cells from the embryo before they can be 
incorporated into adult tissues. 
 
This work investigated cell competition between wild-type mESCs when confronted with 
other mESCs of mutant genotypes, (shown in this work: Bmpr1a-/-; Atg5-/- and 4n mESCs). 
During the first step of differentiation (commitment from naive to primed mESCs) mutant 
cells in this model are eliminated by caspase-dependent apoptosis, rather than differentiating 
or entering senescence.  Elimination of mutant cells is accompanied by an increase in growth 
rate in winner cells (Sancho et al., 2013, and this work).  
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One hypothesis is that cell competition could be linked to changes in signal transduction, as 
secreted factors have been shown to mediate cell competition between mESCs.  A variety of 
signalling pathways mediate their effects by binding of extracellular secreted ligands to cell 
surface receptors, including the FGF and Wnt signalling pathways.  Defects in Wg have been 
shown to trigger cell competition in Drosophila (Vincent et al., 2011).  It is shown here that 
manipulation of both Wnt and FGF signalling in vitro are sufficient to determine the outcome 
of cell competition between mESCs, and after cells have begun differentiating.  These 
signalling pathways have also been shown to rescue defects caused by loss of Bmpr1a-/- in the 
embryo. In Bmpr1anull/floxSox2Cre embryos, Bmpr1a is lost specifically throughout the 
epiblast.  These mice fail to specify the AVE due to aberrant migration of the DVE, and show 
a marked reduction in expression of Wnt throughout the embryo.  Addition of Wnt ligands to 
cultured mutant embryos restores expression of Wnt signalling inhibitors, Dkk1 and Cer1, at 
the anterior side of the embryo, directing AVE migration (Miura et al., 2010).  A second 
model to study the function of BMP signalling in the epiblast was generated using the 
Mox2Cre line leading to Bmpr1a being lost in a mosaic pattern in the epiblast. These studies 
found that Bmpr1anull/floxMox2Cre embryos displayed normal AVE migration and initiated 
gastrulation.  However commitment of cell fate through the primitive streak is perturbed in 
these embryos resulting in mispatterning of paraxial mesoderm.  Interestingly the authors 
reported that inhibition of FGF signalling restores normal timing of paraxial mesoderm 
recruitment in Bmpr1anull/floxMox2Cre embryos (Miura et al., 2006).    These observations 
show that defects in BMP signalling can be rescued by changes in FGF and Wnt signalling. 
 
Could differences in signal transduction between winner and loser cells cause temporary 
stability of c-Myc in winner cells, and at the same time, cause mutant cells to begin to be 
eliminated from co-cultures (Sancho et al., 2013)?  Relative differences in c-Myc expression 
have been shown to induce cell competition in the absence of other mutations and may be a 
conserved trigger in mediating competition within Drosophila (de la Cova et al., 2004; 
Moreno and Basler, 2004); and mouse models (Claveria et al., 2013; Sancho et al., 2013).  
 
Evidence in the literature indicates c-Myc relative expression between cells is what marks 
winner cells from loser cell (Claveria et al., 2013; Sancho et al., 2013).   As both FGF and 
Wnt signalling pathways were able to affect the outcome of cell competition between 
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mESCs, the question arises whether these signalling pathways affect c-Myc stability.  The 
onset of cell competition in mESCs coincides with the differentiation of the epiblast (Claveria 
et al., 2013; Sancho et al., 2013).  Interestingly, both FGF/ERK and WNT signalling are 
involved in differentiation, and could affect cell competition due to their effects on changing 
c-Myc expression upon differentiation.  For example, inhibition of GSK3β results in 
increased c-Myc stability (Cartwright et al., 2005),  this would highlight relative changes in c-
Myc expression between winner and loser cells, resulting in the observed increase in cell 
competition.  In contrast, MEK inhibition results in decreased c-Myc stability (Ying et al., 
2008).  In this instance, the relative differences in c-Myc expression between winner and loser 
cells would be lost, allowing survival of mutant (in this work Bmpr1a-/-) mESCs. 
 
In addition to signalling pathways, the autophagy pathway was also investigated in this 
thesis.  The clearance of apoptotic cells by wild-type neighbours was shown during cell 
competition when Li and Baker observed a wild-type cell in the process of engulfing a 
neighbouring mutant cell (Li and Baker, 2007).  In addition, defects in engulfment have also 
been shown to render cells susceptible to being outcompeted when grown beside wild-type 
neighbours (Li and Baker, 2007).  In competing mESC cultures, clearance of apoptotic 
corpses/neighbouring cells by engulfment has been observed, both in this work and by others 
(Claveria et al., 2013; Sancho et al., 2013).  We investigated the role of autophagy as genes 
involved in autophagy have been shown to have a role in clearance of apoptotic corpses 
during early development. Atg5 and Beclin1 (Atg6) are both components of autophagy and 
embryoid bodies null for these genes cavitate, in that cells at the centre of the embryoid body 
undergo apoptosis.  However, the fluid-filled space at the centre of these mutant embryoid 
bodies is not formed due to persistence of apoptotic corpses (Qu et al., 2007). This suggests 
that components of the autophagy pathway may also be involved in engulfment.  We show in 
this work that Atg5-/- mESCs cells defective in autophagy but which may also be involved in 
engulfment of apoptotic corpses are removed from co-cultures by cell competition (Sancho et 
al., 2013).  It is unclear why a possible defect in engulfment results in elimination by cell 
competition, and this inability probably masks other mutations which trigger cell 
competition.  
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Another hypothesis could be that autophagy is also involved in cell competition via its roles 
in energy homeostasis.  Autophagy is induced in response to signalling pathways in the cell 
that regulate nutrient sensing and cell metabolism, such as AMP-activated protein kinase 
(AMPK) or via growth factor binding downstream of the PKB/Akt pathway (Gwinn et al., 
2008; Yang and Klionsky, 2010).  The lower growth rate of mutant cells when co-cultured 
with wild-type cells could be caused by a lower ability for nutrient uptake, due to the 
presence of faster-growing neighbours.  One hypothesis would be that loser cells increase 
autophagy in order to degrade unneeded organelles or proteins, thus allowing recycling of the 
resulting amino acids for the synthesis of proteins essential for cell survival. Autophagy 
deficient Atg5-/- mESCs also display defects linked to low levels of ATP (Qu et al., 2007).  In 
addition to low levels of ATP, Atg5-/- mESCs would be unable to degrade intracellular 
components for protein synthesis and therefore unable to cope with long periods of 
starvation, resulting in their elimination from competing cultures.    
 
Interestingly the signalling pathways identified in this thesis as affecting cell competition are 
also involved in the regulation of autophagy.  FGF signalling has been shown to directly 
stimulate autophagy (Yang and Klionsky, 2010).  In contrast, Wnt signalling has been shown 
to suppress the autophagy pathway via repression of p62 (Petherick et al., 2013).    A possible 
mechanism for the comparison of cellular fitness could be through changes in autophagy 
downstream of FGF and Wnt signals.  An alternative hypothesis is that changes in activation 
of metabolic sensing kinases (such as AMPK) caused by differences energy homeostasis and 
nutrient signalling between neighbouring cells triggers cell competition.   For example, when 
treated with rapamycin, cell competition was significantly enhanced.  This could be due to 
differences in nutrient uptake between winner and loser cells being exacerbated as 
intracellular resources are degraded faster when autophagy is stimulated.   
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Figure 6.1 Possible model for cell competition between mESCs 
Hypothetical model for how ESCs compete.  As mESCs homogenously high levels of c-Myc are 
present in all cells and no imbalances are seen.  Upon differentiation, levels of c-Myc expression are 
reduced leading to imbalances in c-Myc between competing cells.  These imbalances are mediated by 
differentiation factors such as WNT or FGF/ERK which stabilise or lower c-Myc expression.  1.  
Binding of nutrients and growth factor ligands at the cell surface of winner cells leads to increases in 
c-Myc stability.  2, Loser cells are unable to uptake ligands or nutrients due to the presence of faster 
growing neighbouring cells, therefore intracellular levels of ATP drop, leading to AMPK 
phosphorylation and upregulation of autophagy.  3. Cells sense relative differences in c-Myc and 
nutrient sensing, through an unknown mechanism (?). 4. Differences in c-Myc stability and nutrient 
uptake trigger proliferation in winner cells and apoptosis in loser cells. 
 
 
 
 
 
 
 
 
Cell competition is likely to be a multi-step process and a possible model is illustrated in 
Figure 6.1.  In competing cultures, wild-type cells would be more efficient at internalizing 
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higher levels of nutrients and specific ligands whereas loser cells would not.  Furthermore, 
due to the presence of winner cells internalising survival and growth factors faster, loser cells 
would also be subjected to a higher energy demand.  As described in the literature during 
mouse development, relative c-Myc expression between cells drives cell competition 
(Claveria et al., 2013; Sancho et al., 2013; .  It is therefore possible to hypothesise that 
internalisation of growth and signalling factors; changes in energy homeostasis or protein 
ribosynthesis result either directly or indirectly into changes in c-Myc expression within the 
cell (Claveria et al., 2013; Sancho et al., 2013).  
 
 It is also possible that these changes could co-ordinate with rates of cell differentiation, to 
avoid mispatterning of cells, as the competitive nature of cells occurs during mouse 
development, from E3.5 to E10.5 in mouse (Claveria et al., 2013).  In this environment cells 
could be continuously monitoring each other for fitness, and one mechanism is through 
relative c-Myc expression. Cells with prolonged relatively lower c-Myc would be classified as 
“unfit” or mispatterned by their neighbours. Cells would then use this mutual sensing 
mechanism to class relative levels of c-Myc expression allowing winner cells to identify loser 
cells, triggering a still unknown mechanism to remove loser cells. This would ensure that the 
epiblast is a homogenously fit population from which to derive all adult cell populations 
(Claveria et al., 2013).  It is also still not clear whether winner cells remove loser cells by 
inducing apoptosis, promoting their extrusion or engulfment or, more likely, a combination of 
these methods (Vincent et al., 2013).   
 
Once competitive interactions have been triggered, winner cells identify and remove loser 
cells from their environment.  In a number of models of cell competition loser cells 
upregulate cell stress pathways prior to apoptosis, such as  JNK signalling and this leads to 
activation of proapoptotic genes (Menendez et al., 2010; Moreno and Basler, 2004; Moreno 
et al., 2002; Portela et al., 2010; Tamori et al., 2010).   However, in this work and others, 
disruption of JNK signalling was unable to prevent competition (de la Cova et al., 2004; 
Rodrigues et al., 2012 and this work).  Therefore the mechanisms that winner cells induce 
apoptosis in loser cells could be context dependent.   Considering how efficient cell 
competition is in removing large numbers of mutant cells in cultures, it is also possible that 
multiple signalling pathways lead to differential apoptosis and proliferation during 
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competition.  There are a variety of pathways to investigate during this process.  As 
suggested earlier, removal of loser cells from competing cultures could occur via a 
combination of three different mechanisms; apoptosis; extrusion and engulfment (Vincent et 
al., 2013).  We have shown that caspase inhibition is sufficient to rescue Bmpr1a-/- mESCs 
from competition in co-culture with wild-type cells (Sancho et al., 2013).   Inhibition of RHO 
kinase has been suggested to prevent live cell extrusion (Gu et al., 2011) and it could be 
interesting to investigate whether this could rescue the elimination of mutant cells during 
competition.  Also, wild-type cells increase their growth rate in separate compared to co-
cultures, even though it is still not clear how this is regulated.  It could be that transient 
upregulation of c-Myc in winner cells prior to elimination of mutant cells also promotes 
proliferation (Sancho et al., 2013). 
 
In conclusion, cell competition illustrates that cell survival is ultimately dependent upon its 
microenvironment and neighbours within the organism.  It acts as a selection mechanism 
from very early stages during mammalian development for the fittest cells that will contribute 
to the adult.  Models of cell competition in adult tissues, such as stem cell niches, show that 
this mechanism remains active throughout the lifespan of the organism.  It is possible that 
competitive interactions also occur when tissues start proliferating such as in cancer and 
tissue regeneration following injury, as well as during development (Oertel et al., 2006; 
Stuckey et al., 2011a). In the case of cancer, it is possible that cell competition selects for 
mutated faster growing cells, particularly if the mutation results in upregulation of c-Myc in 
cancerous cells.  In these cases, an understanding of cell competition may help provide 
therapies to prevent mutant cells from eliminating un-mutated neighbours and prevent 
metastasis. Therefore, the study of cell competition, its triggers and mechanism are 
instrumental in understanding cell survival in a variety of contexts.   
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Appendix 
A.1 Growth Rates=Ln (final number of cells/initial number of cells) / 
LN (2) 
Appendix Table 1 – Master List of Growth Rates 
  Growth Rate Control and Bmpr1a-/- (GFP) in GMEM+Serum 
   
 
Control 
       
 
Separate Co-culture t-test 
     D0-1 0.94±0.33 1.05±0.32 0.86 
     D1-2 1.75±0.25 1.67±0.25 0.61 
     D2-3 1.00±0.15 1.27±0.16 0.05 
     D3-4 0.45±0.13 0.64±0.09 0.02 
     
         
 
Bmpr1a-/- 
       
 
Separate Co-culture t-test 
     D0-1 0.43±0.25 0.75±0.2 0.07 
     D1-2 1.67±0.18 1.73±0.22 0.71 
     D2-3 0.86±0.04 0.09±0.18 0.02 
     D3-4 0.39±0.15 -0.44±0.24 0.07 
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         Growth Rate Control (GFP) and Atg5-/-  in GMEM+Serum 
   
 
Control 
       
 
Separate Co-culture t-test 
     D0-1 1.01±0.18 1.17±0.17 0.50 
     D1-2 1.59±0.12 1.42±0.08 0.47 
     D2-3 0.79±0.14 1.12±0.04 0.06 
     D3-4 0.43±0.04 0.40±0.06 0.53 
     
         
 
Atg5-/- 
       
 
Separate Co-culture t-test 
     D0-1 1.16±0.22 1.04±0.023 0.48 
     D1-2 1.48±0.1 1.19±0.12 0.33 
     D2-3 0.34±0.25 0.07±0.2 0.15 
     D3-4 0.21±0.23 0.51±0.18 0.00 
     
         Growth Rate Control and 4n (tetraploid) in GMEM+Serum 
   
 
Control 
       
 
Separate Co-culture t-test 
     D0-1 1.16±0.08 1.08±0.14 0.67 
     D1-2 1.69±0.10 1.76±0.24 0.78 
     D2-3 0.71±0.12 1.18±0.14 0.02 
     D3-4 0.49±0.08 0.87±0.07 0.01 
     
         
 
4n (tetraploid) 
      
 
Separate Co-culture t-test 
     D0-1 0.79±0.24 0.72±0.30 0.56 
     D1-2 0.91±0.17 1.32±0.25 0.22 
     D2-3 0.28±0.05 0.66±0.10 0.01 
     D3-4 0.27±0.12 -0.58±0.07 0.02 
     
         Growth Rate Control and Bmpr1a-/- mESCs in 
transwell 
    
         
 
Control 
       
 
Separate Co-culture t-test 
     D2-3 0.85±0.33 0.66±0.08 
      D3-4 0.41±0.16 0.23±0.03 
      
         
 
Bmpr1a-/- 
       
 
Separate Co-culture t-test 
     D2-3 0.76±0.20 0.11±0.08 
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D3-4 0.21±0.16 0.06±0.18 
      
         
 
Growth Rate Control +Bmpr1a-/- in 10ng/ml rapamycin 
  
 
Day 0 
       
 
Control - 10ng/ml rapamycin 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.08±0.13 1.31±0.18 0.38 
 
1.55±0.19 1.50±0.23 0.73 
 D1-2 1.24±0.14 1.28±0.13 0.94 
 
1.17±0.34 1.38±0.35 0.16 
 D2-3 0.50±0.33 1.39±0.12 0.25 
 
0.54±0.29 0.90±0.14 0.33 
 D3-4 0.63±0.21 0.50±0.22 0.85 
 
0.49±0.24 0.70±0.06 0.54 
 
         
 
Bmpr1a-/- - 10ng/ml rapamycin 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.41±0.11 1.43±0.23 0.94 
 
1.50±0.16 1.59±0.21 0.37 
 D1-2 0.73±0.04 0.74±0.17 0.96 
 
1.03±0.21 0.91±0.30 0.46 
 D2-3 0.38±0.09 -0.47±0.12 0.09 
 
0.35±0.04 -0.21±0.11 0.03 
 D3-4 0.28±0.10 -0.74±0.16 0.02 
 
0.40±0.04 -0.55±0.07 0.00 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 1µM wortmannin 
  
 
Day 0 
       
 
Control - 1µM wortmannin 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.61±0.13 0.43±0.12 0.33 
 
0.69±0.06 0.57±0.12 0.41 
 D1-2 0.77±0.12 1.45±0.17 0.04 
 
1.63±0.01 1.68±0.03 0.47 
 D2-3 0.52±0.10 0.71±0.06 0.09 
 
0.26±0.07 0.95±0.22 0.09 
 D3-4 0.66±0.10 0.97±0.19 0.78 
 
1.14±0.08 0.94±0.13 0.11 
 
         
 
Bmpr1a-/- - 1µM wortmannin 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.69±0.12 0.21±0.09 0.03 
 
0.75±0.08 0.52±0.05 0.34 
 D1-2 1.36±0.04 1.47±0.13 0.50 
 
1.70±0.11 1.81±0.06 0.61 
 D2-3 0.82±0.12 0.73±0.04 0.41 
 
0.41±0.14 0.36±0.14 0.86 
 D3-4 0.06±0.03 -0.83±0.17 0.05 
 
0.23±0.06 -0.44±0.23 0.20 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 10µM SB431542 
  
 
Day 0 
       
 
Control - 10µM SB431542 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.29±0.18 1.15±0.26 0.39 
 
1.29±0.18 1.50±0.16 0.14 
 D1-2 0.82±0.02 0.49±0.17 0.29 
 
1.49±0.19 1.08±0.03 0.19 
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D2-3 1.30±0.14 1.43±0.06 0.35 
 
0.90±0.02 1.70±0.14 0.02 
 D3-4 0.35±0.03 0.58±0.02 0.02 
 
0.36±0.27 0.59±0.05 0.27 
 
         
 
Bmpr1a-/- - 10µM SB431542 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.92±0.20 0.90±0.26 0.89 
 
1.20±0.19 1.20±0.13 1.00 
 D1-2 1.03±0.11 1.10±0.17 0.71 
 
1.15±0.15 1.02±0.05 0.47 
 D2-3 1.08±0.10 1.15±0.17 0.55 
 
0.63±0.11 -0.14±0.33 0.14 
 D3-4 0.25±0.11 -0.05±0.07 0.24 
 
0.37±0.06 -0.51±0.06 0.00 
 
         
 
Day 2 
       
 
Control - 10µM SB431542 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.88±0.04 1.30±0.04 0.02 
 
0.88±0.04 1.30±0.04 0.02 
 D1-2 2.07±0.10 1.31±0.03 0.10 
 
2.07±0.10 1.31±0.03 0.10 
 D2-3 0.43±0.09 1.13±0.04 0.22 
 
0.67±0.08 1.35±0.08 0.28 
 D3-4 0.51±0.07 0.66±0.07 0.70 
 
0.53±0.02 0.90±0.15 0.38 
 
         
 
Bmpr1a-/- - 10µM SB431542 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.87±0.02 0.99±0.06 0.58 
 
0.87±0.02 0.99±0.06 0.58 
 D1-2 1.37±0.01 1.34±0.01 0.14 
 
1.37±0.01 1.34±0.01 0.14 
 D2-3 0.58±0.08 0.02±0.06 0.05 
 
0.78±0.02 0.01±0.08 0.16 
 D3-4 0.18±0.06 -0.71±0.01 0.07 
 
0.22±0.07 -0.32±0.16 0.21 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in LIF 
    
 
Day 0 
       
 
Control - LIF 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.70±0.25 0.61±0.21 0.79 
 
1.07±0.13 1.17±0.26 0.64 
 D1-2 2.01±0.15 2.12±0.18 0.69 
 
1.69±0.14 1.30±0.10 0.06 
 D2-3 1.12±0.08 0.84±0.19 0.24 
 
0.60±0.22 1.11±0.10 0.21 
 D3-4 0.41±0.11 0.36±0.24 0.84 
 
0.68±0.18 1.15±0.13 0.06 
 
         
 
Bmpr1a-/- - LIF 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.52±0.14 0.48±0.13 0.91 
 
0.73±0.04 1.02±0.08 0.11 
 D1-2 2.01±0.17 2.09±0.13 0.85 
 
1.39±0.08 1.47±0.11 0.65 
 D2-3 0.86±0.09 0.95±0.14 0.65 
 
0.57±0.12 -0.11±0.08 0.02 
 D3-4 0.40±0.08 0.58±0.21 0.43 
 
0.43±0.13 -0.65±0.05 0.05 
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Day 2 
       
 
Control - LIF 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.80±0.36 0.96±0.19 0.61 
 
0.80±0.36 0.96±0.19 0.61 
 D1-2 1.84±0.33 1.43±0.07 0.43 
 
1.84±0.33 1.42±0.07 0.42 
 D2-3 0.67±0.07 1.13±0.07 0.03 
 
0.71±0.11 1.17±0.06 0.02 
 D3-4 0.51±0.06 0.84±0.17 0.23 
 
0.44±0.01 0.92±0.11 0.08 
 
         
 
Bmpr1a-/- - LIF 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.72±0.07 0.89±0.10 0.40 
 
0.72±0.07 0.89±0.10 0.40 
 D1-2 1.48±0.05 1.53±0.06 0.78 
 
1.48±0.05 1.52±0.06 0.82 
 D2-3 0.59±0.08 0.16±0.02 0.04 
 
0.51±0.10 0.06±0.07 0.02 
 D3-4 0.42±0.15 -0.37±0.09 0.04 
 
0.43±0.07 -0.81±0.11 0.03 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 1µM PD0325901 
  
 
Day 0 
       
 
Control - 1µM PD0325901 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.00±0.17 0.29±.12 0.21 
 
0.72±0.14 0.68±0.09 0.92 
 D1-2 1.02±0.18 1.38±0.21 0.58 
 
1.53±0.12 1.33±0.13 0.61 
 D2-3 1.17±0.10 1.48±0.25 0.62 
 
1.19±0.14 1.10±0.05 0.32 
 D3-4 0.63±0.14 0.44±0.11 0.61 
 
0.53±0.08 1.10±0.06 0.08 
 
         
 
Bmpr1a-/- - 1µM PD0325901 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.19±0.13 0.48±0.12 0.28 
 
0.10±0.13 0.80±0.11 0.03 
 D1-2 1.20±0.08 1.24±0.08 0.88 
 
1.45±0.17 1.28±0.08 0.57 
 D2-3 1.02±0.14 1.06±0.09 0.93 
 
0.63±0.25 0.22±0.08 0.28 
 D3-4 0.65±0.014 0.72±0.08 0.70 
 
0.71±0.14 -0.31±0.16 0.01 
 
         
 
Day 2 
       
 
Control - 1µM PD0325901 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.34±0.04 0.59±0.08 0.21 
 
1.25±0.04 0.59±0.08 0.21 
 D1-2 1.30±0.03 1.33±0.02 0.85 
 
1.30±0.03 1.33±0.02 0.85 
 D2-3 0.28±0.00 1.27±0.03 0.03 
 
0.92±0.15 1.29±0.11 0.61 
 D3-4 0.78±0.04 0.26±0.07 0.26 
 
0.32±0.12 1.05±0.10 0.34 
 
         
 
Bmpr1a-/- - 1µM PD0325901 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
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D0-1 0.12±0.19 0.51±0.08 0.33 
 
0.12±0.19 0.51±0.08 0.33 
 D1-2 1.15±0.19 1.00±0.04 0.72 
 
1.15±0.19 1.00±0.04 0.72 
 D2-3 0.75±0.06 0.22±0.01 0.17 
 
0.90±0.01 0.48±0.08 0.26 
 D3-4 0.75±0.10 1.02±0.17 0.33 
 
0.49±0.06 -0.29±0.03 0.15 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 2µM PD184352 
  
 
Day 0 
       
 
Control -  2µM PD184352 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.74±0.09 1.09±0.10 0.08 
 
0.90±0.12 1.01±0.07 0.45 
 D1-2 1.89±0.19 1.13±0.14 0.16 
 
1.73±0.11 1.36±0.10 0.28 
 D2-3 0.75±0.10 0.99±0.05 0.37 
 
0.99±0.05 1.33±0.03 0.11 
 D3-4 0.45±0.12 0.58±0.12 0.30 
 
0.55±0.17 0.98±0.18 0.02 
 
         
 
Bmpr1a-/- - 2µM PD184352 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.71±0.13 1.10±0.16 0.02 
 
0.75±0.14 1.00±0.16 0.33 
 D1-2 1.58±0.09 1.30±0.13 0.12 
 
1.50±0.15 1.42±0.04 0.78 
 D2-3 0.75±0.06 0.62±0.07 0.21 
 
0.61±0.06 0.19±.07 0.14 
 D3-4 0.33±0.07 0.53±0.14 0.55 
 
0.51±0.12 -0.35±0.08 0.02 
 
         
 
Day 2 
       
 
Control - 2µM PD184352 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.99±0.15 0.85±0.02 0.53 
 
0.99±0.15 0.85±0.02 0.53 
 D1-2 1.57±0.20 1.31±0.05 0.49 
 
1.57±0.20 1.31±0.05 0.49 
 D2-3 0.67±0.13 1.42±0.07 0.02 
 
0.87±0.07 1.41±0.04 0.01 
 D3-4 0.53±0.09 0.66±0.11 0.39 
 
0.58±0.09 1.08±0.15 0.05 
 
         
 
Bmpr1a-/- - 2µM PD184352 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.74±0.24 0.86±0.11 0.57 
 
0.74±0.24 0.86±0.11 0.57 
 D1-2 1.40±0.19 1.40±0.03 0.99 
 
1.40±0.19 1.40±0.03 0.99 
 D2-3 0.59±0.08 0.24±0.13 0.04 
 
0.77±0.05 0.36±0.09 0.02 
 D3-4 0.48±0.05 0.13±0.08 0.08 
 
0.46±0.02 -0.30±0.02 0.00 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 12.5µM PD98059 
  
 
Day 0 
       
 
Control - 12.5µM PD98059 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
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D0-1 1.00±0.24 1.08±.16 0.59 
 
1.26±0.19 1.35±.17 0.57 
 D1-2 1.49±0.14 1.27±0.15 0.01 
 
1.45±0.12 1.17±0.12 0.05 
 D2-3 1.08±0.01 1.31±0.07 0.12 
 
0.98±0.08 1.50±0.03 0.08 
 D3-4 0.36±0.11 0.92±0.06 0.03 
 
0.57±0.05 0.87±0.06 0.00 
 
         
 
Bmpr1a-/- - 12.5µM PD98059 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.87±0.22 0.93±0.22 0.72 
 
0.97±0.26 1.17±0.22 0.26 
 D1-2 1.24±0.19 1.35±0.12 0.67 
 
1.36±0.18 1.16±.09 0.26 
 D2-3 0.81±0.07 0.13±0.05 0.04 
 
0.41±0.05 -0.45±0.02 0.00 
 D3-4 0.43±0.02 0.05±0.09 0.10 
 
0.62±0.09 -0.22±0.11 0.02 
 
         
 
Day 2 
       
 
Control - 12.5µM PD98059 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.39±0.19 1.34±0.19 0.67 
 
1.39±0.19 1.34±0.19 0.67 
 D1-2 1.20±0.17 1.14±0.16 0.81 
 
1.20±0.17 1.14±0.16 0.81 
 D2-3 0.92±0.09 1.50±0.00 0.04 
 
1.02±0.10 1.56±0.01 0.05 
 D3-4 0.39±0.03 0.70±0.07 0.12 
 
0.60±0.10 0.78±0.04 0.22 
 
         
 
Bmpr1a-/- - 12.5µM PD98059 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.94±0.25 1.10±0.23 0.24 
 
0.94±0.25 1.10±0.23 0.24 
 D1-2 1.32±0.16 1.16±0.13 0.35 
 
1.32±0.16 1.16±0.13 0.35 
 D2-3 0.76±0.03 -0.11±0.03 0.01 
 
0.63±0.07 -0.15±0.03 0.02 
 D3-4 0.29±0.06 -0.31±0.12 0.03 
 
0.52±0.07 -0.38±0.15 0.03 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 10µM U0126 
   
 
Day 0 
       
 
Control - 10µM U0126 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.36±0.02 1.58±0.03 0.01 
 
1.20±0.17 1.72±.06 0.51 
 D1-2 1.06±0.02 0.82±0.03 0.02 
 
1.18±.17 0.96±0.02 0.48 
 D2-3 0.80±0.02 1.03±0.02 0.04 
 
1.05±0.06 1.25±.05 0.21 
 D3-4 0.43±0.12 0.57±0.15 0.31 
 
0.39±0.03 1.05±.04 0.02 
 
         
 
Bmpr1a-/- - 10µM U0126 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.80±0.14 1.28±0.07 0.04 
 
0.98±0.16 1.28±.05 0.21 
 D1-2 1.17±0.15 0.88±0.06 0.31 
 
1.31±0.09 1.14±0.01 0.37 
 D2-3 0.78±0.05 0.69±0.09 0.36 
 
0.45±0.11 -0.35±0.03 0.02 
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D3-4 0.22±0.05 0.11±0.14 0.62 
 
0.38±.04 -0.49±0.03 0.00 
 
         
 
Day 2 
       
 
Control - 10µM U0126 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.50±0.06 1.55±0.08 0.82 
 
1.50±0.06 1.55±0.08 0.82 
 D1-2 1.58±0.21 1.09±0.05 0.31 
 
1.58±0.21 1.09±0.05 0.31 
 D2-3 0.62±0.16 1.27±0.10 0.03 
 
0.61±0.26 1.26±0.01 0.21 
 D3-4 -0.07±0.05 0.47±0.13 0.09 
 
0.30±0.17 0.71±0.04 0.15 
 
         
 
Bmpr1a-/- - 10µM U0126 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.00±0.15 1.31±0.04 0.17 
 
1.00±0.15 1.31±0.04 0.17 
 D1-2 1.38±0.17 1.10±0.08 0.29 
 
1.38±0.17 1.10±0.08 0.29 
 D2-3 0.44±0.10 -0.07±0.04 0.12 
 
0.45±0.10 -0.13±0.06 0.04 
 D3-4 0.01±0.07 -0.99±0.17 0.07 
 
0.26±0.09 -0.65±0.03 0.03 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 100ng/ml PD173074 
  
 
Day 0 
       
 
Control - 100ng/ml PD173074 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.90±0.12 0.96±0.13 0.90 
 
1.22±0.08 1.19±.08 0.69 
 D1-2 1.54±0.12 0.97±0.20 0.10 
 
1.53±0.06 1.35±0.15 0.41 
 D2-3 0.75±0.15 1.02±0.06 0.25 
 
0.99±.13 1.18±0.16 0.76 
 D3-4 0.44±0.18 0.48±0.12 0.58 
 
0.57±0.11 0.90±0.08 0.08 
 
         
 
Bmpr1a-/- - 100ng/ml PD173074 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.44±0.15 0.74±0.14 0.01 
 
0.51±0.04 0.92±0.13 0.02 
 D1-2 1.05±0.11 1.00±0.25 0.29 
 
1.42±0.17 1.13±0.23 0.21 
 D2-3 0.80±0.07 0.92±0.03 0.36 
 
0.48±.02 -0.08±0.12 0.03 
 D3-4 0.58±.10 0.45±0.18 0.88 
 
0.59±.06 -0.53±.30 0.15 
 
         
 
Day 2 
       
 
Control - 100ng/ml PD173074 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.19±0.08 0.65±0.21 0.17 
 
1.19±.08 0.66±0.21 0.18 
 D1-2 1.47±0.08 1.82±0.14 0.12 
 
1.47±.08 1.81±0.14 0.12 
 D2-3 0.73±0.01 1.00±0.07 0.11 
 
0.78±0.01 1.01±0.10 0.19 
 D3-4 0.10±0.07 0.34±0.20 0.30 
 
0.61±0.02 1.25±.15 0.08 
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Bmpr1a-/- - 100ng/ml PD173074 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.27±0.07 0.27±0.17 0.99 
 
0.27±0.07 0.26±0.17 0.96 
 D1-2 1.74±.05 1.83±0.12 0.45 
 
1.74±0.05 1.84±0.11 0.42 
 D2-3 0.09±.04 -0.53±0.02 0.01 
 
0.38±0.04 0.03±0.05 0.02 
 D3-4 0.42±0.05 0.15±0.14 0.18 
 
0.64±0.06 -0.51±0.10 0.03 
 
         
         
 
Control - 5ng/ml FGF4 
  
Control 1ug/ml Heparin 
 
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.22±0.10 1.29±0.13 0.71 
 
1.61±0.13 1.40±0.25 0.82 
 D1-2 1.62±0.10 1.26±0.06 0.19 
 
1.50±0.09 1.28±0.15 0.44 
 D2-3 0.62±0.06 1.27±0.07 0.02 
 
0.63±0.08 1.13±0.18 0.06 
 D3-4 0.71±0.11 1.03±0.13 0.09 
 
0.38±0.13 1.01±0.08 0.00 
 
         
 
Bmpr1a-/- - 100ng/ml PD173074 
 
Bmpr1a-/- 1ug/ml Heparin 
 
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.90±0.04 1.06±0.16 0.61 
 
0.97±0.07 1.19±0.08 0.68 
 D1-2 1.44±0.07 1.36±0.09 0.21 
 
1.52±0.07 1.31±0.11 0.95 
 D2-3 0.54±0.14 -0.09±0.13 0.04 
 
0.39±0.06 -0.26±0.18 0.03 
 D3-4 0.44±0.06 -0.60±0.12 0.04 
 
0.22±0.07 -0.58±0.06 0.00 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 10ng/ml FGF5 
   
 
Day 0 
       
 
Control - 10ng/ml FGF5 
  
Control 1ug/ml Heparin 
 
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.27±0.02 1.22±0.14 0.52 
 
1.61±0.13 1.40±0.25 0.82 
 D1-2 1.67±0.05 1.5±0.08 0.54 
 
1.50±0.09 1.28±0.15 0.44 
 D2-3 0.53±0.03 0.91±0.07 0.08 
 
0.63±0.08 1.13±0.18 0.06 
 D3-4 0.57±0.02 1.16±0.02 0.02 
 
0.38±0.13 1.01±0.08 0.00 
 
         
 
Bmpr1a-/- - 10ng/ml FGF5 
 
Bmpr1a-/- 1ug/ml Heparin 
 
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.83±0.10 0.97±0.16 0.43 
 
0.97±0.07 1.19±0.08 0.68 
 D1-2 1.56±0.08 1.57±0.07 0.49 
 
1.52±0.07 1.31±0.11 0.95 
 D2-3 0.47±0.12 -0.21±0.12 0.19 
 
0.39±0.06 -0.26±0.18 0.03 
 D3-4 0.23±0.05 -0.95±0.04 0.02 
 
0.22±0.07 -0.58±0.06 0.00 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 2µM IWR-1 
   
 
Day 0 
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Control - 2µM IWR-1 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.23±0.07 1.17±0.06 0.13 
 
1.48±0.15 1.17±.12 0.36 
 D1-2 1.57±0.10 1.46±.15 0.31 
 
1.40±0.19 1.55±0.13 0.76 
 D2-3 0.53±0.05 1.07±0.10 0.04 
 
0.52±.05 1.06±0.11 0.14 
 D3-4 0.44±0.03 0.80±0.10 0.08 
 
0.52±0.05 0.78±0.14 0.17 
 
         
 
Bmpr1a-/- - 2µM IWR-1 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.62±0.06 1.04±0.08 0.17 
 
1.07±0.07 0.97±.11 0.72 
 D1-2 1.85±0.11 1.38±0.18 0.10 
 
1.26±0.19 1.60±.12 0.50 
 D2-3 0.12±0.10 -0.50±0.16 0.03 
 
0.35±0.10 -0.37±0.09 0.04 
 D3-4 0.52±.05 -0.54±0.19 0.05 
 
0.45±0.04 -0.22±0.08 0.03 
 
         
 
Day 2 
       
 
Control - 2µM IWR-1 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.25±0.06 1.20±0.04 0.54 
 
1.25±0.06 1.20±.04 0.54 
 D1-2 1.58±.02 1.47±0.07 0.49 
 
1.58±0.02 1.47±0.07 0.49 
 D2-3 0.64±0.10 1.08±0.04 0.10 
 
0.44±0.04 1.06±0.05 0.03 
 D3-4 0.45±0.12 0.73±0.11 0.01 
 
0.49±.05 0.61±0.06 0.01 
 
         
 
Bmpr1a-/- - 2µM IWR-1 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.95±0.11 1.01±.06 0.63 
 
0.95±0.11 1.01±.06 0.63 
 D1-2 1.43±0.25 1.48±0.13 0.79 
 
1.43±0.25 1.48±.13 0.79 
 D2-3 0.35±0.11 -0.37±0.08 0.01 
 
0.39±0.12 -0.33±0.15 0.00 
 D3-4 0.35±0.03 -0.51±0.13 0.06 
 
0.31±0.04 -0.32±0.07 0.05 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 2µM IWP-2 
   
 
Day 0 
       
 
Control - 2µM IWP-2 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.56±0.23 0.90±0.20 0.05 
 
1.09±0.04 1.20±0.11 0.49 
 D1-2 2.05±0.26 1.50±0.26 0.35 
 
1.70±0.18 1.31±.16 0.04 
 D2-3 0.66±0.26 1.24±.17 0.39 
 
0.51±0.17 1.11±0.08 0.09 
 D3-4 0.27±0.07 0.71±0.21 0.15 
 
0.42±0.12 0.71±.11 0.09 
 
         
 
Bmpr1a-/- - 2µM IWP-2 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.19±0.03 0.88±.15 0.23 
 
1.00±0.05 1.22±0.15 0.45 
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D1-2 1.20±0.12 1.63±0.17 0.37 
 
1.53±0.14 1.36±.25 0.48 
 D2-3 0.20±0.17 -0.38±0.17 0.04 
 
0.30±0.07 -0.34±0.21 0.12 
 D3-4 0.39±.11 -0.66±0.20 0.07 
 
0.22±0.05 -0.30±0.12 0.17 
 
         
 
Day 2 
       
 
Control - 2µM IWP-2 
  
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 0.92±0.16 1.03±0.11 0.69 
 
0.92±0.16 1.03±0.11 0.69 
 D1-2 1.71±0.21 1.33±0.09 0.46 
 
1.71±.21 1.33±0.09 0.46 
 D2-3 0.66±0.15 1.21±0.03 0.14 
 
0.62±.12 1.33±0.12 0.15 
 D3-4 0.42±0.09 0.81±0.15 0.08 
 
0.40±.10 0.61±0.21 0.31 
 
         
 
Bmpr1a-/- - 2µM IWP-2 
  
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.29±.07 0.88±0.10 0.05 
 
1.29±.07 0.88±0.10 0.05 
 D1-2 1.08±0.14 1.54±.08 0.10 
 
1.08±0.14 1.54±.08 0.10 
 D2-3 0.36±0.11 -0.25±0.21 0.09 
 
0.36±0.16 -0.20±0.22 0.08 
 D3-4 0.29±0.04 -0.44±0.19 0.15 
 
0.39±0.11 -0.27±.19 0.08 
 
         
         
 
Growth Rate Control +Bmpr1a-/- in 3µM CHIRON99201 
  
 
Day 0 
       
 
Control - 3µM CHIRON99201 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.06±0.11 1.55±0.09 0.02 
 
1.40±0.58 1.56±0.10 0.58 
 D1-2 1.49±0.09 1.27±0.07 0.04 
 
1.43±0.04 0.92±0.13 0.10 
 D2-3 0.86±0.01 0.53±0.05 0.03 
 
0.73±0.15 1.33±0.11 0.02 
 D3-4 0.79±0.01 0.78±0.08 0.91 
 
0.71±0.10 1.13±0.08 0.05 
 
         
 
Bmpr1a-/- - 3µM CHIRON99201 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.15±0.04 1.34±0.02 0.16 
 
1.16±0.12 1.43±0.04 0.32 
 D1-2 1.19±0.08 1.28±0.03 0.45 
 
1.11±0.05 1.08±0.10 0.92 
 D2-3 0.76±0.07 0.59±0.01 0.29 
 
0.52±0.07 -0.30±0.04 0.00 
 D3-4 0.64±.04 0.60±0.10 0.85 
 
0.57±0.14 -0.48±0.22 0.07 
 
         
 
Day 2 
       
 
Control - 3µM CHIRON99201 
 
Control DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.37±0.17 1.29±0.13 0.72 
 
1.37±0.17 1.29±0.13 0.72 
 D1-2 1.46±0.07 1.35±0.22 0.30 
 
1.46±0.07 1.19±0.15 0.30 
 D2-3 0.67±0.14 0.88±0.23 0.03 
 
0.71±0.09 1.24±0.11 0.05 
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D3-4 0.62±0.14 1.01±0.14 0.06 
 
0.70±.12 1.14±0.09 0.11 
 
         
 
Bmpr1a-/- - 3µM CHIRON99201 
 
Bmpr1a-/- DMSO 
  
 
separate co-culture t-test 
 
separate co-culture t-test 
 D0-1 1.04±0.15 1.15±0.11 0.93 
 
1.04±0.15 1.15±0.11 0.93 
 D1-2 1.35±0.17 1.16±0.22 0.30 
 
1.35±.17 1.36±0.13 0.30 
 D2-3 0.55±0.07 0.41±0.24 0.01 
 
0.47±0.13 -0.11±0.11 0.02 
 D3-4 0.50±0.10 -0.14±0.07 0.00 
 
0.53±0.08 -0.39±0.15 0.02 
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 Appendix Table 2 - Ratio of wild-type/Bmpr1a-/- mESCs after 3 days of culture All 
data normalised to ratio after 3 days of culture. 
 All data shown as average ±s.e.m; unless otherwise stated n=3 
   
         
 
1µM PD0325901 DMSO t-test 
    co-culture 1.15 
 
2.95 
     separate 0.47 
 
0.65 n=1 
    
         
 
2µM PD184352 DMSO 
     co-culture 2.21±0.19 
 
2.36±0.21 0.14 
    separate 1.62±0.22 
 
1.60±0.11 
     
         
 
12.5µM PD98059 DMSO 
     co-culture 2.61±0.43 
 
2.51±0.13 0.79 
    separate 1.12±0.23 
 
1.41±0.17 
     
         
 
10µM U0126 DMSO 
     co-culture 2.71±0.31 
 
3.14±0.09 0.26 
    separate 1.25±0.30 
 
1.40±0.12 
     
         
 
100ng/ml PD173074 DMSO 
     co-culture 1.90±0.34 
 
2.10±0.20 n=2 
    separate 0.84±0.16 
 
1.05±0.24 
      
A.2 Ratio wild-type/Bmpr1a-/- mESCs normalised to day 3 of treatment 
